e424b5
Prospectus supplement to prospectus dated March 30,
2006
Filed Pursuant to Rule 424(b)(5) and (b)(7)
A filing fee of $171,200, calculated in accordance with
Rule 457(r), has been transmitted to the SEC in connection
with the securities offered from the registration
statement
(File No.333-132865) by means of this prospectus
supplement.
Intel Corporation
$1,600,000,000
2.95% Junior Subordinated Convertible Debentures due
2035
and
Shares of Common Stock Issuable Upon Conversion of the
Debentures
We originally issued these debentures in private placement
transactions in December 2005. This prospectus supplement and
the accompanying prospectus will be used by selling
securityholders to resell their debentures and the common stock
issuable upon conversion of the debentures.
The debentures will bear interest at a rate of 2.95% per
year until December 15, 2035. Interest on the debentures
will be payable semi-annually in arrears on June 15 and December
15 of each year, beginning June 15, 2006. In addition to
regular interest on the debentures, beginning with the
semi-annual interest period commencing on December 15,
2010, contingent interest will accrue during any semi-annual
interest period where the average trading price of a debenture
for the 10 trading day period immediately preceding the
first day of such semi-annual period is greater than or equal to
$1,300 per $1,000 principal amount of the debentures or is
less than or equal to a threshold that will initially be set at
$800 per $1,000 principal amount of the debentures and that
will increase over time. We will also pay contingent interest
equal to any extraordinary cash dividend or distribution that
our board of directors designates as payable to the holders of
the debentures. In addition, so long as we are not in default in
the payment of interest on the debentures, we may defer payment
of interest on the debentures for a period not exceeding 10
consecutive semi-annual interest payment periods, during which
time interest will continue to accrue on a compounded basis.
Holders may convert their debentures into shares of our common
stock at their option at any time prior to the close of business
on the trading day immediately preceding the maturity date. The
initial conversion rate is 31.7162 shares of our common
stock per $1,000 principal amount of debentures, equivalent to a
conversion price of approximately $31.53 per share of
common stock. The conversion rate is subject to adjustment in
some events but will not be adjusted for accrued interest. In
addition, we will increase the conversion rate for a holder who
elects to convert its debentures in connection with certain
fundamental changes.
We may not redeem the debentures prior to December 15,
2012, except in connection with certain tax-related events. On
or after that date, we may redeem all or part of the debentures
for cash at 100% of the principal amount of the debentures to be
redeemed, plus accrued and unpaid interest to, but excluding,
the redemption date, if the last reported sale price of our
common stock has been at least 130% of the conversion price then
in effect for at least 20 trading days during any 30 consecutive
trading day period prior to the date on which we provide notice
of redemption. On or prior to June 12, 2006, we may also
redeem all or part of the debentures for cash at a premium if
certain U.S. federal tax legislation, regulations or rules
are enacted or are issued.
If we undergo a fundamental change, holders may require us to
purchase all or a portion of their debentures at a price equal
to 100% of the principal amount of the debentures to be
purchased plus any accrued and unpaid interest up to, but
excluding, the purchase date. We will pay cash or, in certain
circumstances, stock or a combination of cash and stock, for all
debentures so purchased.
The debentures are our unsecured junior obligations subordinated
in right of payment to our existing and future senior debt and
effectively subordinated in right of payment to all indebtedness
and other liabilities of our subsidiaries. As of
December 31, 2005, the aggregate amount of our outstanding
senior debt was approximately $171.9 million, and the
aggregate amount of indebtedness and other liabilities of our
subsidiaries was approximately $2.8 billion, excluding
intercompany liabilities and liabilities of a type not required
to be reflected on the balance sheet of such subsidiaries in
accordance with generally accepted accounting principles.
Since their initial issuance, the debentures have been eligible
for trading on the PORTAL Market of the National Association of
Securities Dealers, Inc. However, debentures sold by means of
this prospectus supplement will no longer be eligible for
trading on the PORTAL Market. We do not intend to list the
debentures on any other automated quotation system or any
securities exchange. Our common stock is quoted on The Nasdaq
National Market under the symbol INTC. The last
reported sale price of our common stock on The Nasdaq National
Market on March 24, 2006 was $19.60 per share.
The selling securityholders will receive all of the net proceeds
from the sale of the securities and will pay all underwriting
discounts and selling commissions, if any. We are responsible
for the payment of other expenses incident to the registration
of the securities. We will not receive any proceeds from this
offering.
Neither the Securities and Exchange Commission nor any state
securities commission has approved or disapproved of these
securities or determined if this prospectus supplement and the
accompanying prospectus are truthful and complete. Any
representation to the contrary is a criminal offence.
See Risk factors beginning on page S-5 and
in the documents incorporated by reference in this prospectus
supplement and the accompanying prospectus for a discussion of
certain risks that you should consider in connection with an
investment in the debentures.
March 31, 2006
Table of contents
|
|
|
|
|
|
|
Page | |
|
|
| |
Prospectus Supplement
|
|
|
|
|
|
|
|
S-i |
|
|
|
|
S-1 |
|
|
|
|
S-5 |
|
|
|
|
S-16 |
|
|
|
|
S-16 |
|
|
|
|
S-17 |
|
|
|
|
S-46 |
|
|
|
|
S-54 |
|
|
|
|
S-62 |
|
|
|
|
S-65 |
|
|
|
|
S-65 |
|
|
|
|
|
|
|
|
Page | |
|
|
| |
Prospectus
|
|
|
|
|
|
|
|
2 |
|
|
|
|
3 |
|
|
|
|
4 |
|
|
|
|
4 |
|
|
|
|
4 |
|
|
|
|
5 |
|
|
|
|
10 |
|
|
|
|
11 |
|
|
|
|
12 |
|
|
|
|
14 |
|
|
|
|
14 |
|
|
|
|
14 |
|
|
|
|
14 |
|
|
|
|
14 |
|
Forward-looking statements
This prospectus supplement and the documents incorporated by
reference herein contain forward-looking statements within the
meaning of Section 27A of the Securities Act and
Section 21E of the Securities Exchange Act of 1934, as
amended (the Exchange Act). All statements, other
than statements of historical facts, included or incorporated
herein regarding our strategy, future operations, financial
position, future revenues, projected costs, prospects, plans and
objectives are forward-looking statements. In some cases, you
can identify forward-looking statements by terminology such as
anticipates, believes,
estimates, expects, intends,
may, plans, projects,
will, would, and similar expressions or
expressions of the negative of these terms. Such statements are
only predictions and, accordingly, are subject to substantial
risks, uncertainties and assumptions.
Many factors could affect our actual results, and variances from
our current expectations regarding such factors could cause
actual results to differ materially from those expressed in our
forward-looking statements. We presently consider the factors
set forth below to be important factors that could cause actual
results to differ materially from our published expectations. A
more detailed discussion of these factors, as well as other
S-i
factors that could affect our results, is contained in this
prospectus supplement under the heading Risk factors
and in our filings with the Securities and Exchange Commission
(the SEC), including the report on
Form 10-K for the
year ended December 31, 2005. However, management cannot
predict all factors, or combinations of factors, that may cause
actual results to differ materially from those projected in any
forward-looking statements. Factors that could cause our results
to be different from our expectations include:
|
|
|
|
|
we operate in intensely competitive industries that are
characterized by a high percentage of costs that are fixed or
difficult to reduce in the short term, and by product demand
that is highly variable. Revenue and the gross margin percentage
are affected by the demand for and market acceptance of our
products; the availability of sufficient inventory of Intel
products and related components from other suppliers to meet
demand; pricing pressures; actions taken by Intels
competitors; and our ability to respond quickly to technological
developments and to incorporate new features into our products.
Factors that could cause demand to be different from our
expectations include changes in customer product needs,
including order cancellations; changes in customers level
of inventory; and changes in business and economic conditions; |
|
|
|
our gross margin percentage could vary from expectations based
on changes in revenue levels; product mix and pricing;
variations in inventory valuation, including variations related
to the timing of qualifying products for sale; excess or
obsolete inventory; manufacturing yields; changes in unit costs;
capacity utilization; impairments of long-lived assets,
including manufacturing, assembly/test and intangible assets;
and the timing and execution of the manufacturing ramp and
associated costs, including
start-up costs; |
|
|
|
expenses, particularly certain marketing and compensation
expenses, vary depending on the level of demand for our products
and the level of revenue and profits; |
|
|
|
our results could be impacted by unexpected economic, social and
political conditions in the countries in which we, our customers
or our suppliers operate, including security risks, possible
infrastructure disruptions and fluctuations in foreign currency
exchange rates; |
|
|
|
our results could be affected by adverse effects associated with
product defects and errata (deviations from published
specifications), and by litigation or regulatory matters
involving intellectual property, stockholder, consumer,
antitrust and other issues, such as the litigation and
regulatory matters described in our SEC reports; and |
|
|
|
our results could be affected by the amount, type, and valuation
of share-based awards granted as well as the amount of awards
cancelled due to employee turnover. |
Unless required by law, we undertake no obligation to publicly
update or revise any forward-looking statements to reflect
events or developments after the date of this prospectus
supplement.
S-ii
Summary
The following summary may not contain all the information that
may be important to you. You should read the entire prospectus
supplement and the accompanying prospectus, as well as the
information to which we refer you and the information
incorporated by reference, before making an investment decision.
When used in this prospectus supplement, the terms
Intel, issuer, we,
our, and us refer to Intel Corporation
and its consolidated subsidiaries, unless otherwise specified.
Intel Corporation
We are the worlds largest semiconductor chip maker,
developing advanced integrated digital technology platforms for
the computing and communications industries. Our goal is to be
the preeminent provider of silicon chips and platform solutions
to the worldwide digital economy. We offer products at various
levels of integration, allowing our customers flexibility to
create advanced computing and communications systems and
products.
Intels products include chips, boards and other
semiconductor components that are the building blocks integral
to computers, servers, and networking and communications
products. Our component-level products consist of integrated
circuits used to process information. Our integrated circuits
are silicon chips, known as semiconductors, etched with
interconnected electronic switches.
We were incorporated in California in 1968 and reincorporated in
Delaware in 1989. Our principal executive offices are located at
2200 Mission College Boulevard, Santa Clara, California
95054 and our telephone number is
(800) 765-8119.
The offering
The following summary contains basic information about the
debentures and is not a complete description of the offering.
Thus, it does not contain all the information that is important
to you. For a more detailed description of the debentures you
should read the section titled Description of
debentures. For purposes of this summary and the
Description of debentures, references to the
Company, Intel, Issuer,
we, us, and our refer only
to Intel Corporation and do not include our subsidiaries, except
where the context otherwise requires or as otherwise
indicated.
|
|
|
Issuer |
|
Intel Corporation, a Delaware corporation. |
|
Securities |
|
$1,600,000,000 principal amount of 2.95% Junior Subordinated
Convertible Debentures due 2035. |
|
Maturity |
|
December 15, 2035, unless earlier redeemed, repurchased or
converted. |
|
Interest |
|
2.95% per year, payable semiannually in arrears on June
15 and December 15 of each year, beginning
June 15, 2006. |
|
|
|
In addition to regular interest on the debentures, beginning
with the semi-annual interest period commencing on
December 15, 2010, contingent interest will accrue: |
|
|
|
during any semi-annual interest period where the
average trading price of a debenture for the 10 trading day
period immediately preceding the first day of such semi-annual
period is greater than or equal to $1,300 per $1,000
principal amount of the debentures, in which case contingent
interest will accrue at a rate of 0.40% of such average trading
price per annum; and |
|
|
|
during any semi-annual interest period where the
average trading price of a debenture for the 10 trading day
period immediately |
S-1
|
|
|
|
|
preceding the first day of such semi-annual period is less than
or equal to a threshold that will initially be set at
$800 per $1,000 principal amount of the debentures and that
will increase over time, in which case contingent interest will
accrue at a rate of 0.25% of such average trading price per
annum. |
|
|
|
In addition, we will pay contingent interest at any time the
debentures are outstanding in the event that we pay an
extraordinary cash dividend or distribution to holders of our
common stock that our board of directors designates as payable
to the holders of the debentures. |
|
|
|
So long as we are not in default in the payment of interest on
the debentures, we may defer payment of interest on the
debentures (other than contingent interest relating to
extraordinary dividends) for a period not exceeding
10 consecutive semi-annual interest payment periods, during
which time interest will continue to accrue on a compounded
basis. |
|
Conversion rights |
|
Holders may convert their debentures into shares of our common
stock at any time prior to the close of business on the trading
day immediately preceding the maturity date, in multiples of
$1,000 principal amount. |
|
|
|
The initial conversion rate for the debentures is
31.7162 shares per $1,000 principal amount of debentures
(equal to an initial conversion price of approximately
$31.53 per share), subject to adjustment. |
|
|
|
We will increase the conversion rate for a holder who elects to
convert its debentures in connection with certain fundamental
changes as described under Description of
debentures Conversion rights Conversion
rate adjustments Adjustment to shares delivered upon
conversion upon certain fundamental changes. |
|
|
|
Holders will not receive any cash payment or additional shares
representing accrued and unpaid interest and contingent
interest, additional interest or compounded interest, if any,
upon conversion of a debenture, except in limited circumstances.
Instead, interest will be deemed paid by the shares of common
stock and cash, if any, delivered to holders upon conversion. |
|
Redemption at our option |
|
We may not redeem the debentures prior to December 15,
2012, except in connection with certain tax-related events. On
or after December 15, 2012, we may redeem for cash all or
part of the debentures if the last reported sale price of our
common stock has been at least 130% of the conversion price then
in effect for at least 20 trading days during any
30 consecutive trading day period prior to the date on
which we provide notice of redemption. We may not redeem the
debentures at our option or give notice of redemption unless we
have paid any accrued deferred interest with respect to the
debentures. The redemption price will equal 100% of the
principal amount of the debentures to be redeemed, plus accrued
and unpaid interest, including any contingent interest,
additional |
S-2
|
|
|
|
|
interest or compounded interest, to but excluding the purchase
date. |
|
|
|
We may also redeem all or part of the debentures for cash on or
prior to June 12, 2006 if certain U.S. federal tax
legislation, regulations or rules are enacted or are issued. The
redemption price for any such redemption will be 101.5% of the
principal amount of the debentures being redeemed plus
(i) accrued and unpaid interest, including any contingent
interest, additional interest or compounded interest, to but
excluding the redemption date and (ii) if the conversion
value of the debentures being redeemed exceeds their initial
conversion value, 77% of the amount determined by subtracting
the initial conversion value of such debentures from their
conversion value. |
|
|
|
We will give notice of redemption not less than 30 nor more than
60 days before the redemption date by mail to the trustee,
the paying agent and each holder of debentures. |
|
Fundamental change |
|
If we undergo a fundamental change (as defined in
this prospectus supplement under Description of
debentures Fundamental change permits holders to
require us to purchase debentures), you will have the
option to require us to purchase all or any portion of your
debentures. The fundamental change purchase price will be 100%
of the principal amount of the debentures to be purchased plus
any accrued and unpaid interest, including any additional
interest, to but excluding the fundamental change purchase date.
We may choose to pay the repurchase price in: |
|
|
|
cash; |
|
|
|
shares of our common stock or shares of common stock
of the surviving corporation, at our option and subject to the
satisfaction of certain conditions. The number of shares of
common stock will equal the repurchase price divided by 95% of
the average of the last reported sale prices for our common
stock for the five consecutive trading days immediately
preceding and including the third trading day prior to the
repurchase date; or |
|
|
|
a combination of cash, shares of our common stock or
shares of common stock of the surviving corporation. |
|
Ranking |
|
The debentures are our unsecured junior obligations subordinated
in right of payment to our existing and future unsecured senior
debt and effectively subordinated in right of payment to all
indebtedness and other liabilities of our subsidiaries. |
|
Registration rights |
|
We entered into a registration rights agreement with the initial
purchasers of the debentures in which we agreed to file with the
SEC the shelf registration statement for the resale of the
debentures and the common stock issuable upon conversion of the
debentures of which the accompanying prospectus is a part. |
|
Use of proceeds |
|
The selling securityholders will receive all of the proceeds
from the sale of the debentures and the common stock pursuant to
this prospectus supplement, and we will receive none of such
proceeds. |
S-3
|
|
|
Book-entry form |
|
The debentures were issued in book-entry form only and are
represented by permanent global certificates deposited with, or
on behalf of, The Depository Trust Company (DTC),
and registered in the name of a nominee of DTC. Beneficial
interests in any of the debentures will be shown on, and
transfers will be effected only through, records maintained by
DTC or its nominee and any such interest may not be exchanged
for certificated securities, except in certain limited
circumstances. |
|
Trading |
|
Since their initial issuance, the debentures have been eligible
for trading in the PORTAL Market of the National Association of
Securities Dealers, Inc. However, debentures sold by means of
this prospectus supplement will no longer be eligible for
trading on the PORTAL Market. We do not intend to list the
debentures on any other automated quotation system or any
securities exchange. Furthermore, we can provide no assurances
as to the liquidity of, or trading market for, the debentures.
Our common stock is quoted on The Nasdaq National Market under
the symbol INTC. |
|
Risk factors |
|
Investment in the debentures involves risk. You should carefully
consider the information under the section titled Risk
factors and all other information included in this
prospectus supplement and the documents incorporated by
reference before investing in the debentures. |
S-4
Risk factors
Investing in the debentures and our common stock involves a
high degree of risk. In addition, our business, operations and
financial condition are subject to various risks. You should
carefully consider the risks described below with all of the
other information included or incorporated by reference in this
prospectus supplement and the accompanying prospectus before
making an investment decision. If any of the adverse events
described below were to actually occur, our business, results of
operations, or financial condition would likely suffer. In such
an event, the trading price of the debentures and our common
stock could decline and you could lose all or part of your
investment. Additionally, this section does not attempt to
describe all risks applicable to our industry, our business or
investment in the debentures or our common stock. Risks not
presently known to us or that we currently deem immaterial may
also impair our business operations.
Risks related to our business
|
|
|
Fluctuations in demand for our products may adversely
affect our financial results. |
If demand for our products fluctuates, our revenue and gross
margin could be adversely affected. Important factors that could
cause demand for our products to fluctuate include:
|
|
|
|
|
changes in customer product needs; |
|
|
|
changes in the level of customers inventory; |
|
|
|
changes in business and economic conditions, including a
downturn in the semiconductor industry; |
|
|
|
competitive pressures from companies that have competing
products, chip architectures and manufacturing technologies; |
|
|
|
strategic actions taken by our competitors; and |
|
|
|
market acceptance of our products. |
If demand for our products is reduced, our manufacturing and/or
assembly and test capacity could be under-utilized, and we may
be required to record an impairment on our long-lived assets
including facilities and equipment, as well as intangible
assets, which would increase our expenses. In addition, factory
planning decisions may cause us to record accelerated
depreciation. In the long term, if demand for our products
increases, we may not be able to add manufacturing and/or
assembly and test capacity fast enough to meet market demand.
These changes in demand for our products, and changes in our
customers product needs, could have a variety of negative
effects on our competitive position and our financial results,
and, in certain cases, may reduce our revenue, increase our
costs, lower our gross margin percentage, or require us to
recognize and record impairments of our assets.
|
|
|
The semiconductor industry and our operations are
characterized by a high percentage of costs that are fixed or
otherwise difficult to reduce in the short term, and by product
demand that is highly variable and is subject to significant
downturns that may adversely affect our business, results of
operations and financial condition. |
The semiconductor industry and our operations are characterized
by high costs, such as those related to facility construction
and equipment, research and development, and employment and
training of a highly skilled workforce, that are either fixed or
difficult to reduce in the short term. At the same time, demand
for our products is highly variable and has experienced
downturns, often in connection with maturing product cycles and
downturns in general economic market conditions. These downturns
have been characterized by reduced product demand, manufacturing
overcapacity, high inventory levels and decreased average
selling prices. The combination of these factors may cause our
revenue, gross margin, cash flow and profitability to vary
significantly both in the short term and over the long term.
S-5
|
|
|
We operate in intensely competitive industries, and our
failure to respond quickly to technological developments and
incorporate new features into our products could have an adverse
effect on our ability to compete. |
We operate in intensely competitive industries that experience
rapid technological developments, changes in industry standards,
changes in customer requirements, and frequent new product
introductions and improvements. If we are unable to respond
quickly and successfully to these developments, we may lose our
competitive position, and our products or technologies may
become uncompetitive or obsolete. To compete successfully, we
must maintain a successful R&D effort, develop new products
and production processes, and improve our existing products and
processes at the same pace or ahead of our competitors. We may
not be able to successfully develop and market these new
products; the products we invest in and develop may not be well
received by customers; and products developed and new
technologies offered by others may affect the demand for our
products. These types of events could have a variety of negative
effects on our competitive position and our financial results,
such as reducing our revenue, increasing our costs, lowering our
gross margin percentage, and requiring us to recognize and
record impairments of our assets.
|
|
|
Fluctuations in the mix of products sold may adversely
affect our financial results. |
Because of the wide price differences among mobile, desktop and
server microprocessors, the mix and types of performance
capabilities of microprocessors sold affect the average selling
price of our products and have a substantial impact on our
revenue. Our financial results also depend in part on the mix of
other products we sell, such as chipsets, flash memory and other
semiconductor products. In addition, more recently introduced
products tend to have higher associated costs because of initial
overall development costs and higher
start-up costs.
Fluctuations in the mix and types of our products may also
affect the extent to which we are able to recover our fixed
costs and investments that are associated with a particular
product, and as a result can negatively impact our financial
results.
|
|
|
Our global operations subject us to risks that may
negatively affect our results of operations and financial
condition. |
We have sales offices and research and development,
manufacturing, and assembly and test facilities in many
countries, and as a result, we are subject to risks associated
with doing business globally. Our global operations may be
subject to risks that may limit our ability to manufacture,
assemble and test, design, develop or sell products in
particular countries, which could in turn have an adverse effect
on our results of operations and financial condition, including:
|
|
|
|
|
health concerns; |
|
|
|
natural disasters; |
|
|
|
inefficient and limited infrastructure and disruptions, such as
large-scale outages or interruptions of service from utilities
or telecommunications providers and supply chain interruptions; |
|
|
|
differing employment practices and labor issues; |
|
|
|
local business and cultural factors that differ from our normal
standards and practices; |
|
|
|
regulatory requirements and prohibitions that differ between
jurisdictions; |
|
|
|
security concerns, including crime, political instability,
terrorist activity, armed conflict and civil or military
unrest; and |
|
|
|
restrictions on our operations by governments seeking to support
local industries, nationalization of our operations and
restrictions on our ability to repatriate earnings. |
In addition, although most of our products are priced and paid
for in U.S. dollars, a significant amount of certain types
of expenses, such as payroll, utilities, tax and marketing
expenses, are paid in local currencies. Fluctuations in the rate
of exchange between the U.S. dollar and the currencies of
other countries in which we conduct business, and changes in
currency controls with respect to such countries, could
negatively impact our
S-6
business, operating results and financial condition by resulting
in lower revenue or increased expenses in such countries. In
addition, changes in tariff and import regulations and to U.S.
and
non-U.S. monetary
policies may also negatively impact our revenue in those
affected countries. Varying tax rates in different jurisdictions
could negatively impact our overall tax rate.
|
|
|
Failure to meet our production targets, resulting in
undersupply or oversupply of products, may adversely impact our
business and results of operations. |
Manufacturing and assembly and test of integrated circuits is a
complex process. Disruptions in this process can result from
difficulties in our development and implementation of new
processes, errors and interruptions in the processes, defects in
materials and disruptions in our supply of materials or
resources, all of which could affect the timing of production
ramps and yields. Furthermore, we may not be successful or
efficient in developing or implementing new production
processes. The occurrence of any of the foregoing may result in
our failure to increase production as desired, resulting in
higher costs or substantial decreases in yields, which could
impact our ability to produce sufficient volume to meet specific
product demand. Furthermore, the unavailability or reduced
availability of certain products could make it more difficult to
implement our platform strategy. We may also experience
increases in yields. A substantial increase in yields could
result in higher inventory levels and the possibility of
resulting excess capacity charges as we slow production to
reduce inventory levels. In addition, higher yields, as well as
other factors, can decrease overall unit costs and may cause us
to revalue our existing inventory on certain products to their
lower replacement cost, which would impact our gross margin in
the quarters in which this revaluation occurs. The occurrence of
any of these events could adversely impact our business and
results of operations.
|
|
|
We may have difficulties obtaining the resources or
products we need for manufacturing or assembling our products or
operating other aspects of our business, which could adversely
affect our ability to meet demand for our products and may
increase our costs. |
We have thousands of suppliers providing various materials that
we use in production of our products and other aspects of our
business, and we seek, where possible, to have several sources
of supply for all of these materials. However, we may rely on a
single or a limited number of suppliers, or upon suppliers in a
single country, for these materials. The inability of such
suppliers to deliver adequate supplies of production materials
or other supplies could disrupt our production process or could
make it more difficult for us to implement our platform
strategy. In addition, production could be disrupted by the
unavailability of the resources used in production such as
water, silicon, electricity and gases. The unavailability or
reduced availability of the materials or resources we use in our
business may require us to reduce production of products or may
require us to incur additional costs in order to obtain an
adequate supply of these materials or resources. The occurrence
of any of these events could adversely impact our business and
results of operations.
|
|
|
Costs related to product defects and errata may have an
adverse impact on our results of operations and business. |
Costs associated with unexpected product defects and errata
(deviations from published specifications) include, for example,
the costs of:
|
|
|
|
|
writing down the value of inventory of defective products; |
|
|
|
disposing of defective products that cannot be fixed; |
|
|
|
recalling defective products that have been shipped to customers; |
|
|
|
providing product replacements for or modifications to defective
products; and |
|
|
|
defending against litigation related to defective products. |
These costs could be substantial and may therefore increase our
expenses and adversely affect our gross margin. In addition, our
reputation with our customers or end users of our products could
be damaged as a
S-7
result of such product defects and errata, and the demand for
our products could be reduced. These factors could negatively
impact our financial results and the prospects for our business.
|
|
|
We may be subject to claims of infringement of third-party
intellectual property rights, which could adversely affect our
business. |
From time to time, third parties may assert against us or our
customers alleged patent, copyright, trademark and other
intellectual property rights to technologies that are important
to our business. We may be subject to intellectual property
infringement claims from certain individuals and companies who
have acquired patent portfolios for the sole purpose of
asserting such claims against other companies. Any claims that
our products or processes infringe the intellectual property
rights of others, regardless of the merit or resolution of such
claims, could cause us to incur significant costs in responding
to, defending and resolving such claims, and may divert the
efforts and attention of our management and technical personnel
away from our business. As a result of such intellectual
property infringement claims, we could be required to:
|
|
|
|
|
pay third-party infringement claims; |
|
|
|
discontinue manufacturing, using or selling the infringing
products; |
|
|
|
discontinue using the infringing technology or processes; |
|
|
|
develop non-infringing technology, which could be time-consuming
and costly or may not be possible; or |
|
|
|
license technology from the third party claiming infringement,
which license may not be available on commercially reasonable
terms or at all. |
The occurrence of any of the foregoing could result in
unexpected expenses or require us to recognize an impairment of
our assets, which would reduce the value of our assets and
increase expenses. In addition, if we alter or discontinue our
production of affected items, our revenue could be negatively
impacted.
|
|
|
We may be subject to litigation proceedings that could
adversely affect our business. |
In addition to the litigation risks mentioned above, we may be
subject to legal claims or regulatory matters involving
stockholder, consumer, antitrust and other issues. As described
in Legal Proceedings in Part I, Item 3 of
our Annual Report on
Form 10-K for the
year ended December 31, 2005, we are currently engaged in a
number of litigation matters. Litigation is subject to inherent
uncertainties, and unfavorable rulings could occur. An
unfavorable ruling could include money damages or, in cases for
which injunctive relief is sought, an injunction prohibiting
Intel from manufacturing or selling one or more products. Were
an unfavorable ruling to occur, there exists the possibility of
a material adverse impact on business and results of operations
for the period in which the ruling occurred or future periods.
|
|
|
We may not be able to enforce or protect our intellectual
property rights, which may harm our ability to compete and
adversely affect our business. |
Our ability to enforce our patents, copyrights, software
licenses and other intellectual property is subject to general
litigation risks, as well as uncertainty as to the
enforceability of our intellectual property rights in various
countries. When we seek to enforce our rights, we are often
subject to claims that the intellectual property right is
invalid, is otherwise not enforceable or is licensed to the
party against whom we are asserting a claim. In addition, our
assertion of intellectual property rights often results in the
other party seeking to assert alleged intellectual property
rights of its own against us, which may adversely impact our
business in the manner discussed above. If we are not ultimately
successful in defending ourselves against these claims in
litigation, we may not be able to sell a particular product or
family of products, due to an injunction, or we may have to pay
material amounts of damages, which could in turn negatively
affect our results of operations. In addition, governments may
adopt regulations or courts may render decisions requiring
compulsory licensing of intellectual property to others, or
governments may require that products meet specified standards
that serve
S-8
to favor local companies. Our inability to enforce our
intellectual property rights under these circumstances may
negatively impact our competitive position and our business.
|
|
|
Our licenses with other companies and our participation in
industry initiatives may allow other companies, including
competitors, to use our patent rights. |
Companies in the semiconductor industry often rely on the
ability to license patents from each other in order to compete.
Many of our competitors have broad licenses or cross-licenses
with us, and under current case law, some of these licenses may
permit these competitors to pass our patent rights on to others.
If one of these licensees becomes a foundry, our competitors
might be able to avoid our patent rights in manufacturing
competing products. In addition, our participation in industry
initiatives may require us to license our patents to other
companies that adopt certain industry standards or
specifications, even when such organizations do not adopt
standards or specifications proposed by us. As a result, our
patents implicated by our participation in industry initiatives
might not be available for us to enforce against others who
might otherwise be deemed to be infringing those patents, our
costs of enforcing our licenses or protecting our patents may
increase, and the value of our intellectual property may be
impaired.
|
|
|
In order to compete, we must attract, retain and motivate
key employees, and our failure to do so could have an adverse
effect on our results of operations. |
In order to compete, we must attract, retain and motivate
executives and other key employees, including those in
managerial, technical, sales, marketing and support positions.
Hiring and retaining qualified executives, scientists,
engineers, technical staff and sales representatives are
critical to our business, and competition for experienced
employees in the semiconductor industry can be intense. To
attract, retain and motivate qualified employees, we rely
heavily on stock-based incentive awards such as employee stock
options and restricted stock. If the value of such stock awards
does not appreciate as measured by the performance of the price
of our common stock and/or if our other stock-based compensation
otherwise ceases to be viewed as a valuable benefit, our ability
to attract, retain and motivate our employees could be adversely
impacted, which could negatively affect our results of
operations and/or require us to increase the amount we expend on
cash and other forms of compensation. In addition, our adoption
of Statement of Financial Accounting Standards
(SFAS) No. 123 (revised 2004)
(SFAS No. 123(R)), Share-Based
Payment, during our first quarter of 2006 will result in
significant additional compensation expense compared to prior
periods.
|
|
|
Our results of operations could vary as a result of the
methods, estimates and judgments we use in applying our
accounting policies. |
The methods, estimates and judgments we use in applying our
accounting policies have a significant impact on our results of
operations (see Critical Accounting Estimates in
Part II, Item 7 of our Annual Report on
Form 10-K for the
year ended December 31, 2005). Such methods, estimates and
judgments are, by their nature, subject to substantial risks,
uncertainties and assumptions, and factors may arise over time
that lead us to change our methods, estimates and judgments.
Changes in those methods, estimates and judgments could
significantly affect our results of operations. In particular,
beginning in our first quarter of 2006, the calculation of
share-based compensation expense under SFAS No. 123(R)
requires us to use valuation methodologies (which were not
developed for use in valuing employee stock options) and a
number of assumptions, estimates and conclusions regarding
matters such as expected forfeitures, expected volatility of our
share price, the expected dividend rate with respect to our
common stock and the exercise behavior of our employees.
Furthermore, there are no means, under applicable accounting
principles, to compare and adjust our expense if and when we
learn of additional information that may affect the estimates
that we previously made, with the exception of changes in
expected forfeitures of share-based awards. Factors may arise
over time that lead us to change our estimates and assumptions
with respect to future share-based compensation arrangements,
resulting in variability in our share-based compensation expense
over time. Changes in forecasted share-based compensation
expense could impact our gross margin percentage; research and
development expenses; marketing, general and administrative
expenses; and our tax rate.
S-9
|
|
|
Our failure to comply with applicable environmental laws
and regulations worldwide could adversely impact our business
and results of operations. |
The manufacture, assembly and testing of our products require
the use of hazardous materials that are subject to a broad array
of environmental, health and safety laws and regulations. Our
failure to comply with any of these applicable laws or
regulations could result in:
|
|
|
|
|
regulatory penalties, fines and legal liabilities; |
|
|
|
suspension of production; |
|
|
|
alteration of our fabrication and assembly and test
processes; or |
|
|
|
curtailment of our operations or sales. |
In addition, our failure to properly manage the use,
transportation, emission, discharge, storage, recycling or
disposal of hazardous materials could subject us to increased
costs or future liabilities. Existing and future environmental
laws and regulations could also require us to acquire pollution
abatement or remediation equipment, modify our product designs
or incur other expenses associated with such laws and
regulations. Many new materials that we are evaluating for use
in our operations may be subject to regulation under existing or
future environmental laws and regulations that may restrict our
use of certain materials in our manufacturing, assembly and test
processes or products. Any of these consequences could adversely
impact our business and results of operations by increasing our
expenses and/or requiring us to alter our manufacturing
processes.
|
|
|
Changes in our effective tax rate may have an adverse
effect on our results of operations. |
Our future effective tax rates may be adversely affected by a
number of factors including:
|
|
|
|
|
the jurisdictions in which profits are determined to be earned
and taxed; |
|
|
|
the repatriation of
non-U.S. earnings
for which we have not previously provided for U.S. taxes; |
|
|
|
adjustments to estimated taxes upon finalization of various tax
returns; |
|
|
|
increases in expenses not deductible for tax purposes, including
write-offs of acquired in-process research and development and
impairment of goodwill in connection with acquisitions; |
|
|
|
changes in available tax credits; |
|
|
|
changes in share-based compensation expense; |
|
|
|
changes in the valuation of our deferred tax assets and
liabilities; |
|
|
|
changes in tax laws or the interpretation of such tax
laws; and |
|
|
|
the resolution of issues arising from tax audits with various
tax authorities. |
Any significant increase in our future effective tax rates could
adversely impact net income for future periods. In addition, the
U.S. Internal Revenue Service (IRS) and other
tax authorities regularly examine our income tax returns. The
IRS has issued formal assessments related to amounts reflected
on certain of our tax returns as a tax benefit for our export
sales (see Note 18: Contingencies in
Part II, Item 8 of our Annual Report on
Form 10-K for the
year ended December 31, 2005). Our results of operations
could be adversely impacted if these assessments or any other
assessments resulting from the examination of our income tax
returns by the IRS or other taxing authorities are not resolved
in our favor.
|
|
|
We invest in companies for strategic reasons and may not
realize a return on our investments. |
We make investments in companies around the world to further our
strategic objectives and support our key business initiatives.
Such investments include investments in equity securities of
public companies and investments in non-marketable equity
securities of private companies, which range from early-stage
companies that are often still defining their strategic
direction to more mature companies whose products or
S-10
technologies may directly support an Intel product or
initiative. The success of these companies (or lack thereof) is
dependent on product development, market acceptance, operational
efficiency and other key business success factors. The private
companies in which we invest may fail because they may not be
able to secure additional funding, obtain favorable investment
terms for future financings or take advantage of liquidity
events, such as initial public offerings, mergers and private
sales. If any of these private companies fail, we could lose all
or part of our investment in that company. In addition, if we
determine that an other-than-temporary decline in the fair value
exists for the equity securities of the public and private
companies in which we invest, we write down the investment to
its fair value and record the related write-down as an
investment loss. Furthermore, when the strategic objectives of
an investment have been achieved, or if the investment or
business diverges from our strategic objectives, we may decide
to dispose of the investment. Our investments in non-marketable
equity securities of private companies are not liquid, and we
may not be able to dispose of these investments on favorable
terms or at all. The occurrence of any of these events could
negatively affect our net income and results of operations.
Risks related to the debentures
|
|
|
The debentures are our unsecured junior obligations and
are subordinated in right of payment to our existing and future
senior debt obligations and any indebtedness or other
liabilities of our subsidiaries. |
The debentures are unsecured and subordinated in right of
payment to all of our existing and future senior debt. Because
the debentures are subordinate to our senior debt, if we
experience:
|
|
|
|
|
a bankruptcy, liquidation or reorganization, or |
|
|
|
an acceleration of the debentures due to an event of default
under the indenture, |
we will be permitted to make payments on the debentures only
after we have satisfied all of our senior debt obligations.
Also, if payment or other defaults occur on senior debt,
payments on the debentures may be blocked indefinitely or for
specified periods. Therefore, payments on the debentures may be
delayed or not permitted or we may not have sufficient assets
remaining to pay amounts due on any or all of the debentures. In
addition, the debentures effectively will be subordinate to all
liabilities, including trade payables, of our subsidiaries and
any subsidiaries that we may in the future acquire or establish.
Consequently, our right to receive assets of any subsidiaries
upon their liquidation or reorganization, and the rights of the
holders of the debentures to share in those assets, would be
subordinate to the claims of the subsidiaries creditors.
The debentures will be our obligations exclusively. The
indenture for the debentures does not limit our ability, or that
of any of our presently existing or future subsidiaries, to
incur senior debt, other indebtedness and other liabilities. As
of December 31, 2005, the aggregate amount of our
outstanding senior debt was approximately $171.9 million,
and the aggregate amount of indebtedness and other liabilities
of our subsidiaries was approximately $2.8 billion,
excluding intercompany liabilities and liabilities of a type not
required to be reflected on the balance sheet of such
subsidiaries in accordance with generally accepted accounting
principles. From time to time we and our subsidiaries may incur
additional indebtedness, including senior debt, which could
adversely affect our ability to pay our obligations under the
debentures.
|
|
|
An active public market may not develop for the
debentures. |
The debentures are a new issue of securities with no established
trading market. Since their initial issuance, the debentures
have been eligible for trading in PORTAL. However, the
debentures resold pursuant to this prospectus supplement and the
accompanying prospectus will no longer be eligible for trading
in PORTAL, and we do not intend to list them on any other
automated quotation system or any securities exchange. At the
time of the initial issuance of the debentures in December 2005,
the initial purchasers of the debentures advised us that that
they intended to make a market in the debentures; however, they
are not obligated to do so and may discontinue market making at
any time without notice. In addition, market making activity by
the initial purchasers is subject to the limits imposed by the
Securities Act and the Exchange Act. As a result, a market for
the debentures may not develop or, if one does develop, it may
not be maintained. If
S-11
an active market for the debentures fails to develop or be
sustained, the trading price of the debentures could decline
significantly.
In addition, the liquidity of the trading market for the
debentures, if any, and the market price quoted for the
debentures may be adversely affected by changes in interest
rates in the market for comparable securities and by changes in
our financial performance or prospects, as well as by declines
in the prices of securities, or the financial performance or
prospects of similar companies.
|
|
|
If the market price of our common stock decreases, the
market price of the debentures may similarly decrease. |
We expect that the market price of the debentures will be
significantly affected by the market price of our common stock.
This may result in greater volatility in the market price of the
debentures than would be expected for debt securities. The
market price of our common stock will likely continue to
fluctuate in response to factors including the factors discussed
elsewhere in the sections of this prospectus supplement titled
Risk factors and Forward-looking
statements, many of which are beyond our control. For
instance, the price of our common stock could be affected by
sales of our common stock by investors who view the debentures
as a more attractive means of equity participation in our
company than our common stock, or by other hedging or arbitrage
trading activity that may develop involving our common stock.
This hedging or arbitrage could, in turn, affect the trading
price of the debentures.
|
|
|
Conversion of the debentures will dilute the ownership
interest of existing stockholders, including holders who had
previously converted their debentures. |
The conversion of some or all of the debentures will dilute the
ownership interests of existing stockholders. Any sales in the
public market of the common stock issuable upon such conversion
could adversely affect prevailing market prices of our common
stock. In addition, the existence of the debentures may
encourage short selling by market participants because the
conversion of the debentures could be used to satisfy short
positions, or anticipated conversion of the debentures into
shares of our common stock could depress the price of our common
stock.
|
|
|
The debentures do not contain restrictive
covenants. |
The indenture governing the debentures does not contain any
financial or operating covenants or restrictions on the payments
of dividends, the incurrence of indebtedness or the issuance or
repurchase of securities by us or any of our subsidiaries,
except for certain restrictions during any period in which we
have exercised our option to defer the payment of interest for
up to 10 consecutive semi-annual periods. See Description
of debentures Option to extend interest payment
period. The indenture contains no covenants or other
provisions to afford protection to holders of the debentures in
the event of a fundamental change involving Intel except to the
extent described under Description of
debentures Fundamental change permits holders to
require us to purchase debentures, and Description
of debentures Conversion rights
Conversion rate adjustments Adjustment to shares
delivered upon conversion upon certain fundamental changes.
|
|
|
The adjustment to the conversion rate for debentures
converted in connection with certain types of fundamental
changes may not adequately compensate you for any lost value of
your debentures as a result of such transactions. |
If certain types of fundamental changes occur prior to maturity,
we will increase the conversion rate by a number of additional
shares of our common stock for debentures converted in
connection with such fundamental change. The increase in the
conversion rate will be determined based on the date on which
the specified corporate transaction becomes effective and the
price paid per share of our common stock in such transaction, as
described below under Description of
debentures Conversion rights Adjustment
to shares delivered upon conversion upon certain fundamental
changes. The adjustment to the conversion rate for
debentures converted in connection with a fundamental change may
not adequately compensate you for
S-12
any lost value of your debentures as a result of such
transaction. Moreover, in no event will the total number of
additional shares of common stock issuable upon conversion as a
result of this adjustment exceed 5.7089 per $1,000
principal amount of debentures, subject to adjustments in the
same manner as the adjustments to the conversion rate as set
forth under Description of debentures
Conversion rights Conversion rate adjustments.
Our obligation to increase the conversion rate in connection
with certain types of fundamental changes could be considered a
penalty, in which case the enforceability thereof would be
subject to general principles of reasonableness of economic
remedies.
|
|
|
If you hold debentures, you will not be entitled to any
rights with respect to our common stock, but you will be subject
to all changes made with respect to our common stock. |
If you hold debentures, you will not be entitled to any rights
with respect to our common stock (including, without limitation,
voting rights and rights to receive any dividends or other
distributions on our common stock, other than extraordinary
dividends that our board of directors designates as payable to
the holders of the debentures), but if you subsequently convert
your debentures into common stock, you will be subject to all
changes affecting the common stock. You will have rights with
respect to our common stock only if and when we deliver shares
of common stock to you upon conversion of your debentures and,
to a limited extent, under the conversion rate adjustments
applicable to the debentures. For example, in the event that an
amendment is proposed to our certificate of incorporation or
bylaws requiring stockholder approval and the record date for
determining the stockholders of record entitled to vote on the
amendment occurs prior to delivery of common stock to you, you
will not be entitled to vote on the amendment, although you will
nevertheless be subject to any changes in the powers or rights
of our common stock that result from such amendment.
|
|
|
The price of our common stock historically has been
volatile. This volatility may make it difficult for you to
resell the debentures and the common stock into which the
debentures are convertible, and the sale of substantial amounts
of our common stock could adversely affect the price of our
common stock. |
The market price for our common stock has varied between a high
of $28.71 and a low of $19.54 per share between
December 26, 2004 and March 24, 2006. This volatility
may make it difficult for you to resell the debentures and the
common stock into which the debentures are convertible, and the
sale of substantial amounts of our common stock could adversely
affect the price of our common stock. Our stock price is likely
to continue to be volatile and subject to significant price and
volume fluctuations in response to market and other factors,
including the other factors discussed in the sections of this
prospectus supplement titled Risk factors and
Forward-looking statements.
In the past, many companies have been the subject of securities
class action litigation following periods of volatility in the
market price of their stock. If we became involved in securities
class action litigation in the future, it could result in
substantial costs and diversion of our managements
attention and resources and could harm our stock price,
business, prospects, results of operations and financial
condition.
In addition, the broader stock market has experienced
significant price and volume fluctuations in recent years. This
volatility has affected the market prices of securities issued
by many companies for reasons unrelated to their operating
performance and may adversely affect the price of our common
stock. In addition, our announcements of our quarterly operating
results, changes in general conditions in the economy or the
financial markets and other developments affecting us, our
affiliates or our competitors could cause the market price of
our common stock to fluctuate substantially. The trading price
of the debentures is expected to be affected significantly by
the price of our common stock.
|
|
|
The conversion rate of the debentures may not be adjusted
for all dilutive events, which may adversely affect the trading
price of the debentures. |
The conversion rate of the debentures is subject to adjustment
for certain events, including, but not limited to, the issuance
of dividends on our common stock in excess of $0.10 per
common share in any quarter, the issuance of certain rights or
warrants, subdivisions, combinations, distributions of capital
stock, indebted-
S-13
ness, or assets and certain tender or exchange offers as
described under Description of debentures
Conversion rights Conversion rate adjustments.
However, the conversion rate will not be adjusted for other
events, such as an issuance of common stock for cash, that may
adversely affect the trading price of the debentures or the
common stock. An event that adversely affects the value of the
debentures may occur, and that event may not result in an
adjustment to the conversion rate.
|
|
|
We may not have the ability to raise the funds necessary
to purchase the debentures upon a fundamental change as required
by the indenture governing the debentures. |
Holders of the debentures may require us to purchase their
debentures upon a fundamental change as described under
Description of debentures Fundamental change
permits holders to require us to purchase debentures. A
fundamental change may also constitute an event of default and
result in the effective acceleration of the maturity of our
then-existing indebtedness under another indenture or agreement.
We cannot assure you that we will have sufficient financial
resources, or will be able to arrange financing, to pay the
fundamental change purchase price for the debentures tendered by
the holders in cash. Failure by us to purchase the debentures
when required would result in an event of default with respect
to the debentures. Some significant restructuring transactions
may not constitute a fundamental change, in which case we would
not be obligated to offer to repurchase the debentures.
Upon the occurrence of certain types of fundamental changes, you
have the right to require us to repurchase your debentures.
However, the fundamental change provisions will not afford
protection to holders of debentures in the event of certain
other types of transactions. For example, transactions such as
leveraged recapitalizations, refinancings, restructurings, or
acquisitions initiated by us may not constitute a fundamental
change requiring us to repurchase the debentures. In the event
of any such transaction, the holders would not have the right to
require us to repurchase the debentures, even though each of
these transactions could increase the amount of our
indebtedness, or otherwise adversely affect our capital
structure or any credit ratings, thereby adversely affecting the
holders of debentures.
|
|
|
The debentures will probably not be rated and, if rated,
may receive a lower rating than anticipated. |
We believe it is unlikely that the debentures will be rated.
However, if one or more rating agencies rates the debentures and
assigns the debentures a rating lower than the rating expected
by investors, or reduces their rating in the future, the market
price of the debentures and our common stock would be harmed.
|
|
|
You may be subject to tax upon an adjustment to the
conversion rate of the debentures even though you do not receive
a corresponding cash distribution. |
The conversion rate of the debentures is subject to adjustment
in certain circumstances, including the payment of certain cash
dividends. If the conversion rate is adjusted as a result of a
distribution that is taxable to our common stockholders, such as
a cash dividend, you may be deemed to have received a taxable
dividend subject to United States federal income tax without the
receipt of any cash. If you are a
non-U.S. holder
(as defined in Material United States federal income tax
considerations), such deemed dividend may be subject to
United States federal withholding tax at a 30% rate, or such
lower rate as may be specified by an applicable treaty, which
may be set off against subsequent payments. See Dividend
policy and Material United States federal income tax
considerations.
If certain types of fundamental changes occur on or prior to the
maturity date of the debentures, under some circumstances, we
will increase the conversion rate for debentures converted in
connection with the fundamental change. Such increase may be
treated as a distribution subject to U.S. federal income
tax as a dividend. See Material United States federal
income tax considerations.
|
|
|
U.S. holders will recognize income for
U.S. federal income tax purposes in excess of the current
cash payments on the debentures and will recognize ordinary
income on the disposition of the debentures. |
Pursuant to the terms of the indenture, we and each holder of
the debentures agree to treat the debentures, for United States
federal income tax purposes, as contingent payment debt
instruments. Under
S-14
this characterization, the debentures will be treated as issued
with original issue discount for U.S. federal income tax
purposes, and each U.S. holder will be required to include
such original issue discount in gross income as it accrues
regardless of the holders method of tax accounting. The
amount of original issue discount required to be included in the
holders gross income for each year generally will be in
excess of the payments and accruals on the debentures for
non-tax purposes and in advance of the receipt of cash or other
property attributable thereto in that year. A U.S. holder
will recognize gain or loss on the sale, exchange, conversion,
repurchase or redemption of a debenture in an amount equal to
the difference between the amount realized, including the fair
market value of any of our common stock received, and the
holders adjusted tax basis in the debenture. Any such gain
will be treated as ordinary interest income and any such loss
will be ordinary loss to the extent of the interest previously
included in gross income and, thereafter, capital loss. All
holders should read the discussion of the United States federal
income tax consequences of the purchase, ownership, and the
disposition of the debentures that is contained in this
prospectus supplement under the heading Material United
States federal income tax considerations.
S-15
Ratio of earnings to fixed charges
The following table sets forth our ratio of earnings to fixed
charges for each of the periods indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended | |
| |
December 31, | |
|
December 25, | |
|
December 27, | |
|
December 28, | |
|
December 29, | |
2005 | |
|
2004 | |
|
2003 | |
|
2002 | |
|
2001 | |
| |
|
| |
|
| |
|
| |
|
| |
|
169x |
|
|
|
107x |
|
|
|
72x |
|
|
|
32x |
|
|
|
18x |
|
The ratio of earnings to fixed charges is computed by dividing
(i) income before income taxes plus fixed charges by
(ii) fixed charges. Our fixed charges consist of the
portion of operating lease rental expense that is representative
of the interest factor and interest expense on indebtedness.
Use of proceeds
The proceeds from the sale of the debentures and the common
stock offered pursuant to this prospectus supplement are solely
for the account of the selling securityholders. Accordingly, we
will not receive any proceeds from the sale of the debentures or
the shares of common stock offered by this prospectus supplement.
S-16
Description of debentures
The Company issued the debentures under an indenture dated as of
December 16, 2005 (the indenture) between
itself and Citibank, N.A., as trustee (the trustee).
For purposes of this prospectus supplement, references to the
indenture mean the indenture dated December 16, 2005
between Intel and Citibank, N.A. and not the indenture dated
March 29, 2006 between Intel and Citibank, N.A. that is
described in the accompanying prospectus. The terms of the
debentures include those expressly set forth in the indenture
and those made part of the indenture by reference to the Trust
Indenture Act of 1939, as amended (the Trust Indenture
Act). The debentures and the shares of common stock
issuable upon conversion of the debentures are covered by a
registration rights agreement.
You may request a copy of the indenture and the registration
rights agreement from us.
The following description is a summary of the material
provisions of the debentures and the indenture and does not
purport to be complete. This summary is subject to and is
qualified by reference to all the provisions of the debentures
and the indenture, including the definitions of certain terms
used in the indenture. We urge you to read the indenture because
it, and not this description, defines your rights as a holder of
the debentures.
For purposes of this description, references to the
Company, Intel, we,
our and us refer only to Intel
Corporation and not to its subsidiaries.
General
The debentures:
|
|
|
|
|
are general unsecured, junior subordinated obligations of the
Company; |
|
|
|
are limited to an aggregate principal amount of $1,600,000,000; |
|
|
|
mature on December 15, 2035 (the maturity
date), unless earlier converted or repurchased; |
|
|
|
are issued in denominations of $1,000 and integral multiples of
$1,000; |
|
|
|
are represented by one or more registered debentures in global
form, but in certain limited circumstances may be represented by
debentures in definitive form. See Book-entry, settlement
and clearance; and |
|
|
|
are subordinated in right of payment to existing and future
senior debt of the Company and to all indebtedness and other
liabilities of the Companys subsidiaries; |
The debentures may be converted at an initial conversion rate of
31.7162 shares of common stock per $1,000 principal amount
of debentures (equivalent to a conversion price of approximately
$31.53 per share of common stock). The conversion rate is
subject to adjustment if certain events occur.
Upon conversion of a debenture, you will not receive any
separate cash payment for interest or contingent interest,
additional interest or compounded interest, if any, accrued and
unpaid to the conversion date except under the limited
circumstances described below under Conversion
rights General.
Other than restrictions described under Fundamental change
permits holders to require us to repurchase debentures and
Consolidation, merger and sale of assets below, and
except for the provisions set forth under Conversion
rights Adjustment to shares delivered upon
conversion upon certain fundamental changes, the indenture
does not contain any covenants or other provisions designed to
afford holders of the debentures protection in the event of a
highly leveraged transaction involving us or in the event of a
decline in our credit rating as the result of a takeover,
recapitalization, highly leveraged transaction or similar
restructuring involving us that could adversely affect such
holders. In addition, the indenture does not limit the amount of
debt which may be issued by the Company or its subsidiaries
under the indenture or otherwise, restrict the incurrence of
liens, restrict the payment of dividends (except during any
extension of the interest payment period for the debentures) or
contain financial covenants.
S-17
We may, without the consent of the holders, issue additional
debentures under the indenture with the same terms and with the
same CUSIP numbers as the debentures offered hereby in an
unlimited aggregate principal amount, provided that no such
additional debentures may be issued unless fungible with the
debentures offered hereby for U.S. federal income tax
purposes. We may also from time to time repurchase the
debentures in open market purchases or negotiated transactions
without prior notice to holders.
We use the term debenture in this prospectus
supplement to refer to each $1,000 principal amount of
debentures. We use the term common stock in this
prospectus supplement to refer to the Companys common
stock, $0.001 par value. References in this prospectus
supplement to a holder or holders of
debentures that are held through The Depository Trust Company
(DTC) are references to owners of beneficial
interests in such debentures, unless the context otherwise
requires. However, we and the trustee will treat the person in
whose name debentures are registered (Cede & Co., in
the case of debentures held through DTC) as the owner of such
debentures for all purposes.
|
|
|
Payments on the debentures; paying agent and
registrar |
We will pay principal of and interest (including contingent
interest, additional interest and compounded interest, if any)
on debentures in global form registered in the name of, or held
by, DTC or its nominee in immediately available funds to DTC or
its nominee, as the case may be, as the registered holder of
such global debentures.
We will pay principal of certificated debentures at the office
or agency designated by the Company in the borough of Manhattan,
the City of New York. We have initially designated Citibank,
N.A. as our paying agent and registrar and its corporate trust
office in New York, New York, as a place where debentures may be
presented for payment or for registration of transfer. We may,
however, change the paying agent or registrar without prior
notice to the holders of the debentures, and we may act as
paying agent or registrar. Interest (including additional
interest, if any) on certificated debentures will be payable
(i) to holders having an aggregate principal amount of
$2,000,000 or less, by check mailed to the holders of these
debentures and (ii) to holders having an aggregate
principal amount of more than $2,000,000, either by check mailed
to each holder or, upon application by a holder to the registrar
not later than the relevant record date (as defined below), by
wire transfer in immediately available funds to that
holders account within the United States, which
application shall remain in effect until the holder notifies the
registrar to the contrary in writing.
A holder of debentures may transfer or exchange debentures at
the office of the registrar in accordance with the indenture.
The registrar and the trustee may require a holder, among other
things, to furnish appropriate endorsements and transfer
documents, including signature guarantees. No service charge
will be imposed by the Company, the trustee or the registrar for
any registration of transfer or exchange of debentures, but the
Company may require a holder to pay a sum sufficient to cover
any transfer tax or other similar governmental charge required
by law or permitted by the indenture. The Company is not
required to transfer or exchange any debenture selected for
redemption or surrendered for conversion. Also, the Company is
not required to register any transfer or exchange of any
debenture for a period of 15 days before the mailing of a
notice of redemption.
The debentures bear interest from December 16, 2005 at a
rate of 2.95% per year. We will also pay contingent
interest (as defined below) on the debentures in the
circumstances described under Contingent
interest. Subject to the provisions set forth under
Option to extend interest payment
period, we will pay interest semi-annually in arrears on
June 15 and December 15 of each year to the holders of record at
the close of business on the preceding June 1 and
December 1 (each such date, in respect of the debentures, a
record date), respectively, beginning June 15,
2006; provided that:
|
|
|
|
|
we will not pay interest accrued and unpaid or deferred interest
(as defined below) on any debentures that are converted into our
common stock. See Conversion rights. If
a holder of debentures |
S-18
|
|
|
|
|
converts after a record date for an interest payment but prior
to the corresponding interest payment date, the holder on the
record date will receive the interest payable on the interest
payment date, notwithstanding the conversion of such debentures
prior to such interest payment date, because that holder will
have been the holder of record on the corresponding record date.
However, at the time the holder surrenders those debentures for
conversion, except as provided below, it must pay us an amount
equal to the interest that will be paid on the related interest
payment date. The preceding sentence does not apply, however, to
(i) a holder that converts debentures that have been called
by us for redemption and in respect of which we have specified a
redemption date that is after a record date but on or prior to
the corresponding interest payment date, (ii) a holder that
converts debentures in respect of which we have specified a
fundamental change repurchase date (as defined below) that is
after a record date but on or prior to the corresponding
interest payment date or (iii) a holder that converts
debentures following the regular record date immediately
preceding the final interest payment date. Accordingly, a holder
of debentures who chooses to convert its debentures under any of
the circumstances described in clauses (i), (ii) or
(iii) above will not be required to pay us, at the time it
surrenders the debentures for conversion, the amount of interest
on the debentures that it would have received on the interest
payment date if the debentures had not been called for
redemption, repurchased by us or converted, as applicable. In
addition, a holder that surrenders debentures for conversion
will not be required to pay us any deferred interest or overdue
interest that exists at the time of the conversion, regardless
of whether such conversion occurs during the period between a
record date for an interest payment and the corresponding
interest payment date; |
|
|
|
we will pay interest to a person other than the holder of record
on the record date for an interest payment if we redeem the
debentures on a date that is after the record date and prior to
such interest payment date. In this instance, we will pay
accrued and unpaid interest on the debentures being redeemed, to
but not including the redemption date, to the same person to
whom we will pay the principal of such debentures; |
|
|
|
the record and payment dates for a contingent interest payment
relating to an extraordinary dividend (as defined below) will be
set by our board of directors in connection with the declaration
of such dividend, and may not correspond to the semi-annual
record and payment dates described above; and |
|
|
|
our delivery to a holder of shares of our common stock into
which a debenture is convertible, together with any cash payment
for such holders fractional shares, will be deemed to
satisfy our obligation to pay accrued and unpaid interest,
including any deferred interest, attributable to the period from
the issue date through the conversion date. As a result, we will
treat such interest as paid in full upon settlement rather than
cancelled, extinguished or forfeited. |
All references herein to interest shall include compounded
interest (as defined below) unless otherwise stated.
Subject to the accrual, record date and payment provisions
described above, beginning with the semi-annual interest period
commencing on December 15, 2010, contingent interest
(contingent interest) will accrue:
|
|
|
|
|
during any semi-annual interest period where the average trading
price of the debentures (as determined below) for the ten
trading days immediately preceding the first day of such
semi-annual period is greater than or equal to the upside
trigger (as defined below), in which case such contingent
interest will be payable at a rate per annum equal to 0.40% of
such average trading price; and |
|
|
|
during any semi-annual interest period where the average trading
price of the debentures for the ten trading days immediately
preceding the first day of such semi-annual period is less than
or equal to the downside trigger (as defined below), in which
case such contingent interest will be payable at a rate per
annum equal to 0.25% of such average trading price. |
S-19
In addition, we will pay contingent interest at any time the
debentures are outstanding upon the declaration by our board of
directors of an extraordinary cash dividend or distribution to
all or substantially all holders of our common stock that our
board of directors designates as payable with respect to the
debentures (an extraordinary dividend), in which
case such contingent interest will be payable on the same date
as, and in an amount equal to, the dividend or distribution that
a holder of debentures would have received had such holder
converted its debentures immediately prior to the record date
for the payment of such dividend or distribution to holders of
our common stock.
Upside trigger means $1,300 per $1,000
principal amount of debentures.
Downside trigger means $800 per $1,000
principal amount of debentures during the period prior to
December 15, 2020. Beginning on December 15, 2020 and
ending on December 15, 2034, the downside trigger will
increase in increments of $10 per $1,000 principal amount
of debentures per year on December 15 of each year within such
period. For example, the downside trigger will be $820 per
$1,000 principal amount of debentures during the period
commencing on December 15, 2021 and ending on
December 14, 2022.
We will notify the trustee upon a determination that contingent
interest on the debentures will accrue during a relevant
semi-annual period or upon declaration by our board of directors
of an extraordinary dividend that our board of directors
designates as payable with respect to the debentures.
The trading price of the debentures on any date of
determination means the average of the secondary market bid
quotations per $1,000 principal amount of debentures obtained by
the trustee for $5.0 million principal amount of debentures
at approximately 3:30 p.m., New York City time, on such
determination date from three independent nationally recognized
securities dealers we select; provided that if at least three
such bids cannot reasonably be obtained by the trustee, but two
such bids are obtained, then the average of the two bids shall
be used, and if only one such bid can reasonably be obtained by
the trustee, that one bid shall be used. We will provide prompt
written notice to the trustee identifying the three independent
nationally recognized securities dealers selected by us. If the
trustee cannot reasonably obtain at least one bid for
$5.0 million principal amount of debentures from an
independent nationally recognized securities dealer selected by
us and identified in writing to the trustee or, in the
reasonable judgment or our board of directors (acting through
the board or a committee thereof), the bid quotations are not
indicative of the secondary market value of the debentures, then
the trading price per $1,000 principal amount of debentures will
be determined by our board of directors (acting through the
board or a committee thereof) based on a good faith estimate of
the fair value of the debentures; provided that the trustee
shall not determine the trading price of the debentures unless
requested by us to do so; and provided, further, that we shall
have no obligation to make such request unless a holder of
debentures provides us with reasonable evidence that the trading
price of the debentures is greater than or equal to the upside
trigger or is less than or equal to the downside trigger; at
which time we will instruct the trustee to determine the trading
price of the debentures in the manner described herein beginning
on the next trading day and on each successive trading day until
the trading price of the debentures is less than or equal to the
upside trigger or is greater than or equal to the downside
trigger, as applicable. The trustee shall be entitled to all of
the rights of the trustee set forth in the indenture in
connection with any such determination, and any such
determination shall be conclusive absent manifest error.
|
|
|
Option to extend interest payment period |
So long as we are not in default in the payment of interest on
the debentures, we will have the right to extend the interest
payment period (such extended period, an extension
period), including the period for payment of any
contingent interest other than extraordinary dividends and
additional interest (together with the interest regularly
payable on the debentures, deferred interest), from
time to time for a period not exceeding 10 consecutive
semi-annual interest periods, provided that such extension
period shall terminate upon the occurrence of a default or event
of default, and provided further that no extension period shall
extend beyond the maturity date of the debentures. We have no
current intention of exercising our right to extend an interest
payment period. No deferred interest will be due and payable
during an extension period, except at the end thereof, but
deferred interest will continue to accrue and all such accrued
and unpaid deferred interest will
S-20
itself bear interest at the comparable yield rate (as defined
below), compounded semi-annually (compounded
interest). During any extension period, we will not
(i) declare or pay any dividends on, or redeem, purchase,
acquire or make a distribution or liquidation payment with
respect to, any of our common stock or preferred stock, or make
any guarantee payments with respect thereto (provided that the
foregoing will not apply (a) to repurchases, redemptions or
other acquisitions of shares of our capital stock in connection
with any employment contract, benefit plan or other similar
arrangement with or for the benefit of employees, officers,
directors or consultants, which contract, plan or arrangement is
approved by our board of directors, (b) as a result of an
exchange or conversion of any class or series of our capital
stock for any other class or series of our capital stock,
(c) to the purchase of fractional interests in shares of
our capital stock pursuant to the conversion or exchange
provisions of such capital stock or the security being converted
or exchanged or (d) to stock dividends or other stock
distributions (including rights, warrants or options to purchase
capital stock) paid by us) or (ii) make any payment of
principal, interest or premium, if any, on or repay, repurchase
or redeem any of our debt securities that rank in right of
payment pari passu with, or junior to, the debentures. In
addition, we may not redeem the debentures at our option or give
notice of a redemption at our option during an extension period
or while there is any accrued and unpaid deferred interest with
respect to the debentures. Prior to the termination of any
extension period, we may further extend the interest payment
period; provided that such extension period will be subject to
the limitations described above and, together with all such
previous and further extensions thereof, may not exceed 10
consecutive semi-annual interest payment periods or extend
beyond the maturity of the debentures.
On the first interest payment date occurring on or after the end
of each extension period, we will pay to the holders of
debentures of record on the record date for such interest
payment date, regardless of who the holders of record may have
been on other dates during the extension period, (i) all
accrued and unpaid deferred interest on the debentures and
(ii) compounded interest. Upon the termination of any
extension period and the payment of all amounts then due, we may
commence a new extension period, subject to the above
requirements. We may also prepay at any time, in accordance with
the notice provisions contained in the indenture, all or any
portion of the deferred interest accrued during an extension
period. Consequently, there could be multiple extension periods
of varying lengths throughout the term of the debentures, not to
exceed 10 consecutive semi-annual interest payment periods;
provided, that no such period may extend beyond the stated
maturity of the debentures. The failure by us to make deferred
interest payments during an extension period will not constitute
a default or an event of default under the indenture or our
currently outstanding indebtedness.
Comparable yield rate means the annual interest rate
that Intel would pay, as of the initial issue date of the
debentures, on a fixed-rate nonconvertible debt security with no
contingent payments, but with terms and conditions otherwise
comparable to those of the debentures. We have determined the
comparable yield rate for the debentures to be an annual rate of
6.45%, compounded semi-annually.
Our settlement of conversions during an extension period will be
deemed to satisfy our obligation to pay the principal amount of
the debenture and accrued and unpaid interest, including
deferred interest and compounded interest, if any, to, but not
including, the conversion date. As a result, accrued and unpaid
interest, including deferred interest and compounded interest,
if any, to, but not including, the conversion date will be
deemed to be paid in full rather than cancelled, extinguished or
forfeited.
We will give notice to the trustee of our election of such
extension period at least sixteen calendar days prior to the
earlier of (i) the next succeeding interest payment date or
(ii) the date we are required to give notice to The Nasdaq
National Market (if the debentures are then listed thereon) or
other applicable self-regulatory organization or to holders of
the debentures of the record or payment date of such related
interest payment.
The payment of the principal, any premium and interest on the
debentures, including amounts payable on any redemption or
repurchase, will be subordinated to the prior payment in full of
all of our senior debt. The debentures are also effectively
subordinated to any debt or other liabilities of our
subsidiaries.
S-21
As of December 31, 2005, the aggregate amount of our
outstanding senior debt was approximately $171.9 million,
and the aggregate amount of indebtedness and other liabilities
of our subsidiaries was approximately $2.8 billion,
excluding intercompany liabilities and liabilities of a type not
required to be reflected on the balance sheet of such
subsidiaries in accordance with generally accepted accounting
principles.
Senior debt is defined in the indenture to mean the
principal of (and premium, if any) and interest (including all
interest accruing subsequent to the commencement of any
bankruptcy or similar proceeding, whether or not a claim for
post-petition interest is allowable as a claim in any such
proceeding) on, and all fees and other amounts payable in
connection with, the following, whether absolute or contingent,
secured or unsecured, due or to become due, outstanding on the
date of the indenture or thereafter created, incurred or assumed:
|
|
|
|
|
our indebtedness evidenced by a credit or loan agreement, note,
bond, debenture or other written obligation; |
|
|
|
all of our obligations for money borrowed; |
|
|
|
all of our obligations evidenced by a note or similar instrument; |
|
|
|
our obligations (i) as lessee under leases required to be
capitalized on the balance sheet of the lessee under generally
accepted accounting principles or (ii) as lessee under
other leases for facilities, capital equipment or related
assets, whether or not capitalized, entered into or leased for
financing purposes; |
|
|
|
all of our obligations under interest rate and currency swaps,
caps, floors, collars, hedge agreements, forward contracts or
similar agreements or arrangements; |
|
|
|
all of our obligations with respect to letters of credit,
bankers acceptances and similar facilities (including
reimbursement obligations with respect to the foregoing); |
|
|
|
all of our obligations issued or assumed as the deferred
purchase price of property or services (but excluding trade
accounts payable and accrued liabilities arising in the ordinary
course of business); |
|
|
|
all obligations of the type referred to in the above clauses of
another person and all dividends of another person, the payment
of which, in either case, we have assumed or guaranteed, or for
which we are responsible or liable, directly or indirectly,
jointly or severally, as obligor, guarantor or otherwise, or
which are secured by a lien on our property; and |
|
|
|
renewals, extensions, modifications, replacements, restatements
and refundings of, or any indebtedness or obligation issued in
exchange for, any such indebtedness or obligation described in
the above clauses of this definition. |
Senior debt will not include (i) the debentures,
(ii) any other indebtedness or obligation if its terms or
the terms of the instrument under which or pursuant to which it
is issued expressly provide that it is not superior in right of
payment to the debentures, (iii) any indebtedness or
obligation of ours to any of our subsidiaries or (iv) trade
payables.
We may not make any payment on account of principal, premium or
interest (including additional interest, if any) on the
debentures, or redeem or repurchase the debentures, if either of
the following occurs:
|
|
|
|
|
we default in our obligations to pay principal, premium,
interest or other amounts on our senior debt, including a
default under any redemption or repurchase obligation, and the
default continues beyond any grace period that we may have to
make those payments; or |
|
|
|
any other default occurs and is continuing on any designated
senior debt (a nonpayment default) and (i) the
default permits the holders of the designated senior debt to
accelerate its maturity and (ii) the trustee has received a
notice (a payment blockage notice) of the default
from the Company, the holder of such debt or such other person
permitted to give such notice under the indenture. |
S-22
If payments on the debentures have been blocked by a payment
default on senior debt, payments on the debentures may resume
when the payment default has been cured or waived or ceases to
exist. If payments on the debentures have been blocked by a
nonpayment default, payments on the debentures may resume on the
earlier of (i) the date the nonpayment default is cured or
waived or ceases to exist and (ii) 179 days after the
payment blockage notice is received.
No nonpayment default that existed on the day a payment blockage
notice was delivered to the trustee can be used as the basis for
any subsequent payment blockage notice. In addition, once a
holder of designated senior debt has blocked payment on the
debentures by giving a payment blockage notice, no new period of
payment blockage can be commenced pursuant to a subsequent
payment blockage notice until both of the following are
satisfied:
|
|
|
|
|
365 days have elapsed since the effectiveness of the
immediately prior payment blockage notice; and |
|
|
|
all scheduled payments of principal, any premium and interest
with respect to the debentures that have come due have been paid
in full in cash. |
Designated senior debt means our obligations under
any particular senior debt in which the instrument creating or
evidencing the same or the assumption or guarantee thereof (or
related agreements or documents to which we are a party)
expressly provides that such indebtedness shall be
designated senior debt for purposes of the
indenture. The instrument, agreement or other document
evidencing any designated senior debt may place limitations and
conditions on the right of such senior debt to exercise the
rights of designated senior debt.
Upon any acceleration of the principal due on the debentures as
a result of an event of default or payment or distribution of
our assets to creditors upon any dissolution, winding up,
liquidation or reorganization, whether voluntary or involuntary,
marshaling of assets, assignment for the benefit of creditors,
or in bankruptcy, insolvency, receivership or other similar
proceedings, all principal, premium, if any, interest and other
amounts due on all senior debt must be paid in full before you
are entitled to receive any payment. See Events of
default. By reason of such subordination, in the event of
insolvency, our creditors who are holders of senior debt are
likely to recover more, ratably, than you are, and you will
likely experience a reduction or elimination of payments on the
debentures.
In addition to the contractual subordination provisions
described above, the debentures will also be structurally
subordinated to all indebtedness and other liabilities,
including trade payables and lease obligations, of our
subsidiaries. This occurs because any right of Intel to receive
any assets of its subsidiaries upon their liquidation or
reorganization, and the right of the holders of the debentures
to participate in those assets, will be effectively subordinated
to the claims of that subsidiarys creditors, including
trade creditors, except to the extent that Intel itself is
recognized as a creditor of such subsidiary, in which case the
claims of Intel would still be subordinate to any security
interest in the assets of the subsidiary and any indebtedness of
the subsidiary senior to that held by Intel. The ability of our
subsidiaries to pay dividends and make other payments to us is
also restricted by, among other things, applicable corporate and
other laws and regulations as well as agreements to which our
subsidiaries are or may become a party.
The indenture does not limit our ability to incur senior debt or
our ability or the ability of our subsidiaries to incur any
other indebtedness or liabilities.
We may not be able to comply with the provision of the
debentures that provides that upon a fundamental change each
holder may require us to repurchase all or a portion of the
debentures. In addition, we advise you that there may not be
sufficient assets remaining to pay amounts due on the debentures
then outstanding in the event of our bankruptcy, liquidation,
reorganization or other winding up.
Conversion rights
Holders of the debentures may convert outstanding debentures
into our common stock at an initial conversion rate of
31.7162 shares of common stock per $1,000 principal amount
(equivalent to a conversion
S-23
price of approximately $31.53 per share of common stock) at
any time prior to the close of business on the trading day
immediately preceding the maturity date.
The conversion rate and the equivalent conversion price in
effect at any given time are referred to as the applicable
conversion rate and the applicable conversion
price, respectively, and will be subject to adjustment as
described below. The conversion price at any given time will be
computed by dividing $1,000 by the applicable conversion rate at
such time. A holder may convert fewer than all of such
holders debentures so long as debentures are converted in
an integral multiple of $1,000 principal amount.
Upon conversion, you will not receive any separate cash payment
for accrued and unpaid interest, including contingent interest,
additional interest and compounded interest, if any, unless such
conversion occurs between a regular record date and the interest
payment date to which it relates and you were the holder of
record on such record date. We will not issue fractional shares
of our common stock upon conversion of debentures and in
connection with conversions of debentures to the extent shares
would otherwise be issued in excess of certain limitations
imposed by Nasdaq listing requirements. Instead, we will pay
cash based on the last reported sale price of our common stock
on the trading day prior to the conversion date. Our settlement
of conversions as described herein will be deemed to satisfy our
obligation to pay:
|
|
|
|
|
the principal amount of the debenture; and |
|
|
|
accrued and unpaid interest, including contingent interest,
additional interest, deferred interest and compounded interest,
if any, to, but not including, the conversion date. |
As a result, accrued and unpaid interest, including contingent
interest, additional interest, deferred interest and compounded
interest, if any, to, but not including, the conversion date
will be deemed to be paid in full rather than cancelled,
extinguished or forfeited.
Notwithstanding the preceding paragraph, if debentures are
converted after 5:00 p.m., New York City time, on a record
date, holders of such debentures at 5:00 p.m., New York
City time, on the record date will receive the interest,
including contingent interest, additional interest and
compounded interest, if any, payable on such debentures on the
corresponding interest payment date notwithstanding the
conversion. If debentures are surrendered for conversion during
the period from 5:00 p.m., New York City time, on any
regular record date to 9:00 a.m., New York City time, on
the immediately following interest payment date, such debentures
must be accompanied by funds equal to the amount of such
interest payable on the debentures so converted; provided that
no such payment need be made:
|
|
|
|
|
if we have specified a redemption date that is after a record
date and on or prior to the corresponding interest payment date; |
|
|
|
if we have specified a fundamental change repurchase date (as
defined below) that is after a record date and on or prior to
the corresponding interest payment date; |
|
|
|
for conversions following the regular record date immediately
preceding the final interest payment date; or |
|
|
|
to the extent of any deferred or overdue interest, if any
deferred or overdue interest exists at the time of conversion
with respect to such debenture. |
If a holder converts debentures, we will pay any documentary,
stamp or similar issue or transfer tax due on the issuance of
any shares of our common stock upon the conversion, unless the
tax is due because the holder requests any shares to be issued
in a name other than the holders name or the tax is
imposed by any taxing authority outside the United States, in
which case the holder will pay that tax.
In respect of any debenture presented for conversion, we may, at
our option, in lieu of delivering shares of common stock, elect
to pay the holder surrendering such debenture an amount of cash
equal to the average of the last reported sale price (as defined
below) for our common stock for the five consecutive trading
days immediately following (i) the date of delivery of
notice of our election to deliver cash as described below if we
have not given notice of redemption or (ii) the conversion
date, in the case of a conversion following our notice of
redemption with respect to such debenture, specifying that we
intend to deliver cash upon
S-24
conversion, in either case multiplied by the number of shares of
common stock issuable upon conversion of such debenture on that
date. We will inform holders of our election to deliver shares
of common stock or to pay cash in lieu of the delivery of such
shares by delivering an irrevocable written notice to the
trustee and the paying agent prior to the close of business on
the second business day after the conversion date, unless we
have already informed holders of our election by delivering an
irrevocable notice in connection with our optional redemption of
the debentures as described under Optional
redemption. If we deliver only shares of common stock upon
conversion, such shares will be delivered through the conversion
agent no later than the fifth business day following the
conversion date. If we elect to satisfy all or a portion of our
obligation to deliver shares upon conversion in cash, the
payment, including any delivery of common stock, will be made to
holders surrendering debentures no later than the tenth business
day following the applicable conversion date. If an event of
default, as described under Events of
default, has occurred and is continuing, we may not pay
cash upon conversion of any debentures (other than cash in lieu
of fractional shares).
A business day is any day other than Saturday,
Sunday or any other day on which banking institutions in the
City of New York are authorized or required by any applicable
law to close.
The last reported sale price of our common stock on
any date means the closing sale price per share (or if no
closing sale price is reported, the average of the bid and ask
prices or, if more than one in either case, the average of the
average bid and the average ask prices) on that date as reported
by The Nasdaq National Market or, if our common stock is not
quoted on The Nasdaq National Market, then on the principal
U.S. national or regional securities exchange on which our
common stock is then listed. If our common stock is not either
quoted on The Nasdaq National Market or listed on any
U.S. national or regional securities exchange on the
relevant date, the last reported sale price will be
the last quoted bid price for our common stock in the
over-the-counter market
on the relevant date as reported by the National Quotation
Bureau or similar organization. If our common stock is not so
quoted, the last reported sale price will be the
average of the mid-point of the last bid and ask prices for our
common stock on the relevant date from each of at least three
nationally recognized independent investment banking firms
selected by us for this purpose.
Conversion procedures
If you hold a beneficial interest in a global debenture, to
convert you must comply with DTCs procedures for
converting a beneficial interest in a global debenture and, if
required, pay funds equal to interest payable on the next
interest payment date.
If you hold a certificated debenture, to convert you must:
|
|
|
|
|
complete and manually sign the conversion notice on the back of
the debenture, or a facsimile of the conversion notice; |
|
|
|
deliver the conversion notice, which is irrevocable, and the
debenture to the conversion agent; |
|
|
|
if required, furnish appropriate endorsements and transfer
documents; |
|
|
|
if required, pay all transfer or similar taxes; and |
|
|
|
if required, pay funds equal to interest payable on the next
interest payment date. |
The date you comply with these requirements is the
conversion date under the indenture.
When a holder surrenders debentures for conversion, the
conversion agent at our election may first offer the debentures
to a financial institution chosen by us for exchange in lieu of
conversion. The designated institution will have the option, but
not the obligation (unless separately agreed to by it and us at
the time), to exchange those debentures for the number of shares
of our common stock and the amount of cash, if any, that the
holder of those debentures is entitled to receive upon
conversion. We may, but will not be obligated to, enter into a
separate agreement with the designated institution that would
compensate it for any such transaction. In the event that
debentures are exchanged by a designated institution in lieu of
conversion, the designated institution will deliver through the
conversion agent the number of shares of common stock and the
amount of cash, if any, that the holder is entitled to receive
upon conversion. Delivery to the holder of such
S-25
common stock and cash will be deemed to satisfy our obligation
to pay the principal amount and accrued and unpaid interest,
including contingent interest, additional interest and
compounded interest, if any, to, but not including, the
conversion date, regardless of whether such delivery is made by
us or by the designated institution.
If a holder has already delivered a repurchase notice as
described under Fundamental change permits holders to
require us to repurchase debentures with respect to a
debenture, the holder may not surrender that debenture for
conversion until the holder has withdrawn the notice in
accordance with the indenture.
Conversion rate adjustments
The conversion rate will be adjusted as described below, except
that we will not make any adjustments to the conversion rate if
holders of the debentures participate, as a result of holding
the debentures, in any of the transactions described below
without having to convert their debentures.
|
|
|
(1) If we issue shares of our common stock as a dividend or
distribution on shares of our common stock, or if we effect a
share split or share combination, the conversion rate will be
adjusted based on the following formula: |
|
|
|
where, |
|
|
CR(0) = the conversion rate in effect immediately
prior to such event; |
|
|
CR = the conversion rate in effect immediately
after such event; |
|
|
OS(0) = the number of shares of our common stock
outstanding immediately prior to such event; and |
|
|
OS = the number of shares of our common stock
outstanding immediately after such event. |
|
|
|
(2) If we issue to all or substantially all holders of our
common stock any rights or warrants entitling them for a period
of not more than 45 calendar days to subscribe for or purchase
shares of our common stock at a price per share less than the
last reported sale price of our common stock, then on the day
immediately preceding the date of announcement of such issuance,
the conversion rate will be adjusted based on the following
formula (provided that the conversion rate will be readjusted to
the extent that such rights or warrants are not exercised prior
to their expiration): |
|
|
|
|
|
|
|
|
|
|
|
CR = CR(0) |
|
|
× |
|
|
OS(0) + X
OS(0) + Y |
|
|
|
where, |
|
|
CR(0) = the conversion rate in effect immediately
prior to such event; |
|
|
CR = the conversion rate in effect immediately
after such event; |
|
|
OS(0) = the number of shares of our common stock
outstanding immediately prior to such event; |
|
|
X = the total number of shares of our common stock
issuable pursuant to such rights; and |
|
|
Y = the number of shares of our common stock equal to
the aggregate price payable to exercise such rights divided by
the average of the last reported sale prices of our common stock
over the ten consecutive trading-day period ending on the
business day immediately preceding the record date for the
issuance of such rights. |
S-26
|
|
|
(3) If we distribute shares of our capital stock, evidences
of our indebtedness or other assets or property of ours to all
or substantially all holders of our common stock, excluding: |
|
|
|
|
|
dividends or distributions and rights or warrants referred to in
clause (1) or (2) above or clause (5)
below; and |
|
|
|
dividends or distributions paid exclusively in cash, including
as described in clause (4) below; and |
|
|
|
dividends or distributions in connection with a reclassification
merger, sale or conveyance resulting in a change in the
conversion consideration below |
|
|
|
then the conversion rate will be adjusted based on the following
formula: |
|
|
|
|
|
|
|
|
|
CR = CR(0) |
|
× |
|
SP(0)
SP(0) - FMV |
|
|
|
where, |
|
|
CR(0) = the conversion rate in effect immediately
prior to such distribution; |
|
|
CR = the conversion rate in effect immediately
after such distribution; |
|
|
SP(0) = the average of the last reported sale prices
of our common stock over the ten consecutive trading-day period
ending on the business day immediately preceding the record date
for such distribution (or, if earlier, the ex-date
relating to such distribution); and |
|
|
FMV = the fair market value (as determined by our
board of directors) of the shares of capital stock, evidences of
indebtedness, assets or property distributed with respect to
each outstanding share of our common stock on the record date
for such distribution. |
|
|
|
With respect to an adjustment pursuant to this clause (3)
where there has been a payment of a dividend or other
distribution on our common stock or shares of capital stock of
any class or series, or similar equity interest, of or relating
to a subsidiary or other business unit, which we refer to as a
spin-off, the conversion rate in effect immediately
before 5:00 p.m., New York City time, on the record date
fixed for determination of stockholders entitled to receive the
distribution will be increased based on the following formula: |
|
|
|
|
|
|
|
|
|
CR = CR(0) |
|
× |
|
FMV(0) + MP(0)
MP(0) |
|
|
|
where, |
|
|
CR(0) = the conversion rate in effect immediately
prior to such distribution; |
|
|
CR = the conversion rate in effect immediately
after such distribution; |
|
|
FMV(0) = the average of the last reported sale prices
of the capital stock or similar equity interest distributed to
holders of our common stock applicable to one share of our
common stock over the first ten consecutive trading-day period
after the effective date of the spin-off; and |
|
|
MP(0) = the average of the last reported sale prices
of our common stock over the first ten consecutive trading-day
period after the effective date of the spin-off. |
|
|
|
The adjustment to the conversion rate under the preceding
paragraph will occur on the tenth trading day from, and
including, the effective date of the spin-off. |
|
|
(4) If we pay any cash dividend or distribution to all or
substantially all holders of our common stock (other than an
extraordinary cash dividend or distribution that our board of
directors designates as |
S-27
|
|
|
payable with respect to the debentures), the conversion rate
will be adjusted based on the following formula: |
|
|
|
|
|
|
|
|
|
|
|
CR = CR(0) |
|
|
× |
|
|
SP(0)
SP(0) - C |
|
|
|
where, |
|
|
CR(0) = the conversion rate in effect immediately
prior to the record date for such distribution; |
|
|
CR = the conversion rate in effect immediately
after the record date for such distribution; |
|
|
SP(0) = the last reported sale price of our common
stock on the trading day immediately preceding the record date
for such distribution (or, if earlier, the ex-date
relating to such distribution); and |
|
|
C = the amount in cash per share we distribute to
holders of our common stock that exceeds $0.10 per quarter
(appropriately adjusted from time to time for any share
dividends on, or subdivisions or combinations of, our common
stock). |
|
|
|
(5) If we or any of our subsidiaries makes a payment in
respect of a tender offer or exchange offer for our common stock
subject to the tender offer rules, to the extent that the cash
and value of any other consideration included in the payment per
share of common stock exceeds the last reported sale price of
our common stock on the trading day next succeeding the last
date on which tenders or exchanges may be made pursuant to such
tender or exchange offer, the conversion rate will be increased
based on the following formula: |
|
|
|
|
|
|
|
|
|
|
|
CR = CR(0) |
|
|
× |
|
|
AC + (SP × OS)
OS(0) + SP |
|
|
|
where, |
|
|
CR(0) = the conversion rate in effect on the date such
tender or exchange offer expires; |
|
|
CR = the conversion rate in effect on the day
next succeeding the date such tender or exchange offer expires; |
|
|
AC = the aggregate value of all cash and any other
consideration (as determined by our board of directors) paid or
payable for shares purchased in such tender or exchange offer; |
|
|
OS(0) = the number of shares of our common stock
outstanding immediately prior to the date such tender or
exchange offer expires (including any purchased shares); |
|
|
OS = the number of shares of our common stock
outstanding immediately after the date such tender or exchange
offer expires (not including any purchased shares); and |
|
|
SP = the average of the last reported sale
prices of our common stock over the ten consecutive trading-day
period commencing on the trading day next succeeding the date
such tender or exchange offer expires. |
|
|
|
Notwithstanding the above, certain listing standards of The
Nasdaq National Market may limit the amount by which we may
increase the conversion rate pursuant to the events described in
clauses (2) through (5) and as described in
Adjustment to shares delivered upon conversion upon
certain fundamental charges below. These standards
generally require us to obtain the approval of our stockholders
before entering into certain transactions that potentially
result in the issuance of 20% or more of our common stock
outstanding at the time the debentures are issued unless we
obtain stockholder approval of issuances in excess of such
limitations. In accordance with these listing standards, these
restrictions will apply at any time when the debentures are
outstanding, regardless of whether we then have a class of
securities quoted on The Nasdaq National Market. Accordingly, in
the event of an |
S-28
|
|
|
increase in the conversion rate above that which would result in
the debentures, in the aggregate, becoming convertible into
shares in excess of such limitations, we will either obtain
stockholder approval of such issuances or deliver cash in lieu
of any shares otherwise deliverable upon conversions in excess
of such limitations (based on the last reported sale price of
our common stock on the trading day immediately prior to the
conversion date). |
In addition, in no event will we adjust the conversion rate to
the extent that the adjustment would reduce the conversion price
below the par value per share of our common stock.
As used in this section, ex-date means the first
date on which the shares of our common stock trade on the
applicable exchange or in the applicable market, regular way,
without the right to receive the issuance or distribution in
question.
Except as stated herein, we will not adjust the conversion rate
for the issuance of shares of our common stock or any securities
convertible into or exchangeable for shares of our common stock
or the right to purchase shares of our common stock or such
convertible or exchangeable securities.
In the event of:
|
|
|
|
|
any reclassification of our common stock; |
|
|
|
a consolidation, merger or combination involving us; or |
|
|
|
a sale or conveyance to another person of all or substantially
all of our property and assets, |
in which holders of our outstanding common stock would be
entitled to receive cash, securities or other property for their
shares of common stock, you will be entitled thereafter to
convert your debentures into the kind of cash, securities or
other properties that the holder would have received if the
holder had converted such debentures immediately prior to such
transaction. In such a case, any increase in the conversion rate
by the additional shares as described under Adjustment to
shares delivered upon conversion upon certain fundamental
changes will not be payable in shares of our common stock,
but will represent a right to receive the aggregate amount of
cash, securities or other property into which the additional
shares would convert in the transaction from the surviving
entity (or an indirect or direct parent thereof).
Notwithstanding the first sentence of this paragraph, if we
elect to adjust the conversion rate and our conversion
obligation as described in Conversion after a public
acquiror change of control, the provisions of that section
will apply instead of the provisions described in the first
sentence of this paragraph. If the transaction also constitutes
a fundamental change (as defined below), a holder can require us
to repurchase all or a portion of its debentures as described
below under Fundamental change permits holders to require
us to repurchase debentures.
For purposes of the foregoing, the type and amount of
consideration that a holder of our common stock would have been
entitled to receive in the case of reclassifications,
consolidations, mergers, sales or transfers of assets or other
transactions that cause our common stock to be converted into
the right to receive more than a single type of consideration
(determined based in part upon any form of stockholder election)
will be deemed to be the weighted average of the types and
amounts of consideration received by the holders of our common
stock that affirmatively make such an election.
We are permitted, to the extent permitted by law and subject to
the applicable rules of The Nasdaq National Market (if we are
then listed on The Nasdaq National Market), to increase the
conversion rate of the debentures by any amount for a period of
at least twenty days if our board of directors determines that
such increase would be in our best interest. We may also (but
are not required to) increase the conversion rate to avoid or
diminish income tax to holders of our common stock or rights to
purchase shares of our common stock in connection with a
dividend or distribution of shares (or rights to acquire shares)
or similar event.
A holder of debentures may, in some circumstances, including the
distribution of cash dividends to holders of our shares of
common stock, be deemed to have received a distribution or
dividend subject to U.S. federal income tax as a result of
an adjustment or the nonoccurrence of an adjustment to the
conversion rate. For a discussion of the U.S. federal
income tax treatment of an adjustment to the conversion rate,
see Material United States federal income tax
considerations.
S-29
We do not currently have a preferred stock rights plan. To the
extent that we have a rights plan in effect upon conversion of
the debentures into common stock, you will receive, in addition
to the common stock, the rights under the rights plan, unless
prior to any conversion, the rights have separated from the
common stock, in which case the conversion rate will be adjusted
at the time of separation as if we distributed to all holders of
our common stock, shares of our capital stock, evidences of
indebtedness or assets as described in clause (3) above,
subject to readjustment in the event of the expiration,
termination or redemption of such rights.
The applicable conversion rate will not be adjusted:
|
|
|
|
|
upon the issuance of any shares of our common stock pursuant to
any present or future plan providing for the reinvestment of
dividends or interest payable on our securities and the
investment of additional optional amounts in shares of our
common stock under any plan; |
|
|
|
upon the issuance of any shares of our common stock or options
or rights to purchase those shares pursuant to any present or
future employee, director or consultant benefit plan or program
of or assumed by us or any of our subsidiaries; |
|
|
|
upon the issuance of any shares of our common stock pursuant to
any option, warrant, right or exercisable, exchangeable or
convertible security not described in the preceding bullet and
outstanding as of the date the debentures were first issued; |
|
|
|
for a change in the par value of the common stock; or |
|
|
|
for accrued and unpaid interest, including contingent interest,
additional interest or compounded interest, if any. |
Adjustments to the applicable conversion rate will be calculated
to the nearest 1/10,000th of a share. We will not be
required to make an adjustment in the conversion rate unless the
adjustment would require a change of at least 1% in the
conversion rate. However, we will carry forward any adjustments
that are less than 1% of the conversion rate and take them into
account in any subsequent adjustment of the conversion rate or
in connection with any conversion of the debentures following a
call for redemption, upon a fundamental change or at maturity,
as applicable. Except as described above in this section and as
described under Adjustment to shares delivered upon
conversion upon certain fundamental changes, we will not
adjust the conversion rate.
Adjustment to shares delivered upon conversion upon certain
fundamental changes
If you elect to convert your debentures at any time beginning 30
business days prior to the anticipated effective date of a
make-whole fundamental change (as defined below)
until the related fundamental change repurchase date (or, if
there is no fundamental change repurchase date because the 105%
exception is applicable, then until 30 business days following
the date of such fundamental change (determined without regard
to the 105% exception)), the conversion rate will be increased
by an additional number of shares of common stock (the
additional shares) as described below. We will
notify holders of the debentures, the trustee and the paying
agent of the occurrence and anticipated effective date of a
make-whole fundamental change and issue a press release no later
than 30 business days prior to the anticipated effective date of
such transaction or, if we obtain knowledge of the occurrence of
a make-whole fundamental change less than 30 business days
prior to the anticipated effective date of such transaction, no
later than three business days after we obtain such knowledge.
We will settle conversions of debentures as described below
under Settlement of conversions in a
make-whole fundamental change.
A make-whole fundamental change means any
transaction or event that constitutes a fundamental change
pursuant to clause (2) under the definition of fundamental
change as described under Fundamental change permits
holders to require us to repurchase debentures below
(determined without regard to the 105% exception).
The number of additional shares by which the conversion rate
will be increased will be determined by reference to the table
below, based on the date on which the fundamental change occurs
or becomes effective (the effective date) and the
price (the stock price) paid per share of our common
stock in the
S-30
fundamental change. If holders of our common stock receive only
cash in the fundamental change, the stock price will be the cash
amount paid per share. Otherwise, the stock price will be the
average of the last reported sale prices of our common stock
over the five trading-day period ending on the trading day
preceding the effective date of the fundamental change.
The stock prices set forth in the first row of the table below
(i.e., column headers) will be adjusted as of any date on which
the conversion rate of the debentures is otherwise adjusted. The
adjusted stock prices will equal the stock prices applicable
immediately prior to such adjustment, multiplied by a fraction,
the numerator of which is the conversion rate immediately prior
to the adjustment giving rise to the stock price adjustment and
the denominator of which is the conversion rate as so adjusted.
The number of additional shares will be adjusted in the same
manner as the conversion rate as set forth under
Conversion rate adjustments.
S-31
The following table sets forth the hypothetical stock price and
the number of additional shares to be received per $1,000
principal amount of debentures:
Stock Price
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effective |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date |
|
$26.72 | |
|
$30.00 | |
|
$35.00 | |
|
$40.00 | |
|
$45.00 | |
|
$50.00 | |
|
$55.00 | |
|
$60.00 | |
|
$65.00 | |
|
$70.00 | |
|
$75.00 | |
|
$80.00 | |
|
$85.00 | |
|
$90.00 | |
|
$95.00 | |
|
$100.00 | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
12/16/2005
|
|
|
5.7089 |
|
|
|
4.6174 |
|
|
|
3.3901 |
|
|
|
2.5971 |
|
|
|
2.0584 |
|
|
|
1.6763 |
|
|
|
1.3951 |
|
|
|
1.1813 |
|
|
|
1.0143 |
|
|
|
0.8805 |
|
|
|
0.7710 |
|
|
|
0.6799 |
|
|
|
0.6029 |
|
|
|
0.5368 |
|
|
|
0.4797 |
|
|
|
0.4296 |
|
12/15/2006
|
|
|
5.7089 |
|
|
|
4.4178 |
|
|
|
3.1816 |
|
|
|
2.3944 |
|
|
|
1.8688 |
|
|
|
1.5029 |
|
|
|
1.2383 |
|
|
|
1.0405 |
|
|
|
0.8880 |
|
|
|
0.7673 |
|
|
|
0.6695 |
|
|
|
0.5886 |
|
|
|
0.5205 |
|
|
|
0.4624 |
|
|
|
0.4121 |
|
|
|
0.3683 |
|
12/15/2007
|
|
|
5.7089 |
|
|
|
4.2055 |
|
|
|
2.9533 |
|
|
|
2.1700 |
|
|
|
1.6586 |
|
|
|
1.3112 |
|
|
|
1.0664 |
|
|
|
0.8875 |
|
|
|
0.7524 |
|
|
|
0.6473 |
|
|
|
0.5632 |
|
|
|
0.4943 |
|
|
|
0.4367 |
|
|
|
0.3877 |
|
|
|
0.3455 |
|
|
|
0.3086 |
|
12/15/2008
|
|
|
5.7089 |
|
|
|
3.9974 |
|
|
|
2.7204 |
|
|
|
1.9367 |
|
|
|
1.4391 |
|
|
|
1.1122 |
|
|
|
0.8896 |
|
|
|
0.7323 |
|
|
|
0.6170 |
|
|
|
0.5293 |
|
|
|
0.4605 |
|
|
|
0.4048 |
|
|
|
0.3586 |
|
|
|
0.3195 |
|
|
|
0.2858 |
|
|
|
0.2563 |
|
12/15/2009
|
|
|
5.7089 |
|
|
|
3.7836 |
|
|
|
2.4613 |
|
|
|
1.6674 |
|
|
|
1.1822 |
|
|
|
0.8789 |
|
|
|
0.6836 |
|
|
|
0.5529 |
|
|
|
0.4617 |
|
|
|
0.3950 |
|
|
|
0.3441 |
|
|
|
0.3036 |
|
|
|
0.2704 |
|
|
|
0.2422 |
|
|
|
0.2180 |
|
|
|
0.1967 |
|
12/15/2010
|
|
|
5.7089 |
|
|
|
3.5691 |
|
|
|
2.1655 |
|
|
|
1.3415 |
|
|
|
0.8656 |
|
|
|
0.5929 |
|
|
|
0.4349 |
|
|
|
0.3403 |
|
|
|
0.2804 |
|
|
|
0.2397 |
|
|
|
0.2099 |
|
|
|
0.1866 |
|
|
|
0.1674 |
|
|
|
0.1511 |
|
|
|
0.1369 |
|
|
|
0.1242 |
|
12/15/2011
|
|
|
5.7089 |
|
|
|
3.4095 |
|
|
|
1.8563 |
|
|
|
0.9422 |
|
|
|
0.4598 |
|
|
|
0.2354 |
|
|
|
0.1409 |
|
|
|
0.1018 |
|
|
|
0.0834 |
|
|
|
0.0723 |
|
|
|
0.0641 |
|
|
|
0.0572 |
|
|
|
0.0512 |
|
|
|
0.0459 |
|
|
|
0.0412 |
|
|
|
0.0370 |
|
12/15/2012
|
|
|
5.7089 |
|
|
|
3.3908 |
|
|
|
1.6860 |
|
|
|
0.5301 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/15/2015
|
|
|
5.7089 |
|
|
|
3.3790 |
|
|
|
1.6198 |
|
|
|
0.4558 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/15/2020
|
|
|
5.7089 |
|
|
|
3.6358 |
|
|
|
1.7442 |
|
|
|
0.4918 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/15/2025
|
|
|
5.7089 |
|
|
|
4.0190 |
|
|
|
1.9031 |
|
|
|
0.5247 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/15/2030
|
|
|
5.7089 |
|
|
|
4.1528 |
|
|
|
1.8643 |
|
|
|
0.4544 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/15/2035
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
S-32
The exact stock prices and effective dates may not be set forth
in the table above, in which case:
|
|
|
|
|
if the stock price is between two stock price amounts in the
table or the effective date is between two effective dates in
the table, the number of additional shares will be determined by
a straight-line interpolation between the number of additional
shares set forth for the higher and lower stock price amounts
and the two dates, as applicable, based on a
365-day year; |
|
|
|
if the stock price is greater than $100.00 per share
(subject to adjustment), no additional shares will be issued
upon conversion; and |
|
|
|
if the stock price is less than $26.72 per share (subject
to adjustment), no additional shares will be issued upon
conversion. |
Notwithstanding the foregoing, in no event will the number of
additional shares of common stock issuable upon conversion as a
result of a make-whole fundamental change exceed
5.7089 shares per $1,000 principal amount of debentures,
provided that this limit will be subject to adjustment in the
same manner as the conversion rate as set forth under
Conversion rate adjustments.
At our option, in lieu of increasing the conversion rate as
described in this section in the event of a make-whole
fundamental change, we may elect to make a cash payment in
respect of the additional shares. Such cash payment to any
holder electing to convert its debentures would be equal to the
number of additional shares issuable upon conversion determined
by reference to the table above multiplied by the effective
share price of the transaction which constitutes a fundamental
change. Any such election by us will be disclosed in the notice
of the occurrence of the fundamental change that we are required
to provide to all record holders of debentures. Once this notice
has been provided, we may not modify or withdraw our election.
Our obligation to increase the conversion rate as described
above could be considered a penalty, in which case the
enforceability thereof would be subject to general principles of
economic remedies.
|
|
|
Settlement of conversions in a make-whole fundamental
change |
As described above under Conversion rate
adjustments, in the case of a make-whole fundamental
change that is a fundamental change pursuant to clause (2)
in the definition thereof, upon effectiveness of such make-whole
fundamental change, the debentures will be convertible into cash
and reference property. If, as described above, we are required
to increase the conversion rate as a result of the make-whole
fundamental change, debentures surrendered for conversion will
otherwise be settled as described above under
General. The additional shares or cash
will be delivered to holders who elect to convert their
debentures during the applicable time period described above in
Adjustment to shares delivered upon conversion
upon certain fundamental changes on the later of
(i) five days after the effectiveness of such make-whole
fundamental change and (ii) the conversion settlement date
for those debentures.
|
|
|
Conversion after a public acquiror change of
control |
Notwithstanding the foregoing, in the case of a fundamental
change constituting a public acquiror change of control (as
defined below), we may, in lieu of issuing additional shares
upon conversion as described in Adjustment to
shares delivered upon conversion upon certain fundamental
changes above, elect to adjust the conversion rate and the
related conversion obligation such that from and after the
effective date of such public acquiror change of control,
holders of the debentures will be entitled to convert their
debentures into a number of shares of public acquiror common
stock (as defined below), still subject to the arrangements for
payment upon conversion otherwise applicable, by multiplying the
conversion rate in effect immediately before the public acquiror
change of control by a fraction:
|
|
|
|
|
the numerator of which will be (i) in the case of a share
exchange, consolidation, merger or binding share exchange
pursuant to which our common stock is converted into cash,
securities or other property, the average value of all cash and
any other consideration (as determined by our board of
directors) paid or payable per share of common stock or
(ii) in the case of any other public acquiror change of
control, the average of the last reported sale prices of our
common stock for the five |
S-33
|
|
|
|
|
consecutive trading days prior to but excluding the effective
date of such public acquiror change of control, and |
|
|
|
the denominator of which will be the average of the last
reported sale prices of the public acquiror common stock for the
five consecutive trading days commencing on the trading day
immediately following the effective date of such public acquiror
change of control. |
A public acquiror change of control means a
fundamental change in which the acquiror has a class of common
stock traded on a U.S. national securities exchange or
quoted on The Nasdaq National Market or which will be so traded
or quoted when issued or exchanged in connection with such
change of control (the public acquiror common
stock). If an acquiror does not itself have a class of
common stock satisfying the foregoing requirement, it will be
deemed to have public acquiror common stock if a
corporation that directly or indirectly owns at least a majority
of the acquiror has a class of common stock satisfying the
foregoing requirement. In such case, all references to public
acquiror common stock shall refer to such class of common stock.
Ownership of a majority of the acquiror for these purposes means
having beneficial ownership (as defined in
Rule 13d-3 under
the Exchange Act) of more than 50% of the total voting power of
all shares of that entitys capital stock that are entitled
to vote generally in the election of directors.
Upon a public acquiror change of control, if we so elect,
holders may convert their debentures at the adjusted conversion
rate described above but will not be entitled to receive
additional shares upon conversion as described above in
Adjustment to shares delivered upon conversion
upon certain fundamental changes. We are required to
notify holders of our election in our notice to holders of such
transaction. In addition, upon a public acquiror change of
control, in lieu of converting debentures, the holder can,
subject to certain conditions, require us to repurchase all or a
portion of its debentures as described below under
Fundamental change permits holders to require
us to repurchase debentures.
Optional redemption
No sinking fund is provided for the debentures. Except as
described below, prior to December 15, 2012, the debentures
will not be redeemable. On or after December 15, 2012, we
may redeem for cash all or part of the debentures if the last
reported sale price of our common stock has been at least 130%
of the conversion price then in effect for at least 20 trading
days during any 30 consecutive trading day period prior to the
date on which we provide notice of redemption. The redemption
price will equal 100% of the principal amount of the debentures
being redeemed, plus accrued and unpaid interest, including any
contingent interest, additional interest or compounded interest,
to but excluding the redemption date.
On or prior to June 12, 2006, we may redeem the debentures
in whole or in part for cash if any tax triggering event has
occurred. The redemption price for any such redemption will be
equal to 101.5% of the principal amount of the debentures being
redeemed plus (i) accrued and unpaid interest, including
any contingent interest, additional interest or compounded
interest, to but excluding the redemption date and (ii) if
the conversion value of the debentures being redeemed exceeds
their initial conversion value, 77% of the amount determined by
subtracting the initial conversion value of such debentures from
their conversion value.
We will give notice of redemption not less than 30 nor more than
60 days before the redemption date by mail to the trustee,
the paying agent and each holder of debentures. However, we may
not redeem the debentures at our option or give notice of
redemption during an extension period or while there is any
accrued and unpaid deferred interest with respect to the
debentures.
If debentures are redeemed on a date that is after a record date
for an interest payment and prior to the corresponding interest
payment date, we will pay accrued and unpaid interest to the
same person to whom we pay the principal of the debentures being
redeemed rather than to the holder of record on the record date.
If debentures are redeemed on any interest payment date, accrued
and unpaid interest will be payable to holders of record on the
relevant record date.
We may not redeem any debentures unless all accrued and unpaid
interest thereon, including any contingent interest, additional
interest and compounded interest, has been or is simultaneously
paid for all semi-annual periods or portions thereof terminating
prior to the redemption date.
S-34
If we decide to redeem fewer than all of the outstanding
debentures, the trustee will select the debentures to be
redeemed (in principal amounts of $1,000 or integral multiples
thereof) by lot, or on a pro rata basis or by another method the
trustee considers fair and appropriate.
If the trustee selects a portion of your debentures for partial
redemption and you convert a portion of your debentures, the
converted portion will be deemed to be from the portion selected
for redemption.
In the event of any redemption in part, we shall not be required
to (i) issue, register the transfer of or exchange any
debentures during a period beginning at the opening of business
15 days before any selection for redemption of debentures
and ending at the close of business on the earliest date on
which the relevant notice of redemption is deemed to have been
given to all holders of debentures to be redeemed or
(ii) register the transfer of or exchange any debentures so
selected for redemption, in whole or in part, except the
unredeemed portion of any debentures being redeemed in part.
Tax triggering event means the enactment of
U.S. federal legislation, promulgation of Treasury
regulations, issuance of a published ruling, notice,
announcement or equivalent form of guidance by the Treasury or
the Internal Revenue Service, or the issuance of a judicial
decision if Intel determines, or receives an opinion of its
outside counsel to the effect that, any such authority will have
the effect of lowering the comparable yield or delaying or
otherwise limiting the current deductibility of interest or
original issue discount with respect to the debentures, provided
that Intel determines that such reduction, delay, or limitation
is material.
Conversion value means the product of (i) the
conversion rate in effect on the redemption date and
(ii) the average of the volume-weighted average prices of
our common stock for the five consecutive trading days ending on
the trading day immediately preceding the redemption date.
The volume-weighted average price of our common
stock on a trading day means the price displayed under the
heading Bloomberg VWAP on Bloomberg (or any
successor service) page INTC <equity> AQR (or any
successor page) in respect of the period from 9:30 a.m. to
4:00 p.m. New York City time on that trading day, or, if
such price is not available, the volume-weighted average price
per share of our common stock on that trading day as determined
by a nationally recognized independent investment banking firm
retained for this purpose by us.
Initial conversion value means the product of
(i) the initial conversion rate, prior to adjustments as
described under Conversion rights Conversion
rate adjustments and (ii) $26.72, the last reported
sale price of our common stock on December 13, 2005.
|
|
|
Fundamental change permits holders to require us to
repurchase debentures |
If a fundamental change (as defined below in this section)
occurs at any time, you will have the right, at your option, to
require us to repurchase any or all of your debentures, or any
portion of the principal amount thereof that is equal to $1,000
or an integral multiple of $1,000, on a date (the
fundamental change repurchase date) of our choosing
that is not less than 20 or more than 35 business days after the
date of our notice of the fundamental change. The price we are
required to pay (the fundamental change repurchase
price) is equal to 100% of the principal amount of the
debentures to be repurchased plus accrued and unpaid interest,
including any contingent interest, additional interest and
compounded interest, to but excluding the fundamental change
repurchase date. Any debentures repurchased by us will be paid
for in cash unless we elect otherwise as provided below.
Instead of paying the fundamental change repurchase price in
cash, we may elect (which election shall be irrevocable) to pay
the fundamental change repurchase price in shares of our common
stock (provided that they are publicly traded securities, as
defined below), securities of the acquiror (acquiror
securities) that are publicly traded securities, or a
combination of cash, shares of our common stock and such
publicly traded acquiror securities by so stating in the notice
to be delivered within 20 business days after the occurrence of
a fundamental change, as described below. In such event, the
number of shares of our common stock or acquiror securities a
holder will receive will equal the portion of the repurchase
price payable in such shares divided by 95% of the average of
the last reported sale price of our common stock or acquiror
securities that are publicly
S-35
traded securities, as the case may be, for the five days
immediately preceding and including the third trading day prior
to the repurchase date. However, we may not pay the repurchase
price in our common stock or acquiror securities if an event of
default (as described under Events of default) has
occurred or is continuing and unless we satisfy certain other
conditions prior to the repurchase date as set forth in the
indenture.
A fundamental change will be deemed to have occurred
at the time after the debentures are originally issued that any
of the following occurs:
|
|
|
(1) a person or group within the
meaning of Section 13(d) of the Exchange Act other than us,
our subsidiaries or our or their employee benefit plans, files a
Schedule TO or any schedule, form or report under the
Exchange Act disclosing that such person or group has become the
direct or indirect ultimate beneficial owner, as
defined in
Rule 13d-3 under
the Exchange Act, of more than 50% of the total voting power of
all shares of our capital stock that are entitled to vote
generally in the election of directors; |
|
|
(2) consummation of any share exchange, consolidation or
merger of us pursuant to which our common stock will be
converted into cash, securities or other property or any sale,
lease or other transfer in one transaction or a series of
transactions of all or substantially all of the consolidated
assets of us and our subsidiaries, taken as a whole, to any
person other than us or one of our subsidiaries; provided,
however, that a transaction where (i) our common stock is
not changed or exchanged at all except to the extent necessary
to reflect a change in our jurisdiction of incorporation or
(ii) the holders of more than 50% of all classes of our
common equity immediately prior to such transaction own,
directly or indirectly, more than 50% of the aggregate voting
power of all shares of capital stock of the continuing or
surviving corporation or transferee immediately after such event
shall not be a fundamental change; |
|
|
(3) continuing directors cease to constitute at least a
majority of our board of directors; or |
|
|
(4) our common stock ceases to be listed on a national
securities exchange or quoted on The Nasdaq National Market or
another established automated
over-the-counter
trading market in the United States; |
|
|
|
provided that a fundamental change will not be deemed to have
occurred if either: |
|
|
|
|
|
the last reported sale price of our common stock for any five
trading days within the 10 consecutive trading days ending
immediately before the date of any of the events described in
clauses (1) through (4) above or the public announcement
thereof equals or exceeds 105% of the applicable conversion
price of the debentures immediately before such event or the
public announcement thereof (the 105%
exception); or |
|
|
|
not less than 90% of the consideration, excluding cash payments
for fractional shares and cash payments made in respect of
dissenters rights, associated with any of the events
described in clauses (1) or (2) above consists of
shares of capital stock traded on a U.S. national
securities exchange or quoted on The Nasdaq National Market or
which will be so traded or quoted when issued or exchanged in
connection with such event (publicly traded
securities) and as a result of such event the debentures
become convertible into such publicly traded securities. |
Continuing director means a director who either was
a member of our board of directors on the date of this
prospectus supplement or who becomes a director of the Company
subsequent to that date and whose election, appointment or
nomination for election by our stockholders, is duly approved by
a majority of the continuing directors on the board of directors
of the Company at the time of such approval, either by a
specific vote or by approval of the proxy statement issued by
the Company on behalf of the entire board of directors of the
Company in which such individual is named as nominee for
director.
S-36
On or before the 20th business day after the occurrence of
a fundamental change, we will provide holders of the debentures,
the trustee and the paying agent with notice of the occurrence
of a fundamental change and of the resulting repurchase right.
Such notice shall state, among other things:
|
|
|
|
|
the events causing a fundamental change; |
|
|
|
the date of the fundamental change; |
|
|
|
the last date on which a holder may exercise the repurchase
right; |
|
|
|
the fundamental change repurchase price; |
|
|
|
the fundamental change repurchase date; |
|
|
|
the name and address of the paying agent and the conversion
agent, if applicable; |
|
|
|
if applicable, the applicable conversion rate and any
adjustments to the applicable conversion rate; |
|
|
|
whether we will pay the repurchase price in cash, shares of our
common stock, acquiror securities or a combination thereof,
specifying the percentage of each; |
|
|
|
if applicable, that the debentures with respect to which a
fundamental change repurchase notice has been delivered by a
holder may be converted only if the holder withdraws the
fundamental change repurchase notice in accordance with the
terms of the indenture; and |
|
|
|
the procedures that holders must follow to require us to
repurchase their debentures. |
Simultaneously with providing such notice, we will publish a
notice containing this information in a newspaper of general
circulation in the City of New York or publish the information
on our website or through such other public medium as we may use
at that time.
To exercise the repurchase right, you must deliver, on or before
the business day immediately preceding the fundamental change
repurchase date, the debentures to be repurchased, duly endorsed
for transfer, together with a written repurchase notice and the
form entitled Form of Fundamental Change Repurchase
Notice on the reverse side of the debentures duly
completed, to the paying agent. Your repurchase notice must
state:
|
|
|
|
|
if certificated, the certificate numbers of your debentures to
be delivered for repurchase; |
|
|
|
the portion of the principal amount of debentures to be
repurchased, which must be $1,000 or an integral multiple
thereof; and |
|
|
|
that the debentures are to be repurchased by us pursuant to the
applicable provisions of the debentures and the indenture. |
You may withdraw any repurchase notice (in whole or in part) by
a written notice of withdrawal delivered to the paying agent
prior to the close of business on the business day prior to the
fundamental change repurchase date. The notice of withdrawal
shall state:
|
|
|
|
|
the principal amount of the withdrawn debentures; |
|
|
|
if certificated debentures have been issued, the certificate
numbers of the withdrawn debentures, or if not certificated,
your notice must comply with appropriate DTC procedures; and |
|
|
|
the principal amount, if any, which remains subject to the
repurchase notice. |
We will be required to repurchase the debentures on the
fundamental change repurchase date. You will receive payment of
the fundamental change repurchase price promptly following the
later of the fundamental change repurchase date or the time of
book-entry transfer or the delivery of the debentures. If the
paying agent
S-37
holds money or securities sufficient to pay the fundamental
change repurchase price of the debentures on the business day
following the fundamental change repurchase date, then:
|
|
|
|
|
the debentures will cease to be outstanding and interest,
including any contingent interest, additional interest and
compounded interest, will cease to accrue (whether or not
book-entry transfer of the debentures is made or whether or not
the debenture is delivered to the paying agent); and |
|
|
|
all other rights of the holder will terminate (other than the
right to receive the fundamental change repurchase price and
previously accrued and unpaid interest (including any contingent
interest, additional interest and compounded interest) upon
delivery or transfer of the debentures). |
The repurchase rights of the holders could discourage a
potential acquiror of us. The fundamental change repurchase
feature, however, is not the result of managements
knowledge of any specific effort to obtain control of us by any
means or part of a plan by management to adopt a series of
anti-takeover provisions.
The term fundamental change is limited to specified transactions
and may not include other events that might adversely affect our
financial condition. In addition, the requirement that we offer
to repurchase the debentures upon a fundamental change may not
protect holders in the event of a highly leveraged transaction,
reorganization, merger or similar transaction involving us.
No debentures may be repurchased at the option of holders upon a
fundamental change if there has occurred and is continuing an
event of default other than an event of default that is cured by
the payment of the fundamental change repurchase price of the
debentures.
The definition of fundamental change includes a phrase relating
to the conveyance, transfer, sale, lease or disposition of
all or substantially all of our consolidated assets.
There is no precise, established definition of the phrase
substantially all under applicable law. Accordingly,
the ability of a holder of the debentures to require us to
repurchase its debentures as a result of the conveyance,
transfer, sale, lease or other disposition of less than all of
our assets may be uncertain.
If a fundamental change were to occur, we may not have enough
funds to pay the fundamental change repurchase price or the
terms of subordination could restrict such payment. See
Risk Factors under the captions We may not
have the ability to raise the funds necessary to repurchase the
debentures upon a fundamental change repurchase date, as
required by the indenture governing the debentures and
The debentures are our unsecured junior obligations and
are subordinated in right of payment to our existing and future
senior debt obligations and any indebtedness or other
liabilities of our subsidiaries. If we fail to repurchase
the debentures when required following a fundamental change, we
will be in default under the indenture. In addition, we have,
and may in the future incur, other indebtedness with similar
change in control provisions permitting our holders to
accelerate or to require us to repurchase our indebtedness upon
the occurrence of similar events or on some specific dates.
Consolidation, merger and sale of assets
The indenture provides that the Company shall not consolidate
with or merge with or into, or convey, transfer or lease all or
substantially all of its properties and assets to, another
person (if the Company is not the resulting, surviving or
transferee person) unless (i) the resulting, surviving or
transferee person is a person organized and existing under the
laws of the United States of America, any state thereof or the
District of Columbia, and such entity expressly assumes by
supplemental indenture all the obligations of the Company under
the debentures, the indenture and, to the extent then still
operative, the registration rights agreement and
(ii) immediately after giving effect to such transaction,
no default has occurred and is continuing under the indenture.
Upon any such consolidation, merger or transfer, the resulting,
surviving or transferee person (if not the Company) shall
succeed to, and may exercise every right and power of, the
Company under the indenture. If the predecessor is still in
existence after the transaction, it will be released from its
obligations and covenants under the indenture and the
debentures, except in the case of a lease of all or
substantially all of our properties and assets.
S-38
Although these types of transactions are permitted under the
indenture, certain of the foregoing transactions could
constitute a fundamental change (as defined above) permitting
each holder to require us to repurchase the debentures of such
holder as described above.
Events of default
Each of the following is an event of default:
|
|
|
(1) default in any payment of interest, including any
contingent interest, additional interest (as required by the
registration rights agreement described in Registration
rights) or compounded interest on any debenture when due
and payable and the default continues for a period of
30 days (provided that a valid extension of the interest
payment period by us during an extension period pursuant to the
indenture shall not constitute a default in the payment of
interest for this purpose); |
|
|
(2) default in the payment of principal of any debenture
when due and payable at its stated maturity, upon optional
redemption, upon required repurchase, upon declaration or
otherwise; |
|
|
(3) failure by the Company to comply with its obligation to
convert the debentures into common stock or cash, as applicable,
upon exercise of a holders conversion right and such
failure continues for a period of 10 calendar days; |
|
|
(4) failure by the Company to comply with its obligations
under Consolidation, merger and sale of assets; |
|
|
(5) failure by the Company to issue a fundamental change
notice when due; |
|
|
(6) failure by the Company to comply with any of its other
agreements contained in the debentures or indenture for
90 days after written notice has been received from the
trustee or the holders of at least 25% in principal amount of
the debentures then outstanding; and |
|
|
(7) certain events of bankruptcy, insolvency, or
reorganization of the Company (the bankruptcy
provisions). |
If an event of default occurs and is continuing, the trustee by
notice to the Company, or the holders of at least 25% in
principal amount of the outstanding debentures by notice to the
Company and the trustee, may, and the trustee at the request of
such holders shall, declare 100% of the principal of and accrued
and unpaid interest, including contingent interest, additional
interest and compounded interest, if any, on all the debentures
to be due and payable. Upon such a declaration, such principal
and accrued and unpaid interest will be due and payable
immediately. In addition, upon an event of default arising out
of the bankruptcy provisions, the aggregate principal amount and
accrued and unpaid interest, including contingent interest,
additional interest and compounded interest, will automatically
be due and payable immediately.
The holders of a majority in principal amount of the outstanding
debentures may waive all past defaults (except with respect to
nonpayment of principal or interest, including any additional
interest) and rescind any such acceleration with respect to the
debentures and its consequences if (i) rescission would not
conflict with any judgment or decree of a court of competent
jurisdiction and (ii) all existing events of default, other
than the nonpayment of the principal of and interest (including
any contingent interest, additional interest and compounded
interest) on the debentures that have become due solely by such
declaration of acceleration, have been cured or waived.
Subject to the provisions of the indenture relating to the
duties of the trustee, if an event of default occurs and is
continuing, the trustee will be under no obligation to exercise
any of the rights or powers under the indenture at the request
or direction of any of the holders unless such holders have
offered to the trustee indemnity or security reasonably
satisfactory to it against any loss, liability or expense.
Except to enforce the right to receive payment of principal or
interest, including any contingent interest, additional interest
or
S-39
compounded interest, when due, no holder may pursue any remedy
with respect to the indenture or the debentures unless:
|
|
|
(1) such holder has previously given the trustee notice
that an event of default is continuing; |
|
|
(2) holders of at least 25% in principal amount of the
outstanding debentures have requested the trustee to pursue the
remedy; |
|
|
(3) such holder has offered the trustee security or
indemnity reasonably satisfactory to it against any loss,
liability or expense; |
|
|
(4) the trustee has not complied with such request within
60 days after the receipt of the request and the offer of
security or indemnity; and |
|
|
(5) the holders of a majority in principal amount of the
outstanding debentures have not given the trustee a direction
that, in the opinion of the trustee, is inconsistent with such
request within such
60-day period. |
Subject to certain restrictions, the holders of a majority in
principal amount of the outstanding debentures are given the
right to direct the time, method and place of conducting any
proceeding for any remedy available to the trustee or of
exercising any trust or power conferred on the trustee. The
indenture provides that if an event of default has occurred and
is continuing, the trustee will be required in the exercise of
its powers to use the degree of care that a prudent person would
use in the conduct of its own affairs. The trustee, however, may
refuse to follow any direction that conflicts with law or the
indenture or that the trustee determines is unduly prejudicial
to the rights of any other holder or that would involve the
trustee in personal liability. Prior to taking any action under
the indenture, the trustee will be entitled to indemnification
satisfactory to it in its sole discretion against all losses and
expenses caused by taking or not taking such action.
The indenture provides that if a default occurs and is
continuing and is known to the trustee, the trustee must mail to
each holder notice of the default within 90 days after it
occurs. Except in the case of a default in the payment of
principal of or interest on any debenture, the trustee may
withhold notice if and so long as the trustee in good faith
determines that withholding notice is in the interests of the
holders. In addition, the Company is required to deliver to the
trustee, within 120 days after the end of each fiscal year,
a certificate indicating whether the signers thereof know of any
default that occurred during the previous year.
Modification and amendment
Subject to certain exceptions, the indenture or the debentures
may be amended with the consent of the holders of at least a
majority in principal amount of the debentures then outstanding
(including without limitation, consents obtained in connection
with a purchase of, or tender offer or exchange offer for,
debentures) and, subject to certain exceptions, any past default
or compliance with any provisions may be waived with the consent
of the holders of a majority in principal amount of the
debentures then outstanding (including, without limitation,
consents obtained in connection with a purchase of, or tender
offer or exchange offer for, debentures). However, without the
consent of each holder of an outstanding debenture affected, no
amendment may, among other things:
|
|
|
(1) reduce the amount of debentures whose holders must
consent to an amendment of the indenture or to waive any past
default; |
|
|
(2) reduce the rate of or extend the stated time for
payment of interest, including contingent interest, additional
interest or compounded interest, on any debenture; |
|
|
(3) reduce the principal of or extend the stated maturity
of any debenture; |
|
|
(4) make any change that impairs or adversely affects the
conversion rights or conversion rate of any debenture; |
|
|
(5) reduce the redemption price or the fundamental change
repurchase price of any debenture or amend or modify in any
manner adverse to the holders of debentures the Companys
obligation to make |
S-40
|
|
|
such payments, whether through an amendment or waiver of
provisions in the covenants, definitions or otherwise; |
|
|
(6) make any debenture payable in a currency other than
that stated in the debenture; |
|
|
(7) impair the right of any holder to receive payment of
principal of and interest, including contingent interest,
additional interest or compounded interest, on such
holders debentures on or after the due dates therefor or
to institute suit for the enforcement of any payment on or with
respect to such holders debentures; |
|
|
(8) modify the subordination provisions of the indenture in
a manner that is adverse to the holders of the
debentures; or |
|
|
(9) make any change in the amendment provisions which
require each holders consent or in the waiver provisions
of the indenture. |
Without the consent of any holder, the Company and the trustee
may amend the indenture to:
|
|
|
(1) cure any ambiguity or correct any inconsistent or
otherwise defective provision contained in the indenture, so
long as such action will not adversely affect the interests of
holders, provided that any such amendment made solely to conform
the provisions of the indenture to this prospectus supplement
will be deemed not to adversely affect the interests of holders; |
|
|
(2) provide for the assumption by a successor corporation,
partnership, trust or limited liability company of the
obligations of the Company under the indenture; |
|
|
(3) provide for uncertificated debentures in addition to or
in place of certificated debentures (provided that the Company
receives an opinion of reputable tax counsel that uncertificated
debentures are issued in registered form for purposes of
Section 163(f) of the Code, or in a manner such that the
uncertificated debentures are described in
Section 163(f)(2)(B) of the Code); |
|
|
(4) add guarantees with respect to the debentures; |
|
|
(5) secure the debentures; |
|
|
(6) add to the covenants of the Company for the benefit of
the holders or surrender any right or power conferred upon the
Company; |
|
|
(7) make any change that does not materially adversely
affect the rights of any holder; or |
|
|
(8) comply with any requirement of the Securities and
Exchange Commission in connection with the qualification of the
indenture under the Trust Indenture Act. |
The consent of the holders is not necessary under the indenture
to approve the particular form of any proposed amendment. It is
sufficient if such consent approves the substance of the
proposed amendment. After an amendment under the indenture
becomes effective, the Company is required to mail to the
holders a notice briefly describing such amendment. However, the
failure to give such notice to all the holders, or any defect in
the notice, will not impair or affect the validity of the
amendment.
Discharge
We may satisfy and discharge our obligations under the indenture
by delivering to the registrar for cancellation all outstanding
debentures or by depositing with the trustee or delivering to
the holders, as applicable, after the debentures have become due
and payable, whether at stated maturity, on any redemption or
fundamental change repurchase date, upon conversion or
otherwise, cash or shares of common stock sufficient to pay all
of the outstanding debentures and paying all other sums payable
under the indenture by us. Such discharge is subject to terms
contained in the indenture.
S-41
Calculations in respect of debentures
Except as otherwise provided above, we or our agents will be
responsible for making all calculations called for under the
debentures. These calculations include, but are not limited to,
determinations of the last reported sale prices of our common
stock, accrued interest payable on the debentures and the
conversion rate of the debentures. We or our agents will make
all these calculations in good faith and, absent manifest error,
our calculations will be final and binding on holders of
debentures. We or our agents will provide a schedule of our
calculations to each of the trustee and the conversion agent,
and each of the trustee and conversion agent is entitled to rely
conclusively upon the accuracy of our calculations without
independent verification. The trustee will forward the
calculations to any holder of debentures upon the request of
that holder.
Trustee
Citibank, N.A. is the trustee, registrar, paying agent and
conversion agent.
No personal liability of stockholders, employees, officers or
directors
None of our, or of any successor entitys, direct or
indirect stockholders, employees, officers or directors, as
such, past, present or future, shall have any personal liability
in respect of our obligations under the indenture or the
debentures solely by reason of his or its status as such
stockholder, employee, officer or director.
Governing law
The indenture provides that it and the debentures will be
governed by, and construed in accordance with, the laws of the
State of New York.
Book-entry, settlement and clearance
The debentures initially were issued in the form of one or more
registered debentures in global form, without interest coupons
(the global debentures). Upon issuance, each of the
global debentures will be deposited with the trustee as
custodian for DTC and registered in the name of Cede &
Co., as nominee of DTC.
Ownership of beneficial interests in a global debenture will be
limited to persons who have accounts with DTC (DTC
participants) or persons who hold interests through DTC
participants. We expect that under procedures established by DTC:
|
|
|
|
|
upon deposit of a global debenture with DTCs custodian,
DTC will credit portions of the principal amount of the global
debenture to the accounts of the DTC participants designated by
the initial purchaser; and |
|
|
|
ownership of beneficial interests in a global debenture will be
shown on, and transfer of ownership of those interests will be
effected only through, records maintained by DTC (with respect
to interests of DTC participants) and the records of DTC
participants (with respect to other owners of beneficial
interests in the global debenture). |
Beneficial interests in global debentures may not be exchanged
for debentures in physical, certificated form except in the
limited circumstances described below.
The global debentures and beneficial interests in the global
debentures will be subject to restrictions on transfer as
described under Transfer restrictions.
|
|
|
Book-entry procedures for the global debentures |
All interests in the global debentures are subject to the
operations and procedures of DTC. We provide the following
summary of those operations and procedures solely for the
convenience of investors. The
S-42
operations and procedures of DTC are controlled by that
settlement system and may be changed at any time. Neither we nor
the initial purchaser are responsible for those operations or
procedures.
DTC has advised us that it is:
|
|
|
|
|
a limited purpose trust company organized under the laws of the
State of New York; |
|
|
|
a banking organization within the meaning of the New
York State banking law; |
|
|
|
a member of the Federal Reserve System; |
|
|
|
a clearing corporation within the meaning of the
Uniform Commercial Code; and |
|
|
|
a clearing agency registered under Section 17A
of the Exchange Act. |
DTC was created to hold securities for its participants and to
facilitate the clearance and settlement of securities
transactions between its participants through electronic
book-entry changes to the accounts of its participants.
DTCs participants include securities brokers and dealers,
including the initial purchaser, banks and trust companies,
clearing corporations and other organizations. Indirect access
to DTCs system is also available to others such as banks,
brokers, dealers and trust companies; these indirect
participants clear through or maintain a custodial relationship
with a DTC participant, either directly or indirectly. Investors
who are not DTC participants may beneficially own securities
held by or on behalf of DTC only through DTC participants or
indirect participants in DTC.
So long as DTCs nominee is the registered owner of a
global debenture, that nominee will be considered the sole owner
and holder of the debentures represented by that global
debenture for all purposes under the indenture. Except as
provided below, owners of beneficial interests in a global
debenture:
|
|
|
|
|
will not be entitled to have debentures represented by the
global debenture registered in their names; |
|
|
|
will not receive or be entitled to receive physical,
certificated debentures; and |
|
|
|
will not be considered the owners or holders of the debentures
under the indenture for any purpose, including with respect to
the giving of any direction, instruction or approval to the
trustee under the indenture. |
As a result, each investor who owns a beneficial interest in a
global debenture must rely on the procedures of DTC to exercise
any rights of a holder of debentures under the indenture (and,
if the investor is not a participant or an indirect participant
in DTC, on the procedures of the DTC participant through which
the investor owns its interest).
Payments of principal, and interest (including contingent
interest, additional interest and compounded interest) with
respect to the debentures represented by a global debenture will
be made by the trustee to DTCs nominee as the registered
holder of the global debenture. Neither we nor the trustee will
have any responsibility or liability for the payment of amounts
to owners of beneficial interests in a global debenture, for any
aspect of the records relating to or payments made on account of
those interests by DTC, or for maintaining, supervising or
reviewing any records of DTC relating to those interests.
Payments by participants and indirect participants in DTC to the
owners of beneficial interests in a global debenture will be
governed by standing instructions and customary industry
practice and will be the responsibility of those participants or
indirect participants and DTC.
Transfers between participants in DTC will be effected under
DTCs procedures and will be settled in same-day funds.
S-43
Debentures in physical, certificated form will be issued and
delivered to each person that DTC identifies as a beneficial
owner of the related debentures only if:
|
|
|
|
|
DTC notifies us at any time that it is unwilling or unable to
continue as depositary for the global debentures and a successor
depositary is not appointed within 90 days; |
|
|
|
DTC ceases to be registered as a clearing agency under the
Exchange Act and a successor depositary is not appointed within
90 days; |
|
|
|
we, at our option, notify the trustee that we elect to cause the
issuance of certificated debentures, subject to DTCs
procedures; or |
|
|
|
certain other events provided in the indenture occur. |
We and the initial purchaser entered into a registration rights
agreement before or concurrently with the issuance of the
debentures.
Pursuant to the registration rights agreement, we agreed for the
benefit of the holders of the debentures and the common stock
issuable upon conversion of the debentures that we will, at our
cost:
|
|
|
|
|
no later than the 180th day after the original date of
issuance of the debentures, file a shelf registration statement
covering resales of the debentures and the common stock issuable
upon the conversion thereof pursuant to Rule 415 under the
Securities Act; |
|
|
|
use reasonable best efforts to cause the shelf registration
statement to be declared effective under the Securities Act
within 180 days after the original date of issuance of the
debentures; and |
|
|
|
subject to certain rights to suspend use of the shelf
registration statement, use reasonable efforts to keep the shelf
registration statement effective until the earliest of
(i) the second anniversary of the date of the original
issuance of the debentures and (ii) such time as all of the
debentures and the common stock issuable on the conversion
thereof cease to be outstanding or have either (A) been
sold or otherwise transferred pursuant to an effective
registration statement, (B) been sold pursuant to
Rule 144 under circumstances in which any legend borne by
the debentures or common stock relating to restrictions on
transferability thereof is removed or (C) become eligible
for sale pursuant to Rule 144(k) or any successor provision. |
We are permitted to suspend the effectiveness of the shelf
registration statement or the use of the prospectus that is part
of the shelf registration statement and this prospectus
supplement during specified periods (not to exceed 120 days
in the aggregate in any 12 month period) in certain
circumstances, including circumstances relating to pending
corporate developments. We need not specify the nature of the
event giving rise to a suspension in any notice to holders of
the debentures of the existence of a suspension.
The following requirements and restrictions will generally apply
to a holder selling debentures or common stock issued on the
conversion thereof pursuant to the shelf registration statement:
|
|
|
|
|
the holder will be required to be named as a selling
securityholder in the related prospectus or prospectus
supplement; |
|
|
|
the holder will be required to deliver a prospectus to
purchasers; |
|
|
|
the holder will be subject to some of the civil liability
provisions under the Securities Act in connection with any
sales; and |
|
|
|
the holder will be bound by the provisions of the registration
rights agreement which are applicable to the holder (including
indemnification obligations). |
S-44
We agreed to pay predetermined additional interest as described
herein (additional interest) to holders of the
debentures if the shelf registration statement is not timely
filed or made effective as described above or if the prospectus
is unavailable for periods in excess of those permitted above.
The additional interest will accrue until a failure to file or
become effective or unavailability is cured in respect of any
debentures required to bear the legend set forth in
Transfer restrictions at a rate per annum equal to
0.25% for the first 90 days after the occurrence of the
event and 0.5% after the first 90 days. However, no
additional interest will accrue following the end of the period
during which we are required to use reasonable efforts to keep
the shelf registration statement effective. In no event shall
such additional interest accrue at a rate exceeding
0.5% per annum. If a holder exchanges some or all of the
debentures into our common stock, the holder will not be
entitled to receive additional interest on such common stock.
The additional interest will accrue from and including the date
on which any the registration default occurs to but exclude the
date on which all registration defaults have been cured. We will
have no other liabilities for monetary damages with respect to
our registration obligations.
We will pay all expenses of the shelf registration statement,
provide to each registered holder copies of the related
prospectus, notify each registered holder when the shelf
registration statement has become effective and take other
actions that are required to permit, subject to the foregoing,
unrestricted resales of the debentures and the shares of common
stock issued upon conversion of the debentures.
The summary herein of provisions of the registration rights
agreement is subject to, and is qualified in its entirety by
reference to, all the provisions of the registration rights
agreement, a copy of which is available from us upon request as
described under Where you can find more information.
S-45
Material United States federal income tax considerations
In the opinion of Gibson, Dunn & Crutcher LLP, our tax
counsel, this section summarizes the material U.S. federal
income tax considerations relating to the purchase, ownership,
and disposition of the debentures and of the common stock into
which the debentures may be converted. This summary does not
provide a complete analysis of all potential tax considerations.
The information provided below is based on the Internal Revenue
Code of 1986, as amended (referred to herein as the
code), Treasury regulations issued under the code,
judicial authority and administrative rulings and practice, all
as of the date of this prospectus supplement and all of which
are subject to change, possibly on a retroactive basis. As a
result, the tax considerations of purchasing, owning or
disposing of debentures or common stock could differ from those
described below. This summary deals only with purchasers who
hold debentures or common stock into which debentures have been
converted as capital assets within the meaning of
Section 1221 of the code. This summary does not deal with
persons in special tax situations, such as financial
institutions, insurance companies, S corporations,
regulated investment companies, tax exempt investors, dealers in
securities and currencies, U.S. expatriates, persons
holding debentures as a position in a straddle,
hedge, conversion transaction, or other
integrated transaction for tax purposes, or U.S. Holders
(as defined below) whose functional currency is not the
U.S. dollar. Further, this discussion does not address the
consequences under U.S. alternative minimum tax rules,
U.S. federal estate or gift tax laws, the tax laws of any
U.S. state or locality, or any
non-U.S. tax laws.
As used herein, the term U.S. holder means a
beneficial owner of debentures or common stock into which
debentures have been converted that is, for U.S. federal
income tax purposes:
|
|
|
|
|
an individual citizen or resident of the United States; |
|
|
|
a corporation, or other entity treated as a corporation, created
or organized in or under the laws of the United States, any
state or the District of Columbia; |
|
|
|
an estate, the income of which is subject to U.S. federal
income tax regardless of its source; or |
|
|
|
a trust if, (i) a court within the United States is able to
exercise primary supervision over its administration and one or
more U.S. persons have authority to control all of its
substantial decisions or (ii) it has a valid election in
effect under applicable U.S. Treasury regulations to be
treated as a U.S. person. |
As used herein, the term
non-U.S. holder
means a beneficial owner, other than a partnership, of
debentures or common stock into which debentures have been
converted that is not a U.S. holder.
If a partnership, including for this purpose any entity treated
as a partnership for U.S. tax purposes, is a beneficial
owner of debentures or common stock into which debentures have
been converted, the treatment of a partner in the partnership
generally will depend upon the status of the partner and upon
the activities of the partnership. A holder of debentures that
is a partnership and partners in such a partnership should
consult their independent tax advisors about the
U.S. federal income tax consequences of holding and
disposing of debentures and common stock into which debentures
have been converted.
Classification of the debentures
Pursuant to the terms of the indenture, we and every holder of
debentures have agreed (in the absence of an administrative
pronouncement or judicial ruling to the contrary), for
U.S. federal income tax purposes, to treat the debentures
as debt instruments that are subject to the Treasury regulations
that govern contingent payment debt instruments (the
contingent debt regulations) and to be bound by our
application of the contingent debt regulations to the
debentures, including generally our determination of the rate at
which interest will be deemed to accrue on the debentures (and
the related projected payment schedule as described
below). The remainder of this discussion describes the treatment
of the debentures in accordance with that agreement and our
determinations.
No authority directly addresses the treatment of all aspects of
the debentures for United States federal income tax purposes.
The Internal Revenue Service (the service) issued
Revenue Ruling 2002-31
and
S-46
Notice 2002-36, in
which the service addressed the United States federal income tax
classification and treatment of a debt instrument similar,
although not identical, to the debentures, and the service
concluded that the debt instrument addressed in that published
guidance was subject to the contingent debt regulations. In
addition, the service clarified various aspects of the
applicability of certain other provisions of the code to the
debt instrument addressed in that published guidance. The
applicability of Revenue Ruling
2002-31 and Notice
2002-36 to any
particular debt instrument, however, such as the debentures, is
uncertain. In addition, no rulings are expected to be sought
from the service with respect to any of the United States
federal income tax consequences discussed below, and no
assurance can be given that the service will not take contrary
positions. As a result, no assurance can be given that the
service will agree with the tax characterizations and the tax
consequences described below. A different treatment of the
debentures from that described below could affect the amount,
timing, source and character of income, gain or loss with
respect to an investment in the debentures and could require a
holder to accrue interest income at a rate different from the
comparable yield rate described below.
U.S. holders
|
|
|
Accrual of interest on the debentures |
Pursuant to the contingent debt regulations, U.S. holders
of the debentures will be required to accrue interest income on
the debentures on a constant-yield basis, as described below,
regardless of whether such holders use the cash or accrual
method of tax accounting. Accordingly, U.S. holders will be
required to include interest in income each year in excess of
the accruals on the debentures for non-tax purposes and in
excess of any interest payments actually received in that year.
The contingent debt regulations provide that a U.S. holder
must accrue an amount of ordinary interest income, as original
issue discount for U.S. federal income tax purposes, for
each accrual period prior to and including the maturity date of
the debentures that equals:
|
|
|
|
|
the product of (i) the adjusted issue price (as defined
below) of the debentures as of the beginning of the accrual
period and (ii) the comparable yield to maturity (as
defined below) of the debentures, adjusted for the length of the
accrual period; |
|
|
|
divided by the number of days in the accrual period; and |
|
|
|
multiplied by the number of days during the accrual period that
the U.S. holder held the debentures. |
A debentures issue price is the first price at
which a substantial amount of the debentures is sold to the
public, excluding sales to bond houses, brokers or similar
persons or organizations acting in the capacity of underwriters,
placement agents or wholesalers. The adjusted issue
price of a debenture is its issue price increased by any
interest income previously accrued, determined without regard to
any adjustments to interest accruals described below, and
decreased by the amount of any noncontingent payments and the
projected amount of any contingent payments with respect to the
debentures.
We have determined the comparable yield on the
debentures to be 6.45%. This is the annual yield we believe we
would pay, as of the initial issue date of the debentures, on a
fixed-rate, nonconvertible debt security with no contingent
payments, but with terms and conditions otherwise comparable to
those of the debentures. The precise manner of determining the
comparable yield is not entirely clear. There can be no
assurance that the IRS will not challenge our determination of
the comparable yield or that such challenge will not be
successful. If our determination of the comparable yield were
successfully challenged by the service, the redetermined yield
could be materially greater than or less than the comparable
yield determined by us.
The contingent debt regulations require that we provide to
holders, solely for U.S. federal income tax purposes, a
schedule of the projected amounts of payments (to which we refer
as projected payments) on the debentures. This
schedule must produce a yield to maturity that equals the
comparable yield. The projected payment schedule includes
estimates for certain contingent interest payments and an
estimate for a payment at maturity taking into account the
projected value of the stock into which the debentures are
S-47
convertible at maturity. In this regard, the fair market value
of any common stock (and the amount of any cash) received by a
U.S. holder upon conversion will be treated as a contingent
payment. The comparable yield and the projected payment schedule
will be set forth in the indenture. U.S. holders may obtain
the projected payment schedule by submitting a written request
for such information to us at: Intel Corporation,
2200 Mission College Blvd,
M/S SC4-203,
Santa Clara, CA
95052-8119, Attention:
Corporate Secretary.
The comparable yield and the projected payment schedule are not
used for any purpose other than to determine a holders
interest accruals and adjustments thereto in respect of the
debentures for U.S. federal income tax purposes. They do
not constitute a projection or representation regarding the
actual amounts payable on the debentures or the value at any
time of the common stock into which the debentures may be
converted.
|
|
|
Adjustments to interest accruals on the debentures |
If, during any taxable year, a U.S. holder of debentures
receives actual payments with respect to its debentures that, in
the aggregate, exceed the total amount of projected payments for
that taxable year, the U.S. holder will incur a net
positive adjustment under the contingent debt regulations
equal to the amount of such excess. The U.S. holder will
treat a net positive adjustment as additional
interest income. For this purpose, the payments in a taxable
year include the fair market value of property (including common
stock received upon conversion of the debentures) received in
that year.
If a U.S. holder receives in a taxable year actual payments
with respect to the debentures that, in the aggregate, are less
than the amount of projected payments for that taxable year, the
U.S. holder will incur a net negative
adjustment under the contingent debt regulations equal to
the amount of such deficit. This net negative adjustment will
(i) reduce the U.S. holders interest income on
the debentures for that taxable year, and (ii) to the
extent of any excess after the application of (i), give rise to
an ordinary loss to the extent of the U.S. holders
interest income on the debentures during prior taxable years,
reduced to the extent such interest was offset by prior net
negative adjustments. Any negative adjustment in excess of the
amounts described in (i) and (ii) will be carried
forward to offset future interest income with respect to the
debentures or to reduce the amount realized on a sale, exchange,
conversion, redemption or other disposition of the debentures. A
net negative adjustment is not subject to the two percent floor
limitation on miscellaneous itemized deductions.
Special rules will apply if the amount of a contingent payment
on a debenture becomes fixed more than six months prior to the
due date of the payment. Generally, in this case you would be
required to make adjustments to account for the difference
between the present value of the amount so treated as fixed and
the present value of the projected payment. Your tax basis in
the debenture would also be affected. You are urged to consult
your tax adviser concerning the application of these special
rules.
|
|
|
Sale, exchange, conversion, redemption or other
disposition of debentures |
A U.S. holder generally will recognize gain or loss if the
holder disposes of a debenture in a sale, exchange, conversion,
redemption or other disposition. As described above, our
calculation of the comparable yield and the projected payment
schedule for the debentures includes the receipt of stock upon
conversion as a contingent payment with respect to the
debentures, which generally is binding on holders of debentures.
Accordingly, we intend to treat the receipt of common stock by a
U.S. holder upon the conversion of a debenture as a payment
under the contingent debt regulations. So viewed, a conversion
of a debenture into common stock also will result in taxable
gain or loss to a U.S. holder.
The holders gain or loss will equal the difference between
the proceeds received by the holder, reduced by any net negative
adjustment carried forward, as described above, and the
holders adjusted tax basis in the debenture. The proceeds
received by the holder will include the amount of any cash and
the fair market value of any other property received for the
debenture, including the fair market value of any common stock
received.
The holders tax basis in the debenture generally will
equal the amount the holder paid for the debenture, increased by
any interest income previously accrued by the U.S. holder
under the contingent debt regulations
S-48
(determined without regard to any adjustments to interest
accruals described above) and decreased by the amount of any
noncontingent payments and the projected amount of any
contingent payments that previously have been scheduled to be
made in respect of the debentures (without regard to the actual
amounts paid).
Any gain recognized will be treated as ordinary income pursuant
to the contingent debt regulations. Any loss will be ordinary
loss to the extent of interest previously included in income,
and thereafter capital loss (which will be long-term if the
debenture has been held for more than one year). The
deductibility of capital losses is subject to limitation. A
U.S. holder who sells a debenture at a loss, or who
converts a debenture into our common stock at a loss, that meets
certain thresholds may be required to file a disclosure
statement with the service.
A U.S. holders tax basis in common stock received
upon a conversion of a debenture will equal the then current
fair market value of such common stock. The
U.S. holders holding period for the common stock
received will commence on the day immediately following the date
of conversion.
|
|
|
Purchases of debentures at a price other than the adjusted
issue price |
If a U.S. holder purchases a debenture in the secondary
market for an amount that differs from the adjusted issue price
of the debenture at the time of purchase, the U.S. holder
will be required to accrue interest income on the debenture in
accordance with the comparable yield even if market conditions
have changed since the date of issuance. Except to the extent
described below as to debentures that are considered to be
exchange listed, a U.S. holder must reasonably determine
whether the difference between the purchase price for a
debenture and the adjusted issue price of a debenture is
attributable to a change in expectation as to the contingent
amounts potentially payable in respect of the debenture, a
change in interest rates since the debenture were issued, or
both, and allocate the difference accordingly. Adjustments
allocated to a change in interest rates will cause, as the case
may be, a positive adjustment or a negative adjustment to
interest inclusion. If the purchase price of a debenture is less
than its adjusted issue price of the debenture, a positive
adjustment will result, and if the purchase price is more than
the adjusted issue price of the debenture, a negative adjustment
will result. To the extent that an adjustment is attributable to
a change in interest rates, it must be reasonably allocated to
the daily portions of interest over the remaining term of the
debenture. To the extent that the difference between the
purchase price for the debenture and the adjusted issue price of
the debenture is attributable to a change in expectations as to
the contingent amounts potentially payable in respect of the
debenture, and not to a change in the market interest rates, a
U.S. holder will be required to reasonably allocate that
difference to the contingent payments. Adjustments allocated to
the contingent payments will be taken into account as positive
or negative adjustments, as the case may be, when the contingent
payments are made. Any negative or positive adjustment of the
kind described above will decrease or increase, respectively,
the tax basis in the debenture.
Finally, if a debenture is considered to be exchange listed
property then, instead of allocating the difference between
adjusted issue price of the debenture and the
U.S. holders tax basis in the debenture to any
projected payments, the holder generally would be permitted, but
not required, to allocate such difference on a pro rata basis to
the daily portions of interest determined under the projected
payment schedule over the remaining term of the debenture. This
pro rata allocation, however, would not be reasonable and thus
would not be permitted to the extent that the allocation
produces a deemed yield on the debenture that is less than the
applicable federal rate for the debenture as of the issue date.
The debentures will be considered exchange listed if they are
listed on either a national securities exchange or an
interdealer quotation system sponsored by a national securities
association. Currently, the debentures are not considered to be
exchange listed.
Some U.S. holders will receive
Forms 1099-OID
reporting interest accruals on their debenture. Those forms will
not, however, reflect the effect of any positive or negative
adjustments resulting from the purchase of a debenture in the
secondary market at a price that differs from its adjusted issue
price on the date of purchase. U.S. holders are urged to
consult their tax advisor as to whether, and how, such
adjustments should be made to the amounts reported on any
Form 1099-OID
S-49
|
|
|
Constructive dividends on debentures |
The terms of the debentures allow for changes in the conversion
rate of the debentures in certain circumstances. A change in
conversion rate that allows debenture holders to receive more
shares of common stock on conversion may be treated as a taxable
dividend to U.S. holders, notwithstanding the fact that the
holder does not receive a cash payment. A taxable constructive
stock dividend would result, for example, if the conversion rate
is adjusted to compensate debenture holders for distributions of
cash or property to our stockholders. On the other hand, a
change in conversion rate could simply prevent the dilution of
the debenture holders interests upon a stock split or
other change in capital structure and generally would not be
treated as a constructive stock dividend.
It is unclear whether any such constructive dividend would be
eligible for the preferential rates of U.S. federal income
tax applicable to certain dividends received by noncorporate
holders. It is also unclear whether a corporate holder would be
entitled to claim the dividends received deduction with respect
to a constructive dividend. Any taxable constructive stock
dividends resulting from a change to the conversion rate would
in other respects be treated in the same manner as dividends
paid in cash or other property. These dividends would result in
dividend income to the recipient, to the extent of our current
or accumulated earnings and profits, with any excess treated as
a nontaxable return of capital or as capital gain as more fully
described below. Holders should carefully review the conversion
rate adjustment provisions and consult their tax advisors with
respect to the tax consequences of any such adjustment.
|
|
|
Dividends on common stock |
If, after a U.S. holder converts a debenture into common
stock, we make a distribution in respect of that stock, other
than certain pro rata distributions of shares of common stock,
the distribution will be treated as a taxable dividend, to the
extent it is paid from our current or accumulated earnings and
profits. If the distribution exceeds our current and accumulated
profits, the excess will be treated first as a tax-free return
of the holders investment, up to the holders
adjusted tax basis in its common stock. Any remaining excess
will be treated as capital gain. Eligible dividends received by
a non-corporate U.S. holder in tax years beginning on or
before December 31, 2008, will be subject to tax at the
special reduced rate generally applicable to long-term capital
gain. A U.S. holder generally may be eligible for this
reduced rate only if the U.S. holder has held our common
stock for more than 60 days during the
121-day period
beginning 60 days before the ex-dividend date. If the
U.S. holder is a U.S. corporation, it would generally
be permitted to claim the dividends received deduction, provided
certain requirements are met.
|
|
|
Sale or exchange of common stock |
A U.S. holder will generally recognize gain or loss on a
sale or exchange of common stock. The holders gain or loss
will equal the difference between the proceeds received by the
holder and the holders adjusted tax basis in the stock.
The proceeds received by the holder will include the amount of
any cash and the fair market value of any other property
received for the stock. The gain or loss recognized by a holder
on a sale or exchange of stock will be long-term capital gain or
loss if the holder held the stock for more than one year.
Non-U.S. holders
Subject to the discussion of backup withholding below, a
non-U.S. holder
will not be subject to U.S. federal income tax (or any
withholding thereof) in respect of payments and accruals of
interest on the debentures, including principal and interest
payments, a payment in common stock, or a combination of stock
and cash pursuant to a conversion, and any gain realized upon
the sale, exchange, redemption, retirement or other taxable
disposition of a debenture, if each of the following
requirements is satisfied:
|
|
|
|
|
The amount received is not U.S. trade or business income
(as defined below); |
|
|
|
The
non-U.S. holder
provides us or our paying agent with a properly completed IRS
Form W-8BEN (or
successor form), or an appropriate substitute form, together
with all appropriate attachments, |
S-50
|
|
|
|
|
signed under penalties of perjury, identifying the
non-U.S. holder
and stating, among other things, that the
non-U.S. holder
is not a U.S. person. If a debenture is held through a
securities clearing organization, bank or other financial
institution that holds customers securities in the
ordinary course of its trade or business, this requirement is
satisfied if (i) the
non-U.S. holder
provides such a form to the organization or institution and
(ii) the organization or institution, under penalties of
perjury, certifies to us that it has received such a form from
the beneficial owner or another intermediary and furnishes us or
our paying agent with a copy thereof; |
|
|
|
The
non-U.S. holder
does not actually or constructively own 10% or more of the total
combined voting power of all classes of our stock entitled to
vote; |
|
|
|
The
non-U.S. holder is
not a controlled foreign corporation (as defined in
the code) that is actually or constructively related to
us; and |
|
|
|
With respect only to gain realized on a sale, exchange or
conversion of the debentures, our common stock continues to be
actively traded within the meaning of
Section 871(h)(4)(C)(v)(I) and we have not been a
U.S. real property holding corporation (as defined in the
code) at any time within the five-year period preceding the
disposition or the
non-U.S. holders
holding period, whichever is shorter. We believe that we have
not been during the past five years, are not, and do not
anticipate becoming, a U.S. real property holding
corporation. |
If all of these conditions are not met, a 30%
U.S. withholding tax will apply to interest income on the
debentures, which will be withheld from scheduled interest
payments, contingent interest payments or principal payments on
the debentures, to the extent thereof, unless either (i) an
applicable income tax treaty reduces or eliminates such tax or
(ii) the interest is U.S. trade or business income (as
defined below) and, in each case, the
non-U.S. holder
complies with applicable certification requirements. In the case
of the second exception, the
non-U.S. holder
generally will be subject to U.S. federal income tax with
respect to all income from the debentures on a net income basis
in the same manner as a U.S. holder, as described above.
Additionally,
non-U.S. holders
that are corporations could be subject to a branch profits tax
on such income. Special procedures contained in Treasury
regulations may apply to partnerships, trusts and
intermediaries. We urge
non-U.S. holders
to consult their tax advisors for information on the impact of
these withholding regulations.
For purposes of this discussion, any interest or dividend income
and any gain realized on the sale, exchange, redemption,
retirement or other taxable disposition of a debenture or common
stock will be considered U.S. trade or business
income if such income or gain is (i) effectively
connected with the conduct of a trade or business in the United
States or (ii) in the case of a treaty resident,
attributable to a permanent establishment (or in the case of an
individual, to a fixed base) in the United States.
|
|
|
Constructive dividends on debentures |
A non-U.S. holder
generally will be subject to U.S. federal withholding tax
at a 30% rate on income attributable to an adjustment to the
conversion rate of the debentures that constitutes a
constructive dividend as described in
U.S. holders Constructive dividends on
debentures above, which tax may be withheld from interest,
shares of common stock or proceeds subsequently paid or credited
to a
non-U.S. holder,
unless either (i) an applicable income tax treaty reduces
or eliminates such tax or (ii) the amount received is
U.S. trade or business income (as defined above), and, in
each case, the
non-U.S. holder
complies with applicable certification requirements. In the case
of the second exception, the
non-U.S. holder
generally will be subject to U.S. federal income tax with
respect to the constructive dividend on a net income basis in
the same manner as a U.S. holder, as described above.
Additionally,
non-U.S. holders
that are corporations could be subject to a branch profits tax
on such income at a rate of 30% or a lower rate if so specified
by an applicable income tax treaty.
S-51
Dividends paid to a
non-U.S. holder on
common stock received on conversion of a debenture generally
will be subject to U.S. withholding tax at a 30% rate,
unless either (i) such rate is reduced or eliminated under
the terms of a tax treaty between the United States and the
non-U.S. holders
country of residence or (ii) the dividends are
U.S. trade or business income and, in each case the
non-U.S. holder
complies with the applicable certification requirements. In the
case of the second exception, the
non-U.S. holder
generally will be subject to U.S. federal income tax with
respect to the constructive dividend on a net income basis in
the same manner as a U.S. holder, as described above.
Additionally,
non-U.S. holders
that are corporations could be subject to a branch profits tax
at a rate of 30% on such income or a lower rate if so specified
by an applicable income tax treaty.
|
|
|
Disposition of common stock |
Subject to the discussion of backup withholding below,
generally, a
non-U.S. holder
will not be subject to U.S. federal income tax (or any
withholding thereof) on any gain realized upon the sale or
exchange of common stock unless:
|
|
|
|
|
the gain is U.S. trade or business income; |
|
|
|
such holder is an individual present in the United States for
183 days or more in the taxable year of the sale, exchange,
redemption, retirement or other disposition and certain other
conditions are met; or |
|
|
|
we have been a U.S. real property holding corporation at
any time within the shorter of the five-year period preceding
such sale or exchange and the
non-U.S. holders
holding period in the common stock and our common stock ceases
to be actively traded within the meaning of
Section 871(h)(4)(C)(v)(I) of the code or such holder owns
or is deemed to own more than 5% of our common stock. We believe
that we have not been during the past five years, are not, and
do not anticipate becoming, a U.S. real property holding
corporation. |
A non-U.S. holder
described in the first bullet point above will generally be
subject to U.S. federal income tax on the net gain derived
from the sale in the same manner as a U.S. holder. A
non-U.S. holder
that is a foreign corporation and is described in the first
bullet point above will be subject to tax on gain at
U.S. federal income tax rates and, in addition, may be
subject to a branch profits tax at a 30% rate or a lower rate if
so specified by an applicable income tax treaty. An individual
non-U.S. holder
described in the second bullet point above will be subject to
U.S. federal income tax at a 30% rate, or at a lower rate
specified in an applicable income tax treaty, on the gain
derived from the sale or exchange, which gain may be offset by
U.S. source capital losses, even though the holder is not
considered a resident of the United States.
|
|
|
Backup withholding and information reporting |
Accruals of interest and payment of dividends to both individual
U.S. holders and
non-U.S. holders
of debentures or common stock and payments of the proceeds of
the sale or other disposition of the debentures or common stock
to individual U.S. holders will be subject to information
reporting. In addition, payments of the proceeds of the sale or
other disposition of the debentures or common stock to
non-U.S. holders
may be subject to information reporting unless the
non-U.S. holder
complies with certain certification procedures. Payments and
accruals to both individual U.S. holders and
non-U.S. holders
may also be subject to backup withholding (currently at a rate
of 28%) unless the holder provides us or our paying agent with a
correct taxpayer identification number and otherwise complies
with applicable certification requirements. The certification
procedures required to claim an exemption from the withholding
tax described above will satisfy the certification requirements
necessary to avoid backup withholding as well.
S-52
Backup withholding is not an additional tax. The amount of any
backup withholding from a payment to a holder of debentures or
common stock under the backup withholding rules can be credited
against any U.S. federal income tax liability of the holder.
The preceding discussion of certain U.S. federal
income tax considerations is for general information only; it is
not tax advice. You should consult your own tax advisor
regarding the particular U.S. federal, state, local and
foreign tax consequences of purchasing, holding and disposing of
our debentures or common stock, including the consequences of
any proposed change in applicable laws.
S-53
Selling securityholders
We originally issued the debentures to JP Morgan Securities
Inc., referred to as the initial purchaser, in transactions
exempt from the registration requirements of the Securities Act
of 1933. The debentures were immediately resold by the initial
purchaser to persons reasonably believed by the initial
purchasers to be qualified institutional buyers
within the meaning of Rule 144A under the Securities Act of
1933 in transactions exempt from registration under the
Securities Act of 1933. Selling securityholders, including their
transferees, pledgees or donees or their successors, may from
time to time offer and sell the debentures and the common stock
into which the debentures are convertible. Our registration of
the debentures and the shares of common stock issuable upon
conversion of the debentures does not necessarily mean that the
selling securityholders will sell all or any of the debentures
or the common stock. Except as set forth below, none of the
selling securityholders has, or within the past three years has
had, any position, office or other material relationship with us
or any of our predecessors or affiliates. The following table
sets forth certain information as of March 29, 2006, except
where otherwise noted, concerning the principal amount of
debentures beneficially owned by each selling securityholder and
the number of shares of underlying common stock that may be
offered from time to time by each selling securityholder with
this prospectus. The information is based on information
provided by or on behalf of the selling securityholders. We have
assumed for purposes of the table below that the selling
securityholders will sell all of their debentures and common
stock issuable upon conversion of the debentures pursuant to
this prospectus, and that any other shares of our common stock
beneficially owned by the selling securityholders will continue
to be beneficially owned. Information about the selling
securityholders may change over time. In particular, the selling
securityholders identified below may have sold, transferred or
otherwise disposed of all or a portion of their debentures since
the date on which they provided to us information regarding
their debentures. Any changed or new information given to us by
the selling securityholders will be set forth in supplements to
this prospectus or amendments to the registration statement of
which this prospectus is a part, if and when necessary.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Principal Amount | |
|
|
|
|
|
Number of Shares | |
|
|
|
|
of Debentures | |
|
|
|
|
|
of Common Stock | |
|
|
|
|
Beneficially | |
|
Percentage of | |
|
Number of Shares | |
|
Beneficially | |
|
Natural Person(s) | |
|
|
Owned and | |
|
Debentures | |
|
of Common Stock | |
|
Owned after the | |
|
with Voting or | |
Name of Selling Securityholder(1) |
|
Offered (USD) | |
|
Outstanding(%) | |
|
Offered(2)(3) | |
|
Offering(4) | |
|
Investment Power | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
AHFP Context
|
|
|
220,000 |
|
|
|
* |
|
|
|
6,977 |
|
|
|
0 |
|
|
Michael S. Rosen, William D. Fertig |
Allstate Insurance Company(+)
|
|
|
6,750,000 |
|
|
|
* |
|
|
|
214,084 |
|
|
|
249,000 |
(5) |
|
|
(5) |
|
Allstate Life Insurance Company(+)
|
|
|
9,000,000 |
|
|
|
* |
|
|
|
285,445 |
|
|
|
249,000 |
(5) |
|
|
(5) |
|
Aloha Airlines Non-Pilots Pension Trust
|
|
|
100,000 |
|
|
|
* |
|
|
|
3,171 |
|
|
|
0 |
|
|
|
Ann Houlihan |
|
Altma Fund Sicav PLC in Respect of the Grafton Sub Fund
|
|
|
2,460,000 |
|
|
|
* |
|
|
|
78,021 |
|
|
|
0 |
|
|
Michael S. Rosen, William D. Fertig |
Amaranth LLC(+)
|
|
|
100,000,000 |
|
|
|
6.25 |
% |
|
|
3,171,620 |
|
|
|
0 |
|
|
|
(6) |
|
American Investors Life Insurance Company
|
|
|
1,000,000 |
|
|
|
* |
|
|
|
31,716 |
|
|
|
0 |
|
|
|
Thomas Ray |
|
American Skandia Trust
|
|
|
2,000,000 |
|
|
|
* |
|
|
|
63,432 |
|
|
|
0 |
|
|
|
Maren Lindstrom |
|
Amerisure Mutual Insurance Company(+)
|
|
|
525,000 |
|
|
|
* |
|
|
|
16,651 |
|
|
|
0 |
|
|
|
(7) |
|
AmerUS Life Insurance Company
|
|
|
3,000,000 |
|
|
|
* |
|
|
|
95,148 |
|
|
|
0 |
|
|
|
Thomas Ray |
|
Arkansas PERS
|
|
|
2,405,000 |
|
|
|
* |
|
|
|
76,277 |
|
|
|
0 |
|
|
|
Ann Houlihan |
|
AstraZeneca Holdings Pension
|
|
|
305,000 |
|
|
|
* |
|
|
|
9,673 |
|
|
|
0 |
|
|
|
Ann Houlihan |
|
Attorneys Title Insurance Fund
|
|
|
455,000 |
|
|
|
* |
|
|
|
14,430 |
|
|
|
0 |
|
|
|
Ann Houlihan |
|
Aviva Life Insurance Co.
|
|
|
2,250,000 |
|
|
|
* |
|
|
|
71,361 |
|
|
|
0 |
|
|
|
David Clott |
|
Bancroft Fund, Inc.
|
|
|
1,500,000 |
|
|
|
* |
|
|
|
47,574 |
|
|
|
0 |
|
|
|
(8) |
|
Bank of America Pension Plan
|
|
|
2,500,000 |
|
|
|
* |
|
|
|
79,290 |
|
|
|
0 |
|
|
|
Alex Lach |
|
Bankers Life Insurance Company of New York
|
|
|
500,000 |
|
|
|
* |
|
|
|
15,858 |
|
|
|
0 |
|
|
|
ThomasRay |
|
Barnet Partners Ltd.
|
|
|
5,000,000 |
|
|
|
* |
|
|
|
158,581 |
|
|
|
0 |
|
|
|
Alex Lach |
|
Black Diamond Convertible Offshore LDC
|
|
|
2,000,000 |
|
|
|
* |
|
|
|
63,432 |
|
|
|
0 |
|
|
|
Clint D. Carlson |
|
Black Diamond Offshore Ltd.
|
|
|
1,000,000 |
|
|
|
* |
|
|
|
31,716 |
|
|
|
0 |
|
|
|
Clint D. Carlson |
|
S-54
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Principal Amount | |
|
|
|
|
|
Number of Shares | |
|
|
|
|
of Debentures | |
|
|
|
|
|
of Common Stock | |
|
|
|
|
Beneficially | |
|
Percentage of | |
|
Number of Shares | |
|
Beneficially | |
|
Natural Person(s) | |
|
|
Owned and | |
|
Debentures | |
|
of Common Stock | |
|
Owned after the | |
|
with Voting or | |
Name of Selling Securityholder(1) |
|
Offered (USD) | |
|
Outstanding(%) | |
|
Offered(2)(3) | |
|
Offering(4) | |
|
Investment Power | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
Boilermakers Blacksmith Pension Trust
|
|
|
3,425,000 |
|
|
|
* |
|
|
|
108,627 |
|
|
|
0 |
|
|
|
Ann Houlihan |
|
Bunting Family III, LLC Capital Appreciation(+)
|
|
|
25,000 |
|
|
|
* |
|
|
|
792 |
|
|
|
6,100 |
|
|
|
(9) |
|
CGNU Life Fund
|
|
|
2,900,000 |
|
|
|
* |
|
|
|
91,976 |
|
|
|
0 |
|
|
|
David Clott |
|
Chrysler Corporation Master Retirement Trust(+)
|
|
|
2,100,000 |
|
|
|
* |
|
|
|
66,604 |
|
|
|
0 |
|
|
|
(10) |
|
Citadel Equity Fund Ltd.(+)
|
|
|
102,500,000 |
|
|
|
6.41 |
% |
|
|
3,250,910 |
|
|
|
0 |
|
|
|
(11) |
|
Clariant Corporation Retirement Plan
|
|
|
350,000 |
|
|
|
* |
|
|
|
11,100 |
|
|
|
0 |
|
|
Robert Butman, George Esser, John Idone, Paul Bucci, Bart Tesoriero |
Columbia Convertible Securities Fund
|
|
|
12,923,000 |
|
|
|
* |
|
|
|
409,868 |
|
|
|
0 |
|
|
|
Yanfang (Emma) Yan |
|
Commercial Union Life Fund
|
|
|
3,650,000 |
|
|
|
* |
|
|
|
115,764 |
|
|
|
0 |
|
|
|
David Clott |
|
Context Convertible Arbitrage Fund, LP
|
|
|
1,790,000 |
|
|
|
* |
|
|
|
56,772 |
|
|
|
0 |
|
|
Michael S. Rosen, William D. Fertig |
Context Convertible Arbitrage Offshore, Ltd.
|
|
|
4,190,000 |
|
|
|
* |
|
|
|
132,890 |
|
|
|
0 |
|
|
Michael S. Rosen, William D. Fertig |
Convertible Securities Fund
|
|
|
77,000 |
|
|
|
* |
|
|
|
2,442 |
|
|
|
0 |
|
|
|
Yanfang (Emma) Yan |
|
Cypress Investment Grade Convertible Bond Fund L.P
|
|
|
1,000,000 |
|
|
|
* |
|
|
|
31,716 |
|
|
|
0 |
|
|
Robert Butman, George Esser, John Idone, Paul Bucci, Bart Tesoriero |
DBAG London(+)
|
|
|
88,187,000 |
|
|
|
5.51 |
% |
|
|
2,796,956 |
|
|
|
0 |
|
|
|
Patrick Corrigan |
|
Delaware Group Equity Funds V-Delaware Dividend Income Fund
|
|
|
1,140,000 |
|
|
|
* |
|
|
|
36,156 |
|
|
|
0 |
|
|
|
Damon Andres |
|
Delaware Investments Dividend & Income Fund
|
|
|
255,000 |
|
|
|
* |
|
|
|
8,087 |
|
|
|
0 |
|
|
|
Damon Andres |
|
Delaware Investments Global Dividend & Income Fund
|
|
|
105,000 |
|
|
|
* |
|
|
|
3,330 |
|
|
|
0 |
|
|
|
Damon Andres |
|
Delaware PERS
|
|
|
1,835,000 |
|
|
|
* |
|
|
|
58,199 |
|
|
|
0 |
|
|
|
Ann Houlihan |
|
Delaware Public Employees Retirement System(+)
|
|
|
860,000 |
|
|
|
* |
|
|
|
27,275 |
|
|
|
0 |
|
|
|
(10) |
|
Delta Air Lines Master Trust CV(+)
|
|
|
460,000 |
|
|
|
* |
|
|
|
14,589 |
|
|
|
0 |
|
|
|
(10) |
|
Delta Airlines Master Trust
|
|
|
725,000 |
|
|
|
* |
|
|
|
22,994 |
|
|
|
0 |
|
|
|
Ann Houlihan |
|
Delta Pilots Disability & Survivorship
Trust CV(+)
|
|
|
255,000 |
|
|
|
* |
|
|
|
8,087 |
|
|
|
0 |
|
|
|
(10) |
|
Double Black Diamond Offshore LDC
|
|
|
5,000,000 |
|
|
|
* |
|
|
|
158,581 |
|
|
|
0 |
|
|
|
Clint D. Carlson |
|
Ellsworth Fund Ltd.
|
|
|
1,500,000 |
|
|
|
* |
|
|
|
47,574 |
|
|
|
0 |
|
|
|
(12) |
|
F.M. Kirby Foundation, Inc.(+)
|
|
|
385,000 |
|
|
|
* |
|
|
|
12,210 |
|
|
|
0 |
|
|
|
(10) |
|
Finch Tactical Plus Class B
|
|
|
370,000 |
|
|
|
* |
|
|
|
11,734 |
|
|
|
0 |
|
|
Michael S. Rosen, William D. Fertig |
Fore Convertible Master Fund, Ltd.
|
|
|
346,000 |
|
|
|
* |
|
|
|
10,973 |
|
|
|
0 |
|
|
|
David Egglishaw |
|
Fore ERISA Fund, Ltd.
|
|
|
34,000 |
|
|
|
* |
|
|
|
1,078 |
|
|
|
0 |
|
|
|
David Egglishaw |
|
FPL Group Employees Pension Plan
|
|
|
825,000 |
|
|
|
* |
|
|
|
26,165 |
|
|
|
0 |
|
|
|
Ann Houlihan |
|
Fuji US Income Open
|
|
|
1,500,000 |
|
|
|
* |
|
|
|
47,574 |
|
|
|
0 |
|
|
|
Maren Lindstrom |
|
Grace Convertible Arbitrage Fund, Ltd.
|
|
|
5,000,000 |
|
|
|
* |
|
|
|
158,581 |
|
|
|
0 |
|
|
|
Michael Brailov |
|
Harbert Arbitrage Master Fund, Ltd.(+)
|
|
|
3,000,000 |
|
|
|
* |
|
|
|
95,148 |
|
|
|
0 |
|
|
|
(13) |
|
ICI American Holdings Trust
|
|
|
535,000 |
|
|
|
* |
|
|
|
16,968 |
|
|
|
0 |
|
|
|
Ann Houlihan |
|
Indianapolis Life Insurance Company
|
|
|
17,000,000 |
|
|
|
1.06 |
% |
|
|
539,175 |
|
|
|
0 |
|
|
|
Thomas Ray |
|
Inflective Convertible Opportunity Fund I, L.P.
|
|
|
2,000,000 |
|
|
|
* |
|
|
|
63,432 |
|
|
|
0 |
|
|
|
Thomas Ray |
|
Inflective Convertible Opportunity Fund I, Limited
|
|
|
6,500,000 |
|
|
|
* |
|
|
|
206,155 |
|
|
|
0 |
|
|
|
Thomas Ray |
|
S-55
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Principal Amount | |
|
|
|
|
|
Number of Shares | |
|
|
|
|
of Debentures | |
|
|
|
|
|
of Common Stock | |
|
|
|
|
Beneficially | |
|
Percentage of | |
|
Number of Shares | |
|
Beneficially | |
|
Natural Person(s) | |
|
|
Owned and | |
|
Debentures | |
|
of Common Stock | |
|
Owned after the | |
|
with Voting or | |
Name of Selling Securityholder(1) |
|
Offered (USD) | |
|
Outstanding(%) | |
|
Offered(2)(3) | |
|
Offering(4) | |
|
Investment Power | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
ING Investors Trust ING T. Rowe Price
Capital Appreciation Portfolio
|
|
|
6,270,000 |
|
|
|
* |
|
|
|
198,860 |
|
|
|
1,533,000 |
|
|
|
(9) |
|
Innovest Finanzdienstle(+)
|
|
|
1,975,000 |
|
|
|
* |
|
|
|
62,639 |
|
|
|
0 |
|
|
|
(7) |
|
Institutional Benchmark Series (Master Feeder) Limited in
Respect of Alcor Series
|
|
|
510,000 |
|
|
|
* |
|
|
|
16,175 |
|
|
|
0 |
|
|
Michael S. Rosen, William D. Fertig |
Institutional Benchmark Series Ivan Segregated Acct
|
|
|
1,500,000 |
|
|
|
* |
|
|
|
47,574 |
|
|
|
0 |
|
|
|
Thomas Ray |
|
International Truck & Engine Corporation
Non-Contributory Retirement Plan Trust(+)
|
|
|
205,000 |
|
|
|
* |
|
|
|
6,501 |
|
|
|
0 |
|
|
|
(10) |
|
International Truck & Engine Corporation Retiree Health
Benefit Trust(+)
|
|
|
120,000 |
|
|
|
* |
|
|
|
3,805 |
|
|
|
0 |
|
|
|
(10) |
|
International Truck & Engine Corporation Retirement
Plan for Salaried Employees Trust(+)
|
|
|
110,000 |
|
|
|
* |
|
|
|
3,488 |
|
|
|
0 |
|
|
|
(10) |
|
JNL Series Trust JNL/ T. Rowe Price
Value Fund(+)
|
|
|
1,913,000 |
|
|
|
* |
|
|
|
60,673 |
|
|
|
177,400 |
|
|
|
(9) |
|
John Hancock Funds II Spectrum Income Fund(+)
|
|
|
250,000 |
|
|
|
* |
|
|
|
7,929 |
|
|
|
0 |
|
|
|
(9) |
|
John Hancock Trust Spectrum Income Trust(+)
|
|
|
225,000 |
|
|
|
* |
|
|
|
7,136 |
|
|
|
0 |
|
|
|
(9) |
|
Kanmunting Street Master Fund
|
|
|
15,000,000 |
|
|
|
* |
|
|
|
475,743 |
|
|
|
0 |
|
|
|
Allan Teh |
|
KBC Financial Products (Cayman Islands) Ltd.(#)
|
|
|
10,000,000 |
|
|
|
* |
|
|
|
317,162 |
|
|
|
0 |
|
|
|
(14) |
|
Knollwood Investment Partnership Capital Appreciation(+)
|
|
|
51,000 |
|
|
|
* |
|
|
|
1,617 |
|
|
|
12,200 |
|
|
|
(9) |
|
LLT Limited
|
|
|
1,506,000 |
|
|
|
* |
|
|
|
47,764 |
|
|
|
0 |
|
|
|
(15) |
|
Lord Abbett Bond Debenture Fund, Inc.
|
|
|
20,000,000 |
|
|
|
1.25 |
% |
|
|
634,324 |
|
|
|
0 |
|
|
|
Maren Lindstrom |
|
Lord Abbett Series Fund Bond Debenture Portfolio
|
|
|
1,250,000 |
|
|
|
* |
|
|
|
39,645 |
|
|
|
0 |
|
|
|
Maren Lindstrom |
|
Lydian Global Opportunities Master Fund Limited
|
|
|
7,000,000 |
|
|
|
* |
|
|
|
222,013 |
|
|
|
0 |
|
|
|
David Friezo |
|
Lydian Overseas Partners Master Fund L.P.
|
|
|
23,000,000 |
|
|
|
1.44 |
% |
|
|
729,472 |
|
|
|
0 |
|
|
|
David Friezo |
|
Lyxor/Context Fund Ltd.(+)
|
|
|
1,460,000 |
|
|
|
* |
|
|
|
46,305 |
|
|
|
0 |
|
|
Michael S. Rosen, William D. Fertig |
Lyxor/Inflective Convertible Opportunity Fund
|
|
|
2,000,000 |
|
|
|
* |
|
|
|
63,432 |
|
|
|
0 |
|
|
|
Thomas Ray |
|
Lyxor/Quest Fund Ltd.
|
|
|
3,000,000 |
|
|
|
* |
|
|
|
95,148 |
|
|
|
0 |
|
|
Frank Campana, James Doolin |
MacKay Shields LLC as Investment Advisor to Aftra Health Fund
|
|
|
275,000 |
|
|
|
* |
|
|
|
8,721 |
|
|
|
0 |
|
|
|
(16) |
|
MacKay Shields LLC as Investment Advisor to Bay County Employees
Retirement System
|
|
|
360,000 |
|
|
|
* |
|
|
|
11,417 |
|
|
|
0 |
|
|
|
(16) |
|
MacKay Shields LLC as Investment Advisor to United Overseas
Bank (SGD)
|
|
|
60,000 |
|
|
|
* |
|
|
|
1,902 |
|
|
|
0 |
|
|
|
(16) |
|
MacKay Shields LLC as Investment Advisor to United Overseas
Bank (USD)
|
|
|
50,000 |
|
|
|
* |
|
|
|
1,585 |
|
|
|
0 |
|
|
|
(16) |
|
MacKay Shields LLC as Sub-Advisor to Mainstay Convertible Fund(+)
|
|
|
5,250,000 |
|
|
|
* |
|
|
|
166,510 |
|
|
|
0 |
|
|
|
(16) |
|
S-56
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Principal Amount | |
|
|
|
|
|
Number of Shares | |
|
|
|
|
of Debentures | |
|
|
|
|
|
of Common Stock | |
|
|
|
|
Beneficially | |
|
Percentage of | |
|
Number of Shares | |
|
Beneficially | |
|
Natural Person(s) | |
|
|
Owned and | |
|
Debentures | |
|
of Common Stock | |
|
Owned after the | |
|
with Voting or | |
Name of Selling Securityholder(1) |
|
Offered (USD) | |
|
Outstanding(%) | |
|
Offered(2)(3) | |
|
Offering(4) | |
|
Investment Power | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
MacKay Shields LLC as Sub-Advisor to Mainstay VP Convertible
Fund(+)
|
|
|
3,655,000 |
|
|
|
* |
|
|
|
115,922 |
|
|
|
0 |
|
|
|
(16) |
|
MacKay Shields LLC as Sub-Advisor to New York Life
Insurance Co. Post 82(+)
|
|
|
7,485,000 |
|
|
|
* |
|
|
|
237,395 |
|
|
|
0 |
|
|
|
(16) |
|
MacKay Shields LLC as Sub-Advisor to New York Life
Insurance Co. Pre 82(+)
|
|
|
3,330,000 |
|
|
|
* |
|
|
|
105,614 |
|
|
|
0 |
|
|
|
(16) |
|
MacKay Shields LLC as Sub-Advisor to New York Life
Separate A/C 7(+)
|
|
|
70,000 |
|
|
|
* |
|
|
|
2,220 |
|
|
|
0 |
|
|
|
(16) |
|
Man Mac I, Ltd.
|
|
|
120,000 |
|
|
|
* |
|
|
|
3,805 |
|
|
|
0 |
|
|
|
Michael Collins |
|
Merrill Lynch Insurance Group Bond Debenture Portfolio
|
|
|
25,000 |
|
|
|
* |
|
|
|
792 |
|
|
|
0 |
|
|
|
Maren Lindstrom |
|
Met Investor Series Trust Bond Debenture
|
|
|
6,000,000 |
|
|
|
* |
|
|
|
190,297 |
|
|
|
0 |
|
|
|
Maren Lindstrom |
|
Microsoft Capital Group, L.P.(+)
|
|
|
790,000 |
|
|
|
* |
|
|
|
25,055 |
|
|
|
0 |
|
|
|
(10) |
|
MSS Convertible Arbitrage I
|
|
|
284,000 |
|
|
|
* |
|
|
|
9,007 |
|
|
|
0 |
|
|
Robert Butman, George Esser, John Idone, Paul Bucci, Bart Tesoriero |
Norwich Union Life & Pensions
|
|
|
5,100,000 |
|
|
|
* |
|
|
|
161,752 |
|
|
|
0 |
|
|
|
David Clott |
|
Nuveen Preferred & Convertible Fund JPC
|
|
|
8,540,000 |
|
|
|
* |
|
|
|
270,856 |
|
|
|
0 |
|
|
|
Ann Houlihan |
|
Nuveen Preferred & Convertible Fund JQC
|
|
|
11,880,000 |
|
|
|
* |
|
|
|
376,788 |
|
|
|
0 |
|
|
|
Ann Houlihan |
|
OCM Convertible Trust(+)
|
|
|
850,000 |
|
|
|
* |
|
|
|
26,958 |
|
|
|
0 |
|
|
|
(10) |
|
OCM Global Convertible Securities Fund(+)
|
|
|
230,000 |
|
|
|
* |
|
|
|
7,294 |
|
|
|
0 |
|
|
|
(10) |
|
Partner Reinsurance Company Ltd.(+)
|
|
|
405,000 |
|
|
|
* |
|
|
|
12,845 |
|
|
|
0 |
|
|
|
(10) |
|
Penn Series Funds, Inc. Flexibly Managed Fund(+)
|
|
|
2,668,000 |
|
|
|
* |
|
|
|
84,618 |
|
|
|
657,000 |
|
|
|
(9) |
|
Penn Series Funds, Inc. High Yield Bond Fund(+)
|
|
|
175,000 |
|
|
|
* |
|
|
|
5,550 |
|
|
|
0 |
|
|
|
(9) |
|
Pensionkasse Der Lonza AG
|
|
|
250,000 |
|
|
|
* |
|
|
|
7,929 |
|
|
|
0 |
|
|
|
(17) |
|
Peoples Benefit Life Insurance Company Teamsters
|
|
|
7,500,000 |
|
|
|
* |
|
|
|
237,871 |
|
|
|
0 |
|
|
|
Alex Lach |
|
Piper Jaffray & Co.(#)
|
|
|
2,000,000 |
|
|
|
* |
|
|
|
63,432 |
|
|
|
0 |
|
|
|
(18) |
|
Privilege Portfolio Sicav
|
|
|
14,000,000 |
|
|
|
* |
|
|
|
444,026 |
|
|
|
0 |
|
|
|
David Clott |
|
Prudential Insureance Co. of America(+)
|
|
|
135,000 |
|
|
|
* |
|
|
|
4,281 |
|
|
|
0 |
|
|
|
Ann Houlihan |
|
Putnam Convertible Income Growth Trust(+)
|
|
|
10,700,000 |
|
|
|
* |
|
|
|
339,363 |
|
|
|
0 |
|
|
|
(19) |
|
Quest Global Convertible Master Fund Ltd.
|
|
|
1,000,000 |
|
|
|
* |
|
|
|
31,716 |
|
|
|
0 |
|
|
Frank Campana, James Doolin |
Qwest Occupational Health Trust(+)
|
|
|
190,000 |
|
|
|
* |
|
|
|
6,026 |
|
|
|
0 |
|
|
|
(10) |
|
Qwest Pension Trust(+)
|
|
|
500,000 |
|
|
|
* |
|
|
|
15,858 |
|
|
|
0 |
|
|
|
(10) |
|
RBC Capital Markets(#)
|
|
|
2,000,000 |
|
|
|
* |
|
|
|
63,432 |
|
|
|
0 |
|
|
|
(20) |
|
Redbourn Partners Ltd.
|
|
|
7,500,000 |
|
|
|
* |
|
|
|
237,871 |
|
|
|
0 |
|
|
|
Alex Lach |
|
S.A.C. Arbitrage Fund, LLC
|
|
|
10,000,000 |
|
|
|
* |
|
|
|
317,162 |
|
|
|
0 |
|
|
|
(21) |
|
Southern Farm Bureau Life Insurance
|
|
|
2,075,000 |
|
|
|
* |
|
|
|
65,811 |
|
|
|
0 |
|
|
|
Ann Houlihan |
|
Sphinx Fund
|
|
|
1,106,000 |
|
|
|
* |
|
|
|
35,078 |
|
|
|
0 |
|
|
Robert Butman, George Esser, John Idone, Paul Bucci, Bart Tesoriero |
State of Oregon Equity
|
|
|
6,900,000 |
|
|
|
* |
|
|
|
218,841 |
|
|
|
0 |
|
|
|
Ann Houlihan |
|
Sterling Invest Co.
|
|
|
1,200,000 |
|
|
|
* |
|
|
|
38,059 |
|
|
|
0 |
|
|
|
Ann Houlihan |
|
Syngenta AG
|
|
|
380,000 |
|
|
|
* |
|
|
|
12,052 |
|
|
|
0 |
|
|
|
Ann Houlihan |
|
S-57
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Principal Amount | |
|
|
|
|
|
Number of Shares | |
|
|
|
|
of Debentures | |
|
|
|
|
|
of Common Stock | |
|
|
|
|
Beneficially | |
|
Percentage of | |
|
Number of Shares | |
|
Beneficially | |
|
Natural Person(s) | |
|
|
Owned and | |
|
Debentures | |
|
of Common Stock | |
|
Owned after the | |
|
with Voting or | |
Name of Selling Securityholder(1) |
|
Offered (USD) | |
|
Outstanding(%) | |
|
Offered(2)(3) | |
|
Offering(4) | |
|
Investment Power | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
T. Rowe Price Capital Appreciation Fund(+)
|
|
|
18,328,000 |
|
|
|
1.15 |
% |
|
|
581,294 |
|
|
|
4,500,000 |
|
|
|
(9) |
|
T. Rowe Price High Yield Fund, Inc.(+)
|
|
|
9,125,000 |
|
|
|
* |
|
|
|
289,410 |
|
|
|
0 |
|
|
|
(9) |
|
T. Rowe Price Value Fund, Inc.(+)
|
|
|
12,000,000 |
|
|
|
* |
|
|
|
380,594 |
|
|
|
1,205,000 |
|
|
|
(9) |
|
The St. Paul Travelers Companies, Inc. Commercial
Lines(+)
|
|
|
735,000 |
|
|
|
* |
|
|
|
23,311 |
|
|
|
0 |
|
|
|
(10) |
|
TQA Convertible Master Fund
|
|
|
250,000 |
|
|
|
* |
|
|
|
7,929 |
|
|
|
0 |
|
|
Robert Butman, George Esser, John Idone, Paul Bucci, Bart Tesoriero |
TQA Master Fund
|
|
|
9,188,000 |
|
|
|
* |
|
|
|
291,408 |
|
|
|
0 |
|
|
Robert Butman, George Esser, John Idone, Paul Bucci, Bart Tesoriero |
TQA Master Plus Fund
|
|
|
5,168,000 |
|
|
|
* |
|
|
|
163,909 |
|
|
|
0 |
|
|
Robert Butman, George Esser, John Idone, Paul Bucci, Bart Tesoriero |
UBS Securities LLC(#)
|
|
|
880,000 |
|
|
|
* |
|
|
|
27,910 |
|
|
|
4,941,425 |
|
|
|
(22) |
|
Universal Investment Gesellschaft MBH, Ref. Aventis
|
|
|
4,750,000 |
|
|
|
* |
|
|
|
150,651 |
|
|
|
0 |
|
|
|
(17) |
|
UnumProvident Corporation(+)
|
|
|
255,000 |
|
|
|
* |
|
|
|
8,087 |
|
|
|
0 |
|
|
|
(10) |
|
Vanguard Convertible Securities Fund, Inc.(+)
|
|
|
3,375,000 |
|
|
|
* |
|
|
|
107,042 |
|
|
|
0 |
|
|
|
(10) |
|
Vicis Capital Master Fund
|
|
|
75,000,000 |
|
|
|
4.69 |
% |
|
|
2,378,715 |
|
|
|
0 |
|
|
John Succo, Sky Lucas and Shad Stastney |
Virginia Retirement System(+)
|
|
|
1,675,000 |
|
|
|
* |
|
|
|
53,124 |
|
|
|
0 |
|
|
|
(10) |
|
Zurich Institutional Benchmark Master Fund
|
|
|
2,218,000 |
|
|
|
* |
|
|
|
70,346 |
|
|
|
0 |
|
|
Robert Butman, George Esser, John Idone, Paul Bucci, Bart Tesoriero |
Total:
|
|
|
781,047,000 |
|
|
|
48.82 |
% |
|
|
24,771,842 |
|
|
|
13,530,125 |
|
|
|
n/a |
|
|
|
|
|
* |
Less than one percent (1%). |
|
|
# |
The selling securityholder is a registered broker-dealer. |
|
|
+ |
The selling securityholder is an affiliate of a registered
broker-dealer. |
|
|
|
|
(1) |
Information concerning other selling securityholders will be set
forth in supplements to this prospectus supplement from time to
time, if required. |
|
|
(2) |
Assumes conversion of all of the holders debentures at a
conversion rate of 31.7162 shares of common stock per $1,000
principal amount at maturity of the debentures. This conversion
rate is subject to adjustment as described under
Description of debentures Conversion
rights. As a result, the number of shares of common stock
issuable upon conversion of the debentures may increase or
decrease in the future. Excludes shares of common stock that may
be issued by us upon the repurchase of the debentures as
described under Description of debentures
Fundamental change permits holders to require us to repurchase
debentures and fractional shares. Holders will receive a
cash adjustment for any fractional share amount resulting from
conversion of the debentures, as described under
Description of debentures Conversion
rights. |
|
|
(3) |
Calculated based on
Rule 13d-3(d)(i)
of the Exchange Act. The number of shares of common stock
beneficially owned by each holder named above is less than 1% of
our outstanding common stock calculated based on
5,883 million shares of common stock outstanding as of
January 27, 2006. In calculating this amount for each
holder, we treated as outstanding the number of shares of common |
S-58
|
|
|
|
|
stock issuable upon conversion of all of that holders
debentures, but we did not assume conversion of any other
holders debentures. |
|
|
|
|
(4) |
For purposes of computing the number and percentage of
debentures and shares of common stock to be held by the selling
securityholders after the conclusion of the offering, we have
assumed for purposes of the table above that the selling
securityholders named above will sell all of the debentures and
all of the common stock issuable upon conversion of the
debentures offered by this prospectus, and that any other shares
of our common stock beneficially owned by these selling
securityholders will continue to be beneficially owned. |
|
|
(5) |
The Allstate Corporation (Allstate), which is a NYSE
listed company, is the parent company of Allstate Insurance
Company (AIC), and Illinois insurance company. AIC
is the parent company of Allstate Life Insurance Company
(ALIC), an Illinois insurance company. ALIC is the
parent company of Allstate Life Insurance Company of New York, a
New York insurance company. The Allstate Corporation is also the
parent company of American Heritage Life Investment Corporation,
a Delaware company that is the parent company of American
Heritage Life Insurance Company, a Florida insurance company.
Agents Pension Plan and Allstate Retirement Plan are qualified
ERISA plans that are maintained for the benefit of certain
agents and employees of AIC. BNY Midwest Trust Company, as
Trustee for such Plans, holds title to all Plan investments.
Allstate disclaims any interest in securities held in such
Trust, although the Investment Committee for such Plan consists
of AIC officers. Allstate Plans Master Trust is a trust
for certain Agents Pension Plan and Allstate Retirement Plan
investments. BNY Midwest Trust Company, as Trustee for such
Trust, holds title to all Trust investments. Allstate disclaims
any interest in securities held in such Trust, although the
Investment Committee for such Trust consists of AIC officers.
AIC is the parent company of Allstate New Jersey Holdings, LLC,
a Delaware limited liability company, which is the parent
company of Allstate New Jersey Insurance Company
(ANJIC), an Illinois insurance company. Allstate
Investments, LLC an affiliate of AIC and ALIC, is the investment
manager for these entities. AIC, ANJIC, Agents Pension Plan and
Allstate Retirement Plan hold the shares of common stock
beneficially owned after the sale of any shares of common stock
issuable upon conversion of the debentures. |
|
|
(6) |
Amaranth Advisors L.L.C., the Trading Advisor for Amaranth LLC,
exercises dispositive powers with respect to the debentures, and
voting and/or dispositive power with respect to the common stock
underlying the debentures. Amaranth Advisors L.L.C. has
designated authorized signatories who will sign on behalf of
Amaranth LLC, the selling securityholder. Nicholas M. Maounis is
the managing member of Amaranth Advisors L.L.C. |
|
|
(7) |
Amerisure Mutual Insurance Company and Innovest Finanzdienstle
have both delegated full investment authority to
Nicholas-Applegate, as investment adviser, over these
securities, including full dispositive power. The Chief
Investment Officer of Nicholas-Applegate is Horacio A. Valeiras,
CFA who, in such capacity, has oversight authority over all
portfolio managers at Nicholas-Applegate. |
|
|
(8) |
Bancroft Fund, Inc. is an AMEX listed company. |
|
(9) |
T. Rowe Price Associates, Inc. (T. Rowe Price
Associates) serves as an investment adviser with the power
to direct investments and/or sole power to vote the shares owned
by the funds and accounts to which this footnote applies, as
well as shares owned by certain other individual and
institutional investors. For purposes of the reporting
requirements of the Securities Exchange Act of 1934,
T. Rowe Price Associates may be deemed to be the beneficial
owner of all of the shares listed in this table and to which
this footnote applies; however, T. Rowe Price Associates
expressly disclaims that it is, in fact, the beneficial owner of
such securities. T. Rowe Price Associates is a wholly owned
subsidiary of T. Rowe Price Group, Inc., which is a
publicly traded financial services holding company. |
|
|
(10) |
Oaktree Capital Management LLC (Oaktree) is the
investment manager of the selling securityholder funds and
accounts to which this footnote applies. It does not own any
equity interest in the funds and accounts but has voting and
dispositive power over the aggregate principal amount of
debentures and common stock issuable upon conversion of the
debentures for each selling securityholder. Lawrence Keele is a
principal of Oaktree and is the portfolio manager for the
selling securityholders to which this |
S-59
|
|
|
footnote applies. Mr. Keele, Oaktree and all employees and
members of Oaktree disclaim beneficial ownership of the
securities held by the selling securityholders, except for their
pecuniary interest therein. |
|
(11) |
Citadel Limited Partnership (CLP) is the trading
manager of Citadel Equity Fund Ltd. and consequently has
investment discretion over securities held by Citadel Equity
Fund Ltd. Citadel Investment Group, L.L.C.
(CIG) controls CLP. Kenneth C. Griffin controls
CIG and therefore has ultimate investment discretion over
securities held by Citadel Equity Fund Ltd. CLP, CIG, and
Mr. Griffin each disclaim beneficial ownership of the
shares held by Citadel Equity Fund Ltd. |
|
(12) |
Ellsworth Fund Ltd. is an AMEX listed company. |
|
(13) |
HMC Arbitrage Offshore Manager, LLC serves as investment manager
for the Harbert Arbitrage Master Fund, Ltd. (the
Fund). HMC Investors, LLC serves as managing member
for the investment manager. Jeffrey Parket serves as senior
managing director for the Fund. Michael Luce and Raymond Harbert
may also be deemed to control the managing member. Each person
or entity disclaims any beneficial ownership except to the
extent of their actual pecuniary interest. |
|
(14) |
The securities are under the total control of KBC Financial
Products Cayman Islands Ltd. KBC Financial Products Cayman
Islands Ltd. is a direct wholly-owned subsidiary of KBC
Financial Holdings, Inc., which in turn is a direct wholly-owned
subsidiary of KBC Bank N.V., which in turn is a direct
wholly-owned subsidiary of KBC Group N.V., a publicly traded
entity. |
|
(15) |
Forest Investment Management LP (Forest) has sole
voting control and shared investment control over LLT Limited.
Forest is wholly-owned by Forest Partners II, the sole
General Partner of which is Michael A. Boyd Inc., which is
solely owned by Michael A. Boyd. |
|
(16) |
MacKay Shields LLC is a wholly owned subsidiary of New York Life
Insurance Company. MacKay Shields LLC is the subadvisor of
portfolios MacKay Shields LLC as sub-advisor to New York Life
Insurance Co Post 82, New York Life Insurance Co Pre 82, New
York Life Insurance Separate A/ C 7, Mainstay Convertible Fund,
Mainstay VP Convertible Fund. MacKay Shields LLC does not own
any equity interest in the funds and accounts but has voting and
dispositive power over the aggregate principal amount of
debentures for each selling securityholder. Edward Silverstein,
Managing Director of MacKay Shields LLC., is the portfolio
manager for the selling securityholders. Mr. Silverstein,
MacKay Shields LLC and all employees and members of MacKay
Shields LLC disclaim beneficial ownership of the securities held
by the Selling Securityholders, except for their pecuniary
interest therein. |
|
(17) |
Pensionkasse Der Lonza AG and Universal Investment Gesellschaft
MBH, Ref. Aventis are investment vehicles to which Jefferies
& Company, Inc. provides investment services. Jefferies
& Company, Inc. provides both institutions and
high-net-worth individuals with trading services in equities,
high-yield bonds, convertible bonds and international
securities. Jeffries & Company, Inc. is the main operating
subsidiary of Jefferies Group, Inc. Jeffries Group, Inc. is a
publicly traded entity listed on the NYSE. |
|
(18) |
Piper Jaffray Companies is a NYSE listed company. |
|
(19) |
Putnam Convertible Income-Growth Trust is a mutual fund managed
by Putnam Investment Management, LLC, which is responsible for
all voting and investment decisions for the selling
securityholder. Putnam Investment Management, LLC is owned by
Putnam, LLC, which is owned by Putnam Investments Trust, which
is owned by Marsh & McLennan Companies, Inc., a publicly
traded corporation. |
|
(20) |
RBC Capital Markets is an affiliate of Royal Bank of Canada.
Royal Bank of Canada is a NYSE listed company. |
|
(21) |
Pursuant to investment agreements, each of S.A.C. Capital
Advisors, LLC, a Delaware limited liability company (SAC
Capital Advisors), and S.A.C. Capital Management, LLC, a
Delaware limited liability company (SAC Capital
Management) share all investment and voting power with
respect to the securities held by S.A.C. Arbitrage Fund.
Mr. Steven A. Cohen controls both SAC Capital Advisors and
SAC Capital Management. Each of SAC Capital Advisors, SAC
Capital Management and Mr. Cohen disclaim beneficial
ownership of any of the securities registered herein. |
S-60
|
|
(22) |
UBS AG is the entity in majority control of UBS Securities LLC.
Keith Ackerman is the natural person who has voting control
over these securities. |
Only selling securityholders identified above who beneficially
own the securities set forth opposite each such selling
securityholders name in the foregoing table may sell such
securities under the registration statement. Prior to any use of
this prospectus supplement in connection with an offering of the
debentures and/or the underlying common stock by any holder not
identified above, this prospectus supplement will be
supplemented to set forth the name and other information about
the selling securityholder intending to sell such debentures and
the underlying common stock. The prospectus supplement will also
disclose whether any securityholder selling in connection with
such prospectus supplement has held any position or office with,
been employed by or otherwise had a material relationship with,
us or any of our affiliates during the three years prior to the
date of the prospectus supplement if such information has not
been disclosed in this prospectus supplement.
S-61
Plan of distribution
The selling securityholders and their successors, which includes
their transferees, pledgees or donees or their successors, may,
from time to time, sell the debentures and the underlying common
stock directly to purchasers or through underwriters,
broker/dealers or agents who may receive compensation in the
form of underwriting discounts, concessions or commissions from
the selling securityholders and/or the purchasers of the
securities. These discounts, concessions or commissions may be
in excess of those customary in the types of transactions
involved.
The selling securityholders may sell the debentures and the
underlying common stock, from time to time, in one or more
transactions at:
|
|
|
|
|
fixed prices; |
|
|
|
prevailing market prices at the time of sale; |
|
|
|
prices related to such prevailing market prices; |
|
|
|
varying prices determined at the time of sale; or |
|
|
|
negotiated prices. |
These sales may be effected in transactions (which may involve
block transactions) in the following manner:
|
|
|
|
|
on any national securities exchange or quotation service on
which the debentures or the underlying common stock may be
listed or quoted at the time of sale; |
|
|
|
in the over-the-counter
market; |
|
|
|
in transactions otherwise than on such exchanges or services or
in the over-the-counter
market; or |
|
|
|
through the writing of options, whether such options are listed
on option exchanges or otherwise through the settlement of short
sales. |
These sales may include crosses. Crosses are transactions in
which the same broker acts as an agent on both sides of the
transaction.
The selling securityholders may also enter into hedging
transactions with broker/dealers or other financial institutions
in connection with the sales of the debentures or the underlying
common stock. These broker/dealers or other financial
institutions may in turn engage in short sales of these
securities in the course of hedging their positions. The selling
securityholders may sell short these securities to close out
short positions, or loan or pledge these securities to
broker/dealers that, in turn, may sell such securities.
A short sale of the debentures or the underlying common stock by
a broker-dealer, financial institution or selling securityholder
would involve the sale of such debentures or underlying common
stock that are not owned, and therefore must be borrowed, in
order to make delivery of the security in connection with such
sale. In connection with a short sale of the debentures or the
underlying common stock, a broker-dealer, financial institution
or selling securityholder may purchase the debentures or our
common stock on the open market to cover positions created by
short sales. In determining the source of the debentures or
shares of common stock to close out such short positions, the
broker-dealer, financial institution or selling securityholders
may consider, among other things, the price of debentures or
shares of common stock available for purchase in the open market.
The aggregate proceeds to the selling securityholders from the
sale of the debentures or underlying common stock will be the
purchase price of the debentures or common stock less any
discounts or commissions. A selling securityholder reserves the
right to accept, and together with its agents, to reject (except
when we decide to redeem the debentures in accordance with the
terms of the indenture) any proposed purchase of debentures or
common stock to be made directly or through agents. We will not
receive any of the proceeds from this offering.
S-62
To comply with certain states securities laws, if
applicable, the selling securityholders will offer or sell the
debentures and the common stock into which the debentures are
convertible in such jurisdictions only through registered or
licensed brokers/dealers. In addition, in some states the
selling securityholders may not sell the debentures and the
common stock into which the debentures are convertible unless
such securities have been registered or qualified for sale in
the applicable state or an exemption from registration or
qualification is available and the conditions of which have been
satisfied.
Our outstanding common stock is listed for trading on the Nasdaq
National Market. Since their initial issuance, the debentures
have been eligible for trading on the PORTAL Market of the
National Association of Securities Dealers, Inc. However,
debentures sold by means of this prospectus supplement will no
longer be eligible for trading on the PORTAL Market. We do not
intend to list the debentures for trading on any other automated
quotation system or any securities exchange.
The selling securityholders and any underwriters, broker/
dealers or agents that participate in the distribution of the
debentures and underlying common stock may, in connection with
these sales, be deemed to be underwriters within the
meaning of the Securities Act. Any selling securityholder that
is a broker-dealer or an affiliate of a broker-dealer will be
deemed to be an underwriter within the meaning of
the Securities Act, unless such selling securityholder purchased
its debentures in the ordinary course of business, and at the
time of its purchase of the debentures to be resold, did not
have any agreements or understandings, directly or indirectly,
with any person to distribute the debentures. As a result, any
discounts, commissions, concessions or profit they earn on any
resale of the debentures or the shares of the underlying common
stock may be underwriting discounts and commissions under the
Securities Act. Selling securityholders who are deemed to be
underwriters within the meaning of the Securities
Act will be subject to the prospectus delivery requirements of
the Securities Act and to certain statutory liabilities,
including but not limited to those relating to Sections 11,
12 and 17 of the Securities Act and
Rule 10b-5 under
the Exchange Act. The selling securityholders have agreed to
comply with the prospectus delivery requirements of the
Securities Act, if any. To our knowledge, none of the selling
securityholders who are broker-dealers or affiliates of
broker-dealers, other than the initial purchasers, purchased
debentures outside of the ordinary course of business or, at the
time of the purchase of the debentures, had any agreements or
understandings, directly or indirectly, with any person to
distribute the debentures.
The selling securityholders and any other person participating
in the sale of the debentures or the underlying common stock
will be subject to the Exchange Act. The Exchange Act rules
include, without limitation, Regulation M, which may limit
the timing of purchases and sales of any of the debentures and
the underlying common stock by the selling securityholders and
any other such person. In addition, Regulation M of the
Exchange Act may restrict the ability of any person engaged in
the distribution of the debentures and the underlying common
stock to engage in market-making activities with respect to the
particular debentures and the underlying common stock being
distributed for a period of up to five business days before the
commencement of such distribution. This may affect the
marketability of the debentures and the underlying common stock
and the ability of any person or entity to engage in
market-making activities with respect to the debentures and the
underlying common stock.
We cannot assure you that any selling securityholder will sell
any or all of the debentures or the underlying common stock with
this prospectus supplement and the accompanying prospectus.
Further, we cannot assure you that any such selling
securityholder will not transfer, devise or gift the debentures
and the underlying common stock by other means not described in
this prospectus supplement and the accompanying prospectus. As a
result, there may be, at any time, securities outstanding that
are subject to restrictions on transferability and resale. In
addition, any securities covered by this prospectus supplement
and the accompanying prospectus which qualify for sale pursuant
to Rule 144 or Rule 144A under the Securities Act may
be sold pursuant to Rule 144 or Rule 144A rather than
pursuant to this prospectus supplement and the accompanying
prospectus. Each selling securityholder has represented that it
will not sell any debentures or common stock pursuant to this
prospectus supplement and the accompanying prospectus except as
described in this prospectus supplement and the accompanying
prospectus.
S-63
At the time a particular offering of the debentures or
underlying common stock is made, if required, a prospectus
supplement, or, if appropriate, a post-effective amendment to
the registration statement of which the accompanying prospectus
is a part, will be distributed setting forth the names of the
selling securityholders, the aggregate amount and type of
securities being offered, and, to the extent required, the terms
of the offering, including the name or names of any
underwriters, broker/dealers or agents, any discounts,
commissions and other terms constituting compensation from the
selling securityholders and any discounts, commission or
concessions allowed or reallowed or paid to the broker/dealers.
To our knowledge, there are currently no plans, arrangements or
understandings between any selling securityholder and any
underwriter, broker-dealer or agent regarding the sale of
debentures and the underlying common stock by the selling
securityholders.
Pursuant to the registration rights agreement, all expenses of
the registration of debentures and underlying common stock will
be paid by us, except that the selling securityholders will pay
all underwriting discounts and selling commissions. The selling
securityholders and we have agreed to indemnify each other and
our respective directors, officers and controlling persons
against, and in certain circumstances to provide contribution
with respect to, specific liabilities in connection with the
offer and sale of the debentures and the common stock, including
liabilities under the Securities Act.
The registration rights agreement requires that we use
reasonable efforts to keep the shelf registration statement
effective until the earliest of (i) the second anniversary
of the date of the original issuance of the debentures and
(ii) such time as all of the debentures and the common
stock issuable on the conversion thereof cease to be outstanding
or have either (A) been sold or otherwise transferred
pursuant to an effective registration statement, (B) been
sold pursuant to Rule 144 under circumstances in which any
legend borne by the debentures or common stock relating to
restrictions on transferability thereof is removed or
(C) become eligible for sale pursuant to Rule 144(k)
or any successor provision. Notwithstanding the foregoing
obligations, we may, under certain circumstances, postpone or
suspend the filing or the effectiveness of the shelf
registration statement, or any amendments or supplement thereto,
or the sale of the debentures or underlying common stock
hereunder. See Description of debentures
Registration rights.
S-64
Legal matters
The validity of the securities offered by this prospectus
supplement will be passed upon for us by Gibson, Dunn &
Crutcher LLP, San Francisco, California.
Experts
Ernst & Young LLP, independent registered public
accounting firm, has audited our consolidated financial
statements and schedule included in our Annual Report on
Form 10-K for the
year ended December 31, 2005, and managements
assessment of the effectiveness of our internal control over
financial reporting as of December 31, 2005, as set forth
in their reports, which are incorporated by reference in this
prospectus supplement and elsewhere in the registration
statement. Our financial statements and schedule and
managements assessment are incorporated by reference in
reliance on Ernst & Young LLPs reports, given on
their authority as experts in accounting and auditing.
S-65
PROSPECTUS
INTEL CORPORATION
DEBT SECURITIES
COMMON STOCK
PREFERRED STOCK
WARRANTS
DEPOSITARY SHARES
PURCHASE CONTRACTS
GUARANTEES
UNITS
We or selling securityholders may from time to time offer to
sell debt securities, common stock, preferred stock, warrants,
depositary shares, purchase contracts, guarantees or units. Each
time we or a selling securityholder sells securities pursuant to
this prospectus, we will provide a supplement to this prospectus
that contains specific information about the offering and the
specific terms of the securities offered. You should read this
prospectus and the applicable prospectus supplement carefully
before you invest in our securities.
Our common stock is listed on the Nasdaq National
Market®
under the symbol INTC.
Investing in our securities involves a high degree of risk.
See Risk Factors section of our filings with the SEC
and the applicable prospectus supplement.
Neither the Securities and Exchange Commission nor any state
securities commission has approved or disapproved of these
securities or determined if this prospectus is truthful or
complete. Any representation to the contrary is a criminal
offense.
This prospectus is dated March 30, 2006
If you are in a jurisdiction where offers to sell, or
solicitations of offers to purchase, the securities offered by
this document are unlawful, or if you are a person to whom it is
unlawful to direct these types of activities, then the offer
presented in this document does not extend to you. The
information contained in this document speaks only as of the
date of this document, unless the information specifically
indicates that another date applies.
TABLE OF CONTENTS
|
|
|
|
|
|
|
Page | |
|
|
| |
|
|
|
2 |
|
|
|
|
3 |
|
|
|
|
4 |
|
|
|
|
4 |
|
|
|
|
4 |
|
|
|
|
5 |
|
|
|
|
10 |
|
|
|
|
11 |
|
|
|
|
12 |
|
|
|
|
14 |
|
|
|
|
14 |
|
|
|
|
14 |
|
|
|
|
14 |
|
|
|
|
14 |
|
1
FORWARD-LOOKING STATEMENTS
This prospectus and the documents incorporated by reference
herein contain forward-looking statements within the meaning of
Section 27A of the Securities Act and Section 21E of
the Securities Exchange Act of 1934, as amended (the
Exchange Act). All statements, other than statements
of historical facts, included or incorporated herein regarding
our strategy, future operations, financial position, future
revenues, projected costs, prospects, plans and objectives are
forward-looking statements. In some cases, you can identify
forward-looking statements by terminology such as
anticipates, believes,
estimates, expects, intends,
may, plans, projects,
will, would, and similar expressions or
expressions of the negative of these terms. Such statements are
only predictions and, accordingly, are subject to substantial
risks, uncertainties and assumptions.
Many factors could affect our actual results, and variances from
our current expectations regarding such factors could cause
actual results to differ materially from those expressed in our
forward-looking statements. We presently consider the factors
set forth below to be important factors that could cause actual
results to differ materially from our published expectations. A
more detailed discussion of these factors, as well as other
factors that could affect our results, is contained under the
heading Risk factors in our SEC filings, including
the report on
Form 10-K for the
year ended December 31, 2005. However, management cannot
predict all factors, or combinations of factors, that may cause
actual results to differ materially from those projected in any
forward-looking statements. Factors that could cause our results
to be different from our expectations include:
|
|
|
|
|
we operate in intensely competitive industries that are
characterized by a high percentage of costs that are fixed or
difficult to reduce in the short term, and by product demand
that is highly variable. Revenue and the gross margin percentage
are affected by the demand for and market acceptance of our
products; the availability of sufficient inventory of Intel
products and related components from other suppliers to meet
demand; pricing pressures; actions taken by Intels
competitors; and our ability to respond quickly to technological
developments and to incorporate new features into our products.
Factors that could cause demand to be different from our
expectations include changes in customer product needs,
including order cancellations; changes in customers level
of inventory; and changes in business and economic conditions; |
|
|
|
our gross margin percentage could vary from expectations based
on changes in revenue levels; product mix and pricing;
variations in inventory valuation, including variations related
to the timing of qualifying products for sale; excess or
obsolete inventory; manufacturing yields; changes in unit costs;
capacity utilization; impairments of long-lived assets,
including manufacturing, assembly/test and intangible assets;
and the timing and execution of the manufacturing ramp and
associated costs, including
start-up costs; |
|
|
|
expenses, particularly certain marketing and compensation
expenses, vary depending on the level of demand for our products
and the level of revenue and profits; |
|
|
|
our results could be impacted by unexpected economic, social and
political conditions in the countries in which we, our customers
or our suppliers operate, including security risks, possible
infrastructure disruptions and fluctuations in foreign currency
exchange rates; |
|
|
|
our results could be affected by adverse effects associated with
product defects and errata (deviations from published
specifications), and by litigation or regulatory matters
involving intellectual property, stockholder, consumer,
antitrust and other issues, such as the litigation and
regulatory matters described in our SEC reports; and |
|
|
|
our results could be affected by the amount, type, and valuation
of share-based awards granted as well as the amount of awards
cancelled due to employee turnover. |
Unless required by law, we undertake no obligation to publicly
update or revise any forward-looking statements to reflect
events or developments after the date of this prospectus.
2
ABOUT THIS PROSPECTUS
This prospectus is part of a registration statement we filed
with the SEC using a shelf registration process. We
may sell any combination of the securities described in this
prospectus from time to time.
The types of securities that we or selling securityholders may
offer and sell from time to time pursuant to this prospectus are:
|
|
|
|
|
debt securities; |
|
|
|
common stock; |
|
|
|
preferred stock; |
|
|
|
warrants; |
|
|
|
depositary shares; |
|
|
|
purchase contracts; |
|
|
|
guarantees; and |
|
|
|
units consisting of any of the securities listed above. |
Each time we or selling securityholders sell securities pursuant
to this prospectus, we will describe in a prospectus supplement,
which will be delivered with this prospectus, specific
information about the offering and the terms of the particular
securities offered. In each prospectus supplement we will
include the following information, if applicable:
|
|
|
|
|
the type and amount of securities that we or selling
securityholders propose to sell; |
|
|
|
the initial public offering price of the securities; |
|
|
|
the names of any underwriters or agents through or to which we
or selling securityholders will sell the securities; |
|
|
|
any compensation of those underwriters or agents; and |
|
|
|
information about any securities exchanges or automated
quotation systems on which the securities will be listed or
traded. |
In addition, the prospectus supplement may also add, update or
change the information contained in this prospectus.
Wherever references are made in this prospectus to information
that will be included in a prospectus supplement, to the extent
permitted by applicable law, rules or regulations, we may
instead include such information or add, update or change the
information contained in this prospectus by means of a
post-effective amendment to the registration statement of which
this prospectus is a part, through filings we make with the SEC
that are incorporated by reference into this prospectus or by
any other method as may then be permitted under applicable law,
rules or regulations.
3
THE COMPANY
We are the worlds largest semiconductor chip maker,
developing advanced integrated digital technology platforms for
the computing and communications industries. Our goal is to be
the preeminent provider of silicon chips and platform solutions
to the worldwide digital economy. We offer products at various
levels of integration, allowing our customers flexibility to
create advanced computing and communications systems and
products.
Intels products include chips, boards and other
semiconductor components that are the building blocks integral
to computers, servers, and networking and communications
products. Our component-level products consist of integrated
circuits used to process information. Our integrated circuits
are silicon chips, known as semiconductors, etched with
interconnected electronic switches.
We were incorporated in California in 1968 and reincorporated in
Delaware in 1989. Our principal executive offices are located at
2200 Mission College Boulevard, Santa Clara, California
95054 and our telephone number is (408) 765-8080.
USE OF PROCEEDS
We intend to use the net proceeds we receive from the sale of
securities by us as set forth in the applicable prospectus
supplement. Unless otherwise specified in the applicable
prospectus supplement, we will not receive any proceeds from the
sale of securities by selling securityholders.
RATIO OF EARNINGS TO FIXED CHARGES
The following table sets forth our ratio of earnings to fixed
charges for each of the periods indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended | |
| |
December 31, | |
|
December 25, | |
|
December 27, | |
|
December 28, | |
|
December 29, | |
2005 | |
|
2004 | |
|
2003 | |
|
2002 | |
|
2001 | |
| |
|
| |
|
| |
|
| |
|
| |
|
169x |
|
|
|
107x |
|
|
|
72x |
|
|
|
32x |
|
|
|
18x |
|
The ratio of earnings to fixed charges is computed by dividing
(i) income before income taxes plus fixed charges by
(ii) fixed charges. Our fixed charges consist of the
portion of operating lease rental expense that is representative
of the interest factor and interest expense on indebtedness.
4
DESCRIPTION OF DEBT SECURITIES
The following sets forth certain general terms and provisions of
the indenture under which the debt securities are to be issued,
unless otherwise specified in a prospectus supplement. The
particular terms of the debt securities to be sold will be set
forth in a prospectus supplement relating to such debt
securities.
The debt securities will represent unsecured general obligations
of the Company, unless otherwise provided in the prospectus
supplement. As indicated in the applicable prospectus
supplement, the debt securities will either be senior debt or
subordinated debt as described in such prospectus supplement.
Unless otherwise specified in the applicable prospectus
supplement, the debt securities will be issued under an
indenture dated as of March 29, 2006 between us and
Citibank, N.A. that has been filed as an exhibit to the
registration statement of which this prospectus is a part,
subject to such amendments or supplemental indentures as are
adopted from time to time. The following summary of certain
provisions of that indenture does not purport to be complete and
is subject to, and qualified in its entirety by, reference to
all the provisions of that indenture, including the definitions
therein of certain terms. Wherever particular sections or
defined terms of the indenture are referred to, it is intended
that such sections or defined terms shall be incorporated herein
by reference.
General
The indenture does not limit the amount of debt securities that
may be issued thereunder. The applicable prospectus supplement
with respect to any debt securities will set forth the following
terms of the debt securities offered pursuant thereto:
(i) the title and series of such debt securities, including
CUSIP numbers; (ii) any limit upon the aggregate principal
amount of such debt securities of such title or series;
(iii) whether such debt securities will be in global or
other form; (iv) the date(s) and method(s) by which
principal and any premium on such debt securities is payable;
(v) interest rate or rates (or method by which such rate
will be determined), if any; (vi) the dates on which any
such interest will be payable and the method of payment;
(vii) whether and under what circumstances any additional
amounts are payable with respect to such debt securities;
(viii) the notice, if any, to holders of such debt
securities regarding the determination of interest on a floating
rate debt security; (ix) the basis upon which interest on
such debt securities shall be calculated, if other than that of
a 360 day year of twelve
30-day months;
(x) the place or places where the principal of and interest
or additional amounts, if any, on such debt securities will be
payable; (xi) any redemption or sinking fund provisions, or
the terms of any repurchase at the option of the holder of the
debt securities; (xii) the denominations of such debt
securities, if other than $1,000 and integral multiples thereof;
(xiii) any rights of the holders of such debt securities to
convert the debt securities into other securities or property;
(xiv) the terms, if any, on which payment of principal or
any premium, interest or additional amounts on such debt
securities will be payable in a currency other than
U.S. dollars; (xv) the terms, if any, by which the
amount of payments of principal or any premium, interest or
additional amounts on such debt securities may be determined by
reference to an index, formula, financial or economic measure or
other methods; (xvi) if other than the principal amount
hereof, the portion of the principal amount of such debt
securities that will be payable upon declaration of acceleration
of the maturity thereof or provable in bankruptcy;
(xvii) any events of default or covenants in addition to or
in lieu of those described herein and remedies therefor;
(xviii) whether such debt securities will be subject to
defeasance or covenant defeasance; (xix) the terms, if any,
upon which such debt securities are to be issuable upon the
exercise of warrants; (xx) any trustees other than
Citibank, N.A., and any authenticating or paying agents,
transfer agents or registrars or any other agents with respect
to such debt securities; (xxi) the terms, if any, on which
such debt securities will be subordinate to other debt of the
Company; and (xxii) any other specific terms of such debt
securities and any other deletions from or additions to or
modifications of the indenture with respect to such debt
securities.
Debt securities may be presented for exchange, conversion or
transfer in the manner, at the places and subject to the
restrictions set forth in the debt securities and the prospectus
supplement. Such services will be provided without charge, other
than any tax or other governmental charge payable in connection
therewith, but subject to the limitations provided in the
indenture.
The indenture does not contain any covenant or other specific
provision affording protection to holders of the debt securities
in the event of a highly leveraged transaction or a change in
control of the Company, except
5
to the limited extent described below under
Consolidation, Merger and Sale of
Assets. The Companys certificate of incorporation
also contains other provisions which may prevent or limit a
change of control. See Description of Capital Stock.
Modification and Waiver
The indenture provides that supplements to the indenture and the
applicable supplemental indentures may be made by the Company
and the trustee for the purpose of adding any provisions to or
changing in any manner or eliminating any of the provisions of
the indenture or of modifying in any manner the rights of the
holders of debt securities of a series under the indenture or
the debt securities of such series, with the consent of the
holders of a majority (or such other amount as is provided for a
particular series of debt securities) in principal amount of the
outstanding debt securities issued under such indenture that are
affected by the supplemental indenture, voting as a single
class; provided that no such supplemental indenture may, without
the consent of the holder of each such debt security affected
thereby, among other things: (a) change the stated maturity
of the principal of, or any premium, interest or additional
amounts on, such debt securities, or reduce the principal amount
thereof, or reduce the rate or extend the time of payment of
interest or any additional amounts thereon, or reduce any
premium payable on redemption thereof or otherwise, or reduce
the amount of the principal of debt securities issued with
original issue discount that would be due and payable upon an
acceleration of the maturity thereof or the amount thereof
provable in bankruptcy, or change the redemption provisions or
adversely affect the right of repayment at the option of the
holder, or change the place of payment or currency in which the
principal of, or any premium, interest or additional amounts
with respect to any debt security is payable, or impair or
affect the right of any holder of debt securities to institute
suit for the payment after such payment is due, (b) reduce
the percentage of outstanding debt securities of any series, the
consent of the holders of which is required for any such
supplemental indenture, or the consent of whose holders is
required for any waiver or reduce the quorum required for
voting; (c) modify any of the provisions of the sections of
such indenture relating to supplemental indentures with the
consent of the holders, waivers of past defaults or securities
redeemed in part, except to increase any such percentage or to
provide that certain other provisions of such indenture cannot
be modified or waived without the consent of each holder
affected thereby; or (d) make any change that adversely
affects the right to convert or exchange any security into or
for common stock or other securities, cash or other property in
accordance with the terms of the applicable debt security.
The indenture provides that a supplemental indenture that
changes or eliminates any covenant or other provision of the
indenture that has expressly been included solely for the
benefit of one or more particular series of debt securities, or
that modifies the rights of the holders of such series with
respect to such covenant or other provision, shall be deemed not
to affect the rights under the indenture of the holders of debt
securities of any other series.
The indenture provides that the Company and the applicable
trustee may, without the consent of the holders of any series of
debt securities issued thereunder, enter into additional
supplemental indentures for one of the following purposes:
(1) to evidence the succession of another corporation to
the Company and the assumption by any such successor of the
covenants of the Company in such indenture and in the debt
securities issued thereunder; (2) to add to the covenants
of the Company or to surrender any right or power conferred on
the Company pursuant to the indenture; (3) to establish the
form and terms of debt securities issued thereunder; (4) to
evidence and provide for a successor trustee under such
indenture with respect to one or more series of debt securities
issued thereunder or to provide for or facilitate the
administration of the trusts under such indenture by more than
one trustee; (5) to cure any ambiguity, to correct or
supplement any provision in the indenture that may be
inconsistent with any other provision of the indenture or to
make any other provisions with respect to matters or questions
arising under such indenture which shall not adversely affect
the interests of the holders of any series of debt securities
issued thereunder in any material respect; (6) to add to,
delete from or revise the conditions, limitations and
restrictions on the authorized amount, terms or purposes of
issue, authentication and delivery of securities under the
indenture, (7) to add any additional events of default with
respect to all or any series of debt securities; (8) to
supplement any of the provisions of the indenture as may be
necessary to permit or facilitate the defeasance and discharge
of any
6
series of debt securities, provided that such action does not
adversely affect the interests of any holder of an outstanding
debt security of such series or any other security in any
material respect; (9) to make provisions with respect to
the conversion or exchange rights of holders of debt securities
of any series; (10) to amend or supplement any provision
contained in such indenture or any supplemental indenture,
provided that no such amendment or supplement shall materially
adversely affect the interests of the holders of any debt
securities then outstanding; or (11) to qualify such
indenture under the Trust Indenture Act of 1939.
Events of Default
Unless otherwise provided in any prospectus supplement, the
following will be events of default under the indenture with
respect to each series of debt securities issued thereunder:
(a) default in the payment of principal (or premium, if
any) or any additional amounts with respect to such principal or
premium on any series of the debt securities outstanding under
the indenture when due; (b) default in the payment of any
interest or any additional amounts with respect to such interest
on any series of the debt securities outstanding under the
indenture when due, continued for 30 days; (c) default
in the payment, if any, of any sinking fund installment when and
as due by the terms of any debt security of such series, subject
to any cure period that may be specified in any debt security of
such series; (d) failure to perform any other covenant or
warranty of the Company contained in such indenture or such debt
securities continued for 90 days after written notice;
(e) certain events of bankruptcy, insolvency or
reorganization of the Company; and (f) any other event of
default provided in a supplemental indenture with respect to a
particular series of debt securities. In case an event of
default other than a default specified in clause (e) above
shall occur and be continuing with respect to any series of such
debt securities, the applicable trustee or the holders of not
less than 25% in aggregate principal amount of the debt
securities of such series then outstanding (each such series
acting as a separate class) may declare the principal (or, in
the case of discounted debt securities, the amount specified in
the terms thereof) of such series to be due and payable. If an
event of default described in (e) above shall occur and be
continuing then the principal amount (or, in the case of
discounted debt securities, the amount specified in the terms
thereof) of all the debt securities outstanding shall be and
become due and payable immediately, without notice or other
action by any holder or the applicable trustee, to the full
extent permitted by law. Any event of default with respect to
particular series of debt securities under such indenture may be
waived by the holders of a majority in aggregate principal
amount of the outstanding debt securities of such series (voting
as a class), except in each case a failure to pay principal of
or premium, interest or additional amounts, if any, on such debt
securities or a default in respect of a covenant or provision
which cannot be modified or amended without the consent of each
holder affected thereby.
The indenture provides that the applicable trustee may withhold
notice to the holders of any default with respect to any series
of debt securities (except in payment of principal of or
interest or premium on, or sinking fund payment in respect of,
the debt securities) if the applicable trustee considers it in
the interest of holders to do so.
The indenture contains a provision entitling the applicable
trustee to be indemnified by the holders before proceeding to
exercise any trust or power under such indenture at the request
of such holders. The indenture provides that the holders of a
majority in aggregate principal amount of the then outstanding
debt securities of any series may direct the time, method and
place of conducting any proceedings for any remedy available to
the applicable trustee or of exercising any trust or power
conferred upon the applicable trustee with respect to the debt
securities of such series; provided, however, that the
applicable trustee may decline to follow any such direction if,
among other reasons, the applicable trustee determines in good
faith that the actions or proceedings as directed may not
lawfully be taken or would be unduly prejudicial to the holders
of the debt securities of such series not joining in such
direction. The right of a holder to institute a proceeding with
respect to the applicable indenture will be subject to certain
conditions precedent including, without limitation, that the
holders of not less than 25% in aggregate principal amount of
the debt securities of such series then outstanding under such
indenture make a written request upon the applicable trustee to
exercise its powers under such indenture, indemnify the
applicable trustee and afford the applicable trustee reasonable
opportunity to act, but the holder has an absolute right to
receipt of the principal of, premium, if any, and
7
interest when due on the debt securities, to require conversion
of debt securities if such indenture provides for convertibility
at the option of the holder and to institute suit for the
enforcement thereof.
Consolidation, Merger and Sale of Assets
The indenture provides that the Company may not consolidate
with, merge into or sell, convey or lease all or substantially
all of its assets to any person unless the successor person is a
corporation organized under the laws of any domestic
jurisdiction and assumes the Companys obligations on the
debt securities issued thereunder, and under such indenture, and
after giving effect thereto no event of default, and no event
that, after notice or lapse of time or both, would become an
event of default, shall have occurred and be continuing, and
that certain other conditions are met.
Certain Covenants
Existence. Except as permitted under
Consolidation, Merger and Sale of
Assets, the indenture requires the Company to do or cause
to be done all things necessary to preserve and keep in full
force and effect its corporate existence, rights (by certificate
of incorporation, bylaws and statute) and franchises;
provided, however, that the Company will not be required
to preserve any right or franchise if the Company determines
that the preservation thereof is no longer desirable in the
conduct of its business.
Calculation of Original Issue Discount. The Company shall
file with the trustee promptly at the end of each calendar year
a written notice specifying the amount of original issue
discount accrued on outstanding securities at the end of such
year and any other specific information as may then be relevant
under the Internal Revenue Code of 1986, as amended.
Additional Covenants. Any additional covenants of the
Company with respect to any series of debt securities will be
set forth in the prospectus supplement relating thereto.
Conversion Rights
The terms and conditions, if any, upon which the debt securities
are convertible into common stock or preferred stock will be set
forth in the applicable prospectus supplement relating thereto.
Such terms will include the conversion price (or manner of
calculation thereof), the conversion period, provisions as to
whether conversion will be at the option of the holders or the
Company, the events requiring an adjustment of the conversion
price and provisions affecting conversion in the event of
redemption of such debt securities and any restrictions on
conversion.
Redemption; Repurchase at the Option of the Holder; Sinking
Fund
The terms and conditions, if any, upon which (i) the debt
securities are redeemable at the option of the Company,
(ii) the holder of debt securities may cause the Company to
repurchase such debt securities or (iii) the debt
securities are subject to any sinking fund will be set forth in
the applicable prospectus supplement relating thereto.
Repurchases on the Open Market
The Company or any affiliate of the Company may at any time or
from time to time repurchase any debt security in the open
market or otherwise. Such debt securities may, at the option of
the Company or the relevant affiliate of the Company, be held,
resold or surrendered to the trustee for cancellation.
Discharge, Defeasance and Covenant Defeasance
The indenture provides, with respect to each series of debt
securities issued thereunder, that the Company may terminate its
obligations under such debt securities of a series and such
indenture with respect to debt securities of such series if:
(A)(i) all debt securities of such series previously
authenticated and delivered, with certain exceptions, have been
accepted by the applicable trustee for cancellation; or
(ii) the debt securities of such series have become due and
payable, or mature within one year, or all of them are to be
called for redemption within one year under arrangements
satisfactory to the applicable trustee for giving the notice of
redemption, (B) the Company irrevocably deposits in trust
with the applicable trustee, as trust funds solely for the
benefit of the holders of such debt securities, for that
purpose, money sufficient to pay the entire indebtedness on the
debt securities of such series to maturity or redemption, as the
case may be, and to pay all
8
other sums payable by it under such indenture, and (C) the
Company delivers to the applicable trustee an officers
certificate and an opinion of counsel, in each case stating that
all conditions precedent provided for in such indenture relating
to the satisfaction and discharge of such indenture with respect
to the debt securities of such series have been complied with.
With respect to the foregoing clause (i) and (ii),
certain obligations of the Company to the Trustee shall survive.
With respect to the foregoing clause (ii), the
Companys obligations to execute and deliver debt
securities of such series for authentication, to maintain an
office or agency in respect of the debt securities of such
series, to have moneys held for payment in trust, to register
the transfer or exchange of debt securities of such series, to
deliver debt securities of such series for replacement, to pay
additional amounts, if any, in certain circumstances, and with
respect to rights of conversion or exchange, if any, shall
survive until such debt securities are no longer outstanding.
Thereafter, only the Companys obligations to compensate
and indemnify the applicable trustee and its right to recover
excess money held by the applicable trustee shall survive.
The indenture provides that the Company (i) will be deemed
to have paid and will be discharged from any and all obligations
in respect of the debt securities issued thereunder of any
series, and the provisions of such indenture will, except as
noted below, no longer be in effect with respect to the debt
securities of such series and (ii) may omit to comply with
any term, provision, covenant or condition of such indenture,
and such omission shall be deemed not to be an event of default
under clause (d) or (f) of the first paragraph of
Events of Default with respect to the
outstanding debt securities of such series; provided that the
following conditions shall have been satisfied: (A) the
Company has irrevocably deposited in trust with the applicable
trustee as trust funds solely for the benefit of the holders of
the debt securities of such series, for payment of the principal
of and interest of the debt securities of such series, money or
government obligations or a combination thereof sufficient (in
the opinion of a nationally recognized firm of independent
public accountants expressed in a written certification thereof
delivered to the applicable trustee) without consideration of
any reinvestment to pay and discharge the principal of and
accrued interest on the outstanding debt securities of such
series to maturity or earlier redemption (irrevocably provided
for under arrangements satisfactory to the applicable trustee),
as the case may be; (B) such deposit will not result in a
breach or violation of, or constitute a default under, such
indenture or any other material agreement or instrument to which
the Company is a party or by which it is bound; (C) no
default with respect to such debt securities of such series
shall have occurred and be continuing on the date of such
deposit; (D) the Company shall have delivered to such
trustee an opinion of counsel as described in the indenture to
the effect that (1) the holders of the debt securities of
such series will not recognize income, gain or loss for Federal
income tax purposes as a result of the Companys exercise
of its option under this provision of such indenture and will be
subject to federal income tax on the same amount and in the same
manner and at the same times as would have been the case if such
deposit and defeasance had not occurred, and (2) after the
91st day after the establishment of such trust, the amounts in
such trust will not be subject to any case or proceeding in
respect of the Company under applicable bankruptcy, insolvency
or similar law; and (E) the Company has delivered to the
applicable trustee an officers certificate and an opinion
of counsel, in each case stating that all conditions precedent
provided for in such indenture relating to the defeasance
contemplated have been complied with. Subsequent to a legal
defeasance under clause (i) above, the Companys
obligations to execute and deliver debt securities of such
series for authentication, to maintain an office or agency in
respect of the debt securities of such series, to have moneys
held for payment in trust, to register the transfer or exchange
of debt securities of such series, to deliver debt securities of
such series for replacement, to pay additional amounts, if any,
in certain circumstances, and with respect to rights of
conversion or exchange, if any, shall survive until such debt
securities are no longer outstanding.
Applicable Law
The indenture provides that the debt securities and the
indenture will be governed by and construed in accordance with
the laws of the State of New York.
About the Trustee
Unless otherwise specified in the applicable prospectus
supplement, Citibank, N.A. is the trustee under the indenture.
9
DESCRIPTION OF CAPITAL STOCK
General
Under Intels second restated certificate of incorporation
(the certificate of incorporation), Intel is
authorized to issue up to 10 billion shares of common
stock. The common stock is not redeemable, does not have any
conversion rights and is not subject to call. Holders of shares
of common stock have no preemptive rights to maintain their
percentage of ownership in future offerings or sales of stock of
Intel. Holders of shares of common stock have one vote per share
in all elections of directors and on all other matters submitted
to a vote of stockholders of Intel. The holders of common stock
are entitled to receive dividends, if any, as and when declared
from time to time by the board of directors of Intel out of
funds legally available therefor. Upon liquidation, dissolution
or winding up of the affairs of Intel, the holders of common
stock will be entitled to participate equally and ratably, in
proportion to the number of shares held, in the net assets of
Intel available for distribution to holders of common stock. The
shares of common stock currently outstanding are fully paid and
nonassessable. As of January 27, 2006, there were
approximately 5,883 million shares of common stock issued
and outstanding.
Under the certificate of incorporation, Intel is authorized to
issue up to 50 million shares of preferred stock. The
preferred stock may be issued in one or more series, and the
board of directors of Intel is expressly authorized (i) to
fix the descriptions, powers, preferences, rights,
qualifications, limitations, and restrictions with respect to
any series of preferred stock and (ii) to specify the
number of shares of any series of preferred stock. As of
January 27, 2006, there were no shares of preferred stock
issued and outstanding.
Certain certificate of incorporation provisions
Intel has adopted a number of provisions in its certificate of
incorporation that might discourage certain types of
transactions that involve an actual or threatened change of
control of Intel. The provisions may make it more difficult and
time consuming to change majority control of the board of
directors and thus reduce the vulnerability of Intel to an
unsolicited offer, particularly an offer that does not
contemplate the acquisition of all of Intels outstanding
shares.
These provisions are intended to encourage persons seeking to
acquire control of Intel to initiate such an acquisition through
arms-length negotiations with Intels management and
board of directors. Additionally, such provisions provide
management with the time and information necessary to evaluate a
takeover proposal, to study alternative proposals and to help
ensure that the best transaction involving Intel is ultimately
undertaken. Nonetheless, the provisions could have the effect of
discouraging a third party from making a tender offer or
otherwise attempting to obtain control of Intel, even though
such an attempt might be beneficial to Intel and its
stockholders.
The certificate of incorporation contains a fair price provision
(the fair price provision) which requires that
mergers and certain other business combinations (business
combinations) involving Intel and persons beneficially
owning 5% or more of the outstanding shares of common stock (an
interested stockholder) either (i) meet certain
minimum price and procedural requirements, (ii) be approved
by a majority of the members of Intels board of directors
who are unaffiliated with the 5% stockholder and who were
directors before the stockholder became a 5% stockholder (the
disinterested directors) or (iii) be approved
by the holders of at least
662/3
% of the voting power of Intels outstanding voting
stock (voting stock).
10
Minimum price and procedural requirements. To consummate
a business combination based on the minimum price and procedural
requirements condition, all the following conditions must be
satisfied:
|
|
|
(a) Intels stockholders shall have the right to
receive cash for their shares if cash was paid by the interested
stockholder to acquire any shares of Intels stock, or any
interest therein, in the two years prior to the announcement of
the transaction; |
|
|
(b) The aggregate amount of the cash and the fair market
value (calculated in accordance with the fair price provision)
to be paid shall equal the higher of: (1) the highest price
per share paid by the interested stockholder in acquiring any
shares of voting stock during the five years prior to the date
of the consummation of the business combination (the
consummation date) or (2) the fair market value
per share of common stock on the date on which the interested
stockholder became an interested stockholder (the
determination date) or the consummation date
whichever is higher; |
|
|
(c) after the determination date and prior to the
consummation date (1) if Intel pays regular dividends,
Intel shall not have failed to pay dividends, reduced the annual
rate of dividends or failed to increase the rate of dividends to
reflect a reduction in the number of shares of voting stock,
unless approved by a majority of the disinterested directors;
(2) the interested stockholder shall not have acquired any
additional shares of voting stock, directly from Intel or
otherwise, in any transaction after the transaction pursuant to
which it became an interested stockholder and (3) the
interested stockholder shall not have received, at any time
after it became an interested stockholder, whether in connection
with the proposed business combination or otherwise, the benefit
of any loan or other financial assistance or tax advantage
provided by Intel (other than proportionately as a
stockholder); and |
|
|
(d) a proxy or information statement disclosing the terms
and conditions of the proposed business combination and
complying with the requirements of the proxy rules promulgated
under the Exchange Act must be mailed to all stockholders of
Intel at least 30 days before the consummation of a
business combination. The disinterested directors must be
provided in such proxy statement an opportunity to state their
views regarding the proposed business combination and to include
therewith an opinion of an independent investment banking firm
they have selected. |
662/3%
vote required to amend or repeal the fair price provision.
The certificate of incorporation requires the affirmative vote
of the holders of 66 2/3% or more of the outstanding voting
stock to amend, alter or repeal, or to adopt any provisions
inconsistent with, the fair price provision.
|
|
|
No action by stockholder consent |
Intels certificate of incorporation prohibits action that
is required or permitted to be taken at any annual or special
meeting of stockholders of Intel from being taken by the written
consent of stockholders without a meeting. This provision may be
altered, amended or repealed only if the holders of
662/3
% or more of voting stock vote in favor of such action.
|
|
|
Proposal to repeal certain provisions of our certificate
of incorporation |
Our proxy statement for our 2006 annual meeting contains a
stockholder proposal to remove the fair price provision from our
certificate of incorporation and to repeal the super-majority
vote provisions in our certificate of incorporation, including
those related to the fair price provision, certain amendments to
our certificate of incorporation and stockholder approval of a
compromise or arrangement between Intel and its creditors or
stockholders.
DESCRIPTION OF OTHER SECURITIES
We will set forth in the applicable prospectus supplement a
description of any warrants, depositary shares, purchase
contracts, guarantees or units that may be offered pursuant to
this prospectus.
11
PLAN OF DISTRIBUTION
The securities being offered by this prospectus may be sold by
us or by a selling securityholder:
|
|
|
|
|
through agents, |
|
|
|
to or through underwriters, |
|
|
|
through broker-dealers (acting as agent or principal), |
|
|
|
directly by us or a selling securityholder to purchasers,
through a specific bidding or auction process or otherwise, |
|
|
|
through a combination of any such methods of sale; |
|
|
|
through any other methods described in a prospectus supplement |
The distribution of securities may be effected from time to time
in one or more transactions, including block transactions and
transactions on the Nasdaq National Market or any other
organized market where the securities may be traded. The
securities may be sold at a fixed price or prices, which may be
changed, or at market prices prevailing at the time of sale, at
prices relating to the prevailing market prices or at negotiated
prices. The consideration may be cash or another form negotiated
by the parties. Agents, underwriters or broker-dealers may be
paid compensation for offering and selling the securities. That
compensation may be in the form of discounts, concessions or
commissions to be received from us or from the purchasers of the
securities. Dealers and agents participating in the distribution
of the securities may be deemed to be underwriters, and
compensation received by them on resale of the securities may be
deemed to be underwriting discounts. If such dealers or agents
were deemed to be underwriters, they may be subject to statutory
liabilities under the Securities Act.
Agents may from time to time solicit offers to purchase the
securities. If required, we will name in the applicable
prospectus supplement any agent involved in the offer or sale of
the securities and set forth any compensation payable to the
agent. Unless otherwise indicated in the prospectus supplement,
any agent will be acting on a best efforts basis for the period
of its appointment. Any agent selling the securities covered by
this prospectus may be deemed to be an underwriter, as that term
is defined in the Securities Act, of the securities.
If underwriters are used in a sale, securities will be acquired
by the underwriters for their own account and may be resold from
time to time in one or more transactions, including negotiated
transactions, at a fixed public offering price or at varying
prices determined at the time of sale, or under delayed delivery
contracts or other contractual commitments. Securities may be
offered to the public either through underwriting syndicates
represented by one or more managing underwriters or directly by
one or more firms acting as underwriters. If an underwriter or
underwriters are used in the sale of securities, an underwriting
agreement will be executed with the underwriter or underwriters
at the time an agreement for the sale is reached. The applicable
prospectus supplement will set forth the managing underwriter or
underwriters, as well as any other underwriter or underwriters,
with respect to a particular underwritten offering of
securities, and will set forth the terms of the transactions,
including compensation of the underwriters and dealers and the
public offering price, if applicable. The prospectus and the
applicable prospectus supplement will be used by the
underwriters to resell the securities.
If a dealer is used in the sale of the securities, we, a selling
securityholder, or an underwriter will sell the securities to
the dealer, as principal. The dealer may then resell the
securities to the public at varying prices to be determined by
the dealer at the time of resale. To the extent required, we
will set forth in the prospectus supplement the name of the
dealer and the terms of the transactions.
We or a selling securityholder may directly solicit offers to
purchase the securities and we or a selling securityholder may
make sales of securities directly to institutional investors or
others. These persons may be deemed to be underwriters within
the meaning of the Securities Act with respect to any resale of
the securities. To the extent required, the prospectus
supplement will describe the terms of any such sales, including
the terms of any bidding or auction process, if used.
12
Agents, underwriters and dealers may be entitled under
agreements which may be entered into with us to indemnification
by us against specified liabilities, including liabilities
incurred under the Securities Act, or to contribution by us to
payments they may be required to make in respect of such
liabilities. If required, the prospectus supplement will
describe the terms and conditions of such indemnification or
contribution. Some of the agents, underwriters or dealers, or
their affiliates may be customers of, engage in transactions
with or perform services for us or our subsidiaries in the
ordinary course of business.
Under the securities laws of some states, the securities offered
by this prospectus may be sold in those states only through
registered or licensed brokers or dealers.
Any person participating in the distribution of common stock
registered under the registration statement that includes this
prospectus will be subject to applicable provisions of the
Exchange Act, and the applicable SEC rules and regulations,
including, among others, Regulation M, which may limit the
timing of purchases and sales of any of our common stock by any
such person. Furthermore, Regulation M may restrict the
ability of any person engaged in the distribution of our common
stock to engage in market-making activities with respect to our
common stock. These restrictions may affect the marketability of
our common stock and the ability of any person or entity to
engage in market-making activities with respect to our common
stock.
Certain persons participating in an offering may engage in
over-allotment, stabilizing transactions, short-covering
transactions and penalty bids in accordance with
Regulation M under the Exchange Act that stabilize,
maintain or otherwise affect the price of the offered
securities. If any such activities will occur, they will be
described in the applicable prospectus supplement.
13
SELLING SECURITYHOLDERS
Information about selling securityholders, where applicable,
will be set forth in a prospectus supplement, in a
post-effective amendment, or in filings we make with the SEC
under the Exchange Act that are incorporated by reference.
LEGAL MATTERS
In connection with particular offerings of the securities in the
future, and if stated in the applicable prospectus supplements,
the validity of those securities will be passed upon for us by
Gibson, Dunn & Crutcher LLP, and for any underwriters
or agents by counsel named in the applicable prospectus
supplement.
EXPERTS
Ernst & Young LLP, independent registered public
accounting firm, has audited our consolidated financial
statements and schedule included in our Annual Report on
Form 10-K for the
year ended December 31, 2005, and managements
assessment of the effectiveness of our internal control over
financial reporting as of December 31, 2005, as set forth
in their reports, which are incorporated by reference in this
prospectus and elsewhere in the registration statement. Our
financial statements and schedule and managements
assessment are incorporated by reference in reliance on
Ernst & Young LLPs reports, given on their
authority as experts in accounting and auditing.
WHERE YOU CAN FIND MORE INFORMATION
We file annual, quarterly and current reports, proxy statements
and other information with the SEC under the Exchange Act. You
may read and copy any reports, statements or other information
on file at the SECs public reference room located at
450 Fifth Street, NW, Washington, D.C. 20549. Please
call the SEC at
1-800-SEC-0330 for
further information on the public reference room. The SEC
filings are also available to the public from commercial
document retrieval services. These filings are also available at
the Internet website maintained by the SEC at
http://www.sec.gov.
INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE
THIS PROSPECTUS INCORPORATES DOCUMENTS BY REFERENCE WHICH ARE
NOT PRESENTED IN OR DELIVERED WITH THIS PROSPECTUS. YOU SHOULD
RELY ONLY ON THE INFORMATION CONTAINED IN THIS PROSPECTUS AND IN
THE DOCUMENTS THAT WE HAVE INCORPORATED BY REFERENCE INTO THIS
PROSPECTUS. WE HAVE NOT AUTHORIZED ANYONE TO PROVIDE YOU WITH
INFORMATION THAT IS DIFFERENT FROM OR IN ADDITION TO THE
INFORMATION CONTAINED IN THIS DOCUMENT AND INCORPORATED BY
REFERENCE INTO THIS PROSPECTUS.
We incorporate information into this prospectus by reference,
which means that we disclose important information to you by
referring you to another document filed separately with the SEC.
The information incorporated by reference is deemed to be part
of this prospectus, except to the extent superseded by
information contained herein or by information contained in
documents filed with or furnished to the SEC after the date of
this prospectus. This prospectus incorporates by reference the
documents set forth below that
14
have been previously filed with the SEC. These documents contain
important information about us and our financial condition.
|
|
|
Intel SEC Filings (File No. 000-06217) |
|
Period |
|
|
|
Annual report on Form 10-K (including the portions of our
proxy statement for our 2006 annual meeting of stockholders
incorporated by reference therein)
|
|
Year ended December 31, 2005 |
Current reports on Form 8-K
|
|
Filed, January 19, 2006 and February 9, 2006. |
We also incorporate by reference into this prospectus additional
documents that we may file with the SEC under
Section 13(a), 13(c), 14 or 15(d) of the Exchange Act from
the date of this prospectus to the end of the offering of the
debentures. These documents may include annual reports on
Form 10-K,
quarterly reports on
Form 10-Q and
current reports on
Form 8-K, as well
as proxy statements. We are not incorporating by reference any
information furnished under items 2.02 or 7.01 (or corresponding
information furnished under item 9.01 or included as an
exhibit) in any past or future current report on
Form 8-K that we
may file with the SEC, unless otherwise specified in such
current report. Notwithstanding any statements to the contrary
in such report, we are not incorporating by reference our
current report on
Form 8-K filed
January 17, 2006 or March 3, 2006. As we announced on
March 3, 2006, Intels Business Outlook, published in
our Annual Report on
Form 10-K for the
year ended Dec. 31, 2005 no longer reflects our
expectations and should not be relied upon.
You may obtain copies of any of these filings through Intel as
described below, through the SEC or through the SECs
Internet website as described above. Documents incorporated by
reference are available without charge, excluding all exhibits
unless an exhibit has been specifically incorporated by
reference into this prospectus, by requesting them in writing,
by telephone or via the Internet at:
Intel Corporation
2200 Mission College Blvd., M/S SC4-203
Santa Clara, CA 95052-8119
Attn: Corporate Secretary
(408) 765-8080
www.intel.com
THE INFORMATION CONTAINED ON OUR WEBSITE DOES NOT CONSTITUTE A
PART OF THIS PROSPECTUS.
15